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Abstract 
Campylobacter is the leading cause of bacterial food-borne diarrheal disease worldwide, 
with the bacteria being  pathogens in humans and chickens. There are differences in the 
mechanistic understanding between Campylobacter strains, due, in part, to genomic and 
phenotypic strain diversity, which leads to inconsistent findings. This study aimed to 
understand underlying infection biology in host-pathogen interactions between 
populations of Campylobacter and the chicken host. A collection of Campylobacter 
jejuni strains were used to investigate the genotypic and phenotypic differences which 
yielded a diverse pan-geome of 2715 genes with genome wide association studies 
uncovering genes related to flagella assocaited with strains isolated from both humans 
and chickens. The C. jejuni strains were then used with a new commercially available 
chicken cell line to investigate the chicken systems with host responses measured in 
comparison to human systems. The pathogenic diversity of C. jejuni was measured 
through their inflammatory, cytotoxicity, adhesion, invasion and signalling responses in 
a high-throughput model using avian and human intestinal epithelial cells. C. jejuni 
induced IL-8 and CXCLi1/2 in human and avian epithelial cells, respectively, in a MAP 
kinase-dependent manner. In contrast, IL-10 responses in both cell types were PI 3-
kinase/Akt-dependent. C. jejuni strains showed diverse levels of invasion with high 
invasion dependent on MAP kinase signaling in both cell lines. C. jejuni induced 
diverse cytotoxic responses in both cell lines with cdt-positive isolates showing 
significantly higher toxicity. Blockade of endocytic pathways suggested that invasion 
by C. jejuni was clathrin- and dynamin-dependent but caveolae- independent in both 
cells. In contrast, IL-8 (and CXCLi1/2) production was dependent on clathrin, dynamin, 
and caveolae. Strong correlations were found between IL-8 with invasion and toxicity 
responses with GWAS being able to associated genes to expression of IL-8,-10 and 
level of invasion. Campylobacter strains were isolated from the caeca, ileum and liver 
and a pan-genome created with GWAS analysis discovering genes relating to iron 
transport and heat shock proteins in strains from the liver. Subsequently, caecal tonsils 
were extracted from chickens uninfected and chickens infected with a cocktail of six 
Campylobacter strains with a Campylobacter effect found where infected chickens 
produced significantly higher Th1, Th2 and Th17 cytokines. The work in this thesis 
contributes invaluable knowledge on the chicken innate immune system in response to 
Campylobacter and  how similar host defence pathways to humans are utlised. The 
diversity found strongly indicates that a „one strain fits all‟ approach to in vitro and in 
vivo experimental infections may not give accurate results on Campylobacter 
pathogenesis. Campylobacter isolates can use host immune responses to its advantage 
and to move from   the gut of chickens to infect edible tissues such as the liver. 
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Chapter 1: Introduction  
1.1 History of Campylobacter 
Campylobacter was first described in 1886 as a Vibrio-like organism in stool samples of 
infants by Theodor Escherich, who observed and described non-culturable spiral-shaped 
bacteria (Silva et al., 2011). Following this, in 1906, Vibrio-like organisms were 
identified by two British veterinarians who described the presence of a „large number of 
a peculiar organism‟ in the uterine mucus of a pregnant sheep (Zilbauer et al., 2008). In 
1913, McFadyean and Stockman isolated microorganisms from aborted bovine foetuses 
(Skirrow, 2006), and in 1927 Smith and Orcutt named a group of bacteria Vibrio jejuni; 
these were isolated from the faeces of cattle suffering from diarrhoea. Doyle in 1944, 
isolated a different „Vibrio’ from the faeces of pigs and classified the bacteria as Vibrio 
coli (Doyle, 1944; Vandamme et al., 2010). The genus Campylobacter was first 
proposed in 1963 by Sebald and Véron due to the low  guanine-cytosine content (GC-
content)of the bacteria, their microaerobic growth requirement and their non-
fermentative metabolism (On, 2001).  It took until 1973, for Belgium scientists  to first 
describe the isolation of  Campylobacter from human diarrhoeastool samples (Butzler et 
al., 1973). Later, Campylobacter spp. were  established as a common human pathogens 
(Altekruse et al., 1999; Skirrow, 1977).  
1.2 Campylobacter 
Campylobacter refers to a genus of microaerophilic, cytochrome oxidase positive, 
curved Gram-negative rods, which exhibit a characteristic corkscrew motility. There are 
currently 17 species and 6 sub-species within the genus (Parte, 2014).  
Campylobacter is the leading cause of bacterial food-borne diarrhoal disease 
worldwide, with symptoms ranging from mild diarrhoea to more serious infections that 
can result in chronic conditions such as reactive arthritis and neurological problems; 
especially in elderly people (Silva et al., 2011). It is frequently found in poultry, 
particularly in chicken, with the result that chicken-associated Campylobacter is a major 
cause of foodborne infection (PHE, 2017). In the UK alone, an estimated 700,000 cases 
of infection and more than 100 deaths can be attributed to Campylobacter annually 
(PHE, 2017). The cost to the UK economy is estimated to be £900 million (DEFRA, 
2012) but this may well be an underestimation, due to under-reporting of cases. In 
comparison, there were 8,630 confirmed laboratory cases of Salmonella in England and 
Wales in 2016 (PHE, 2018).  In the developed world, there are two main species that are 
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primarily responsible for human cases of Campylobacter,  which are also detected in 
poultry at retail sale (Silva et al., 2011). These are Campylobacter jejuni and 
Campylobacter coli. However, Campylobacter upsaliensis is also important in 
developing countries (Parkhill et al., 2000). 
1.3 Campylobacteriosis  
1.3.1 Human infections 
Campylobacter infection of humans is termed campylobacteriosis; with C. jejuni being 
the most commonly isolated species from stool samples (WHO, 2012). 
Campylobacteriosis is one of the most common bacterial infections in humans and is 
primarily attributed to a foodborne source. Each year almost 1 in 10 people fall ill from 
foodborne diseases which can be severe; especially in the young and elderly (WHO, 
2012). Campylobacter is 1 of 4 key global causes of diarrhoeal diseases, with ~550 
million people contracting the infection annually (WHO, 2012). It is estimated that 1% 
of the EU population is infected each year. Human  infections can come from several 
different sources; the most frequently reported is from contaminated chicken meat, as 
discussed above. However, cattle and sheep faeces and carcasses, wild birds and 
environmental waters (Figure 1.1) have been attributed as sources of human disease 
(Dasti et al., 2010; Kaakoush et al., 2015). 
The onset of campylobacteriosis symptoms occur usually within 2 to 5 days after 
infection with the bacteria, but the incubation period can sometimes range from 1 to 10 
days; with the most common clinical symptoms being diarrhoea, severe abdominal pain, 
high fever, headache and nausea. Symptoms can last from 3 to 6 days, with most cases 
being self-limiting. While death from campylobacteriosis is not common; young 
children, elderly and immunocompromised patients, such as those suffering from AIDS, 
are the most at risk (European Food Standards Agency, 2018; WHO, 2018). 
Campylobacteriosis can sometimes cause complications such as bacteraemia, hepatitis, 
pancreatitis and miscarriage with various degrees of frequency. Post-infection 
complications have also been reported which include; reactive arthritis and neurological 
disorders such as Guillain-Barré syndrome (European Food Standards Agency and 
Agency, 2014; WHO, 2012). 
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1.3.1 Chickens and Campylobacter 
Campylobacter jejuni strains can cause disease in chickens and Ruiz-Palacios et al., 
(1981) were the first to show that the bacterium  causes diarrhoea in these animals. 
Sanyal et al ., (1984) also demonstrated that C. jejuni causes diarrhoea in infant 
chickens and that damage to the gut mucosa resulted in extra-intestinal spread of the 
bacteria to the blood, spleen and liver. Chickens infected with Campylobacter have been 
shown to have poorer performance than non-infected animals and can develop hock 
marks and pododermatitis, indicators of poor gut health (Humphrey et al., 2014; Ruiz-
palacios et al., 1981; Williams et al., 2013).  Inflammation and damage of the gut 
mucosa have also been observed in infected chickens (Awad et al 2014; Humphrey et 
al., 2014).                    .                                                                                                                                                            
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Figure 1.1. Source and transmission routes of Campylobacter in human and animal reservoirs with the main sources of infection attributed 
to poultry and cattle with rarer transmission from wild birds.
Chicken Meat  Meat/Milk 
Cattle 
Wild Birds 
Chicken 
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1.4 Campylobacter in different hosts 
Many species of Campylobacter have been observed to be specific to one host, such as 
Campylobacter rectus isolated only from humans and Campylobacter mucosalis which 
is found in pigs (Rams et al., 1993; Roop et al., 1985; van der Walt et al., 1988). In 
contrast, other species such as C. jejuni and C. coli, have been isolated from many 
different hosts (Figure 1.1)  including: humans, chickens, cattle, wild birds and many 
different water sources such as groundwater, sewage and untreated drinking water, 
suggesting a more generalist nature (Ogden et al., 2009; Pielsticker et al., 2012). The 
advancement in genomic techniques over the past decade has led to the characterisation 
of thousands of Campylobacter isolates using Multilocus sequence typing (MLST) 
which has identified clonal complexes and sequence types (STs) that are usually only 
sampled from the gut of a single host species and can be termed „host specialists‟; 
which include „chicken specialists‟ such as STs-661, -573, -574, -607, -443, -460, -283 
and ST-257 and „cattle specialists‟ such as STs-61 and -42 (Dearlove et al., 2016; 
Pascoe et al., 2015). Other STs, such as -45 and -21 clonal complexes have been found 
in multiple host species and can be termed „host generalists‟ (Sheppard et al., 2011).  
Analysis of Campylobacter populations show that certain clusters may be differentiated 
by their host sources (Colles et al., 2008; McCarthy et al., 2007; Sheppard et al., 2010b, 
2010a). 
1.5 Campylobacter Genomics 
Campylobacter jejuni strain 11168 was the first sequenced in 2000 by the Sanger Centre 
and this showed that it had 1,641,481 base pairs, containing 1,654 protein coding genes. 
Sequencing of this C. jejuni also revealed that the bacterium has hypervariable 
sequences, which may be important as a survival strategy (Parkhill et al., 2000).  
Campylobacter coli and C. jejuni have naturally high transformation rates of 1/1000 and 
1/10,000 bacterial cells respectively (Wang and Taylor, 1990). This ability to 
incorporate foreign DNA into the genome has a major influence on the population 
genomics and evolution of the species (Wilson et al., 2009). MLST data have shown 
that Campylobacter populations are subject to high levels of horizontal gene transfer 
within and between species and they display partial clonality, where strains with similar 
genotypes form clusters, known as clonal complexes, which contain related sequence 
types (STs) (Sheppard et al., 2008; Smith et al., 1993).  
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Campylobacter populations are highly structured into clusters of related lineages, which 
include deep branching clades, with regards to C. coli, and clonal complexes of isolates 
that share four or more alleles at seven MLST loci (Dingle et al., 2001; Sheppard et al., 
2008).  
1.6 Isolation and identification of Campylobacter 
Campylobacter can be isolated by direct culture onto selective agars or put through an 
enrichment process and then plated onto a selective medium such as blood-free selective 
medium (CCDA) and incubated microaerobically for 24-48h at 42
o
C. Colonies on the 
selective agar are scrutinised for the characteristic moist translucent appearance, Gram 
stained and confirmed further through a positive oxidase test (Health Protection 
Agency, 2013) and a lack of growth in air on blood agar. 
Further identification of Campylobacter can also be undertaken using established 
molecular methods such as pulsed field gel electrophoresis (PFGE) and MLST together 
with whole genome sequencing (WGS) (Health Protection Agency, 2013). PFGE can 
detect variation between different strains using rare-cutting restriction endonucleases 
and the resultant fragments can then be separated based on their size on an agarose gel. 
PFGE can be used to characterise isolates related epidemiologically from an outbreak 
due to its nature of being highly discriminatory (Ribot et al., 2001). PFGE has been 
used successfully to identify Campylobacter and characterise subtypes of C. jejuni 
(Ribot et al., 2001). 
MLST determines variations in DNA sequences in a set of housekeeping genes and 
characterises strains by their unique allelic profiles. The housekeeping genes used for 
MLST for C. jejuni and C. coli are aspA, glnA, gltA, pgm, tkt and uncA which encode 
for aspartate, ammonia-lyase, glutamine synthetase, citrate synthase, 2,3-
bisphosphoglycerate-independent phophoglycerate mutase, transketolase and ATP 
synthase alpha subunit respectively (Dingle et al., 2001). MLST involves PCR 
amplification followed by DNA sequencing, which yields nucleotide differences 
between strains, which can be checked at a variable number of genes. MLST detects all 
the nucleotide polymorphisms within a gene rather than just non-synonymous changes 
that alter the electrophoretic mobility of the protein product and thus is a highly 
discriminatory technique. MLST has been used successfully to differentiate strains and 
identify clonal lineages of Campylobacter species; such as C. jejuni, C. coli, C. fetus 
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and emerging species such as C. curvus and C. concisus (Dingle et al., 2005; Miller et 
al., 2012). MLST comes with disadvantages for laboratory testing, as there are 
substantial costs and work required to amplify, determine and proof read the nucleotide 
sequence of the target DNA fragments (Dingle et al., 2001, 2005; Health Protection 
Agency, 2013). 
WGS is a method by which the complete DNA sequence of an organism‟s genome is 
determined and has been used to sequence the complete genome of C. jejuni (Parkhill et 
al., 2000). The process of WGS sequences all chromosomal DNA as well as that 
contained in plasminds (Parkhill et al., 2000).  WGS has been suggested to be able to 
connect strains epidemiologically from the same infection source despite the incident 
being identified originally as a sporadic infection (Kovanen et al., 2014). Advances in 
sequencing technology have led to lower WGS costs and the ability to produce large 
volumes of sequence data. WGS can identify a broad range a variants and can identify 
SNPs, stuructural variants, copy number variants and repeat expansion which yields 
more accurate sequence information (Heather and Chain, 2016; Levy and Myers, 2016; 
Schwarze et al., 2018). 
1.7 Virulence 
C. jejuni has six important gene functions that determine its pathogenic potential, 
including: i) motility, ii) attachment, iii) invasion and internalisation, iv) intracellular 
survival, v) metabolic and environmental regulation, vi) endotoxin and exotoxin 
production (Bolton, 2015).  
1.7.1 Motility 
C. jejuni is a highly motile organism which utilizes unipolar and bipolar flagella, which 
are very important for infection/colonisation in humans and other animals (Guerry, 
2007). This process is regulated by a complex chemotaxis system that allows the 
organism to swim toward attractants and away from repellents (Lertsethtakarn et al., 
2011). 
Type III secretion systems (T3SS) are complex macromolecular structures which allow 
gram-negative bacteria to secrete proteins across the inner and outer membranes without 
a periplasmic intermediate. Classical T3SS in bacteria such as Salmonella allow the 
bacteria to deliver effector proteins from the bacteria cytosol directly to the cytosol of a 
target cell. These delivered effector proteins modulate host cell behaviour to facilitate 
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uptake of the bacteria (Neal-McKinney and Konkel, 2012). The classical T3SS are 
comprised of a protein complex, which spans both bacterial membranes, which is 
attached to a needle complex that extends from the cell. The needle complex contains 
translocon proteins in a hollow conduit at the tip which incorporate into the membrane 
of the host cell, thus allowing for delivery of effector proteins into the host cytosol 
(Guerry, 2007; Neal-McKinney and Konkel, 2012).   
The flagellum in Campylobacter, which is a T3SS with components homologous to the 
classical T3SS, is comprised of a basal body, hook and filament (Neal-McKinney and 
Konkel, 2012). The basal body spans both bacterial membranes attached to the hook 
which is a curved conduit. The hook is composed primarily of the protein FlgE with 
hook-filament proteins FlgK and FlgL at its cap. The flagellar T3SS can change its 
export specificity to allow secretion of FlaA and FlaB which go on to form the flagellar 
filament (Guerry, 2007; Lertsethtakarn et al., 2011; Matsunami et al., 2016; Neal-
McKinney and Konkel, 2012; Samuelson et al., 2013). The flagella can also function to 
secrete non-flagellar proteins which help module virulence such as CiaC (Neal-
McKinney and Konkel, 2012; Poly, 2008).  
The flagella of Campylobacter are composed of major and minor flagellin sub-units, 
FlaA and FlaB, which are regulated by σ28 dependent and σ54-dependent promoters, 
respectively (Guerry, 2007). Expression of flagella in C. jejuni is mediated by FlgS, a 
σ54 sensor kinase and FlgR, a σ54 response regulator (Hendrixson and Dirita, 2003). 
Another protein, FlaC, is highly conserved among C. jejuni strains and its gene was 
thought originally to be a third flagellin based on amino acid carboxy region similarities 
with FlaA and FlaB (Faber et al., 2015; Guerry, 2007). FlaC also requires a flagellar 
structure to be present before it can be secreted and has been proposed to act as a 
secreted effector protein which modulates the immune response in the intestinal tract 
and may contribute to the persistence of the Campylobacter in the gut (Faber et al., 
2015).The two other flagellin genes, flaA and flaB, are arranged in tandem. The flaA 
gene is essential for adherance and invasion of epithelial cells, and 
colonisation/infection of the gastrointestinal tract (Jain et al., 2008). C. jejuni possesses 
a flagellum that is made up of an O-linked glycosylated flagellin; a two component 
system compromising the sensor FlgS and the response regulator FlgR which is central 
for the regulation of the Campylobacter flagellum (Silva et al., 2011). 
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Campylobacter flagellar are heavily glycosylated up to 19 times, with changes in the 
glycan composition affecting the autoaggulation and microcolony formation on the 
intestinal epthelial cells which contribute to virulence (Merino and Tomás, 2014).  
Chemotaxis is the mechanism by which Campylobacter and other bacteria sense and 
move toward more favourable conditions and/or nutrients (Lertsethtakarn et al., 2011). 
In the chicken gut C. jejuni uses chemotaxis to locate the mucus filled crypts to 
proliferate (Chang and Miller, 2006). The primary chemoattractants are mucins and 
glycoproteins, which make up the mucus in the chicken gut (Hermans et al., 2012). 
Many chemoattractants for Campylobacter have been found, including some metabolic 
substrates such as: L-aspartate, L-asparagine, L-cysteine, L-glutamate, pyruvate and L-
serine, as well as electron donors and electron acceptors including L-malate, succinate, 
fumarate, nitrite, and nitrate (Guccione et al., 2008; Mohammed et al., 2004; 
Velayudhan et al., 2004; Weingarten et al., 2008; Westfall et al., 1986). There are also 
substances which repel Campylobacter such as bile salts (Beery et al., 1988; Negretti et 
al., 2017). The sensing of chemoattractants and chemorepellents is mediated by methyl-
accepting chemotaxis proteins which possess a large cytoplasmic signalling and 
adaption domain and a periplasmic ligand interaction domain. There are four proteins, 
CheA, CheY, CheW and CheZ, which are responsible for transduction of the signal 
from the receptors of the flagellar motor (Lertsethtakarn et al., 2011). 
1.7.2 Adhesion 
Campylobacter adheres to host gastrointestinal epithelial cells, aiding colonisation and 
potentiating infection. This is mediated by several adhesins (Table 1.1) on the bacterial 
cell surface (Bolton, 2015; Jin et al., 2001). Campylobacter is able to adhere to 
fibronectin in the extracellular matrix, and this is mediated by CadF, a 37kDa 
fibronectin-binding outer membrane protein, encoded by the cadF gene (Hofreuter et 
al., 2006).  The binding of Campylobacter to fibronectin triggers a signalling process 
that leads to the activation of the GTPases Rac1 and Cdc42 which induce 
Campylobacter invasion and cell internalisation (Bolton, 2015).  
Genes such as peb1a, peb3 and peb4 may also have a function in adhesion. peb1a, 
which encodes a 21-kDa periplasmic binding protein has been found commonly in C. 
jejuni strains (Bolton, 2015). peb3, a transport protein is involved in the utilisation of 3-
phophoglycerate (Min et al., 2009), peb4 has a main function as a chaperone protein, 
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with an important role in exporting proteins such as CapF to the outer membrane (Kale, 
2011). 
Campylobacter adhesion protein (CadA), encoded by cadA, appears more multi-
functional than its name would suggest being involved as either an autotransporter 
lipoprotein or as a putative protein with a role in either adhesion or invasion (Ashgar et 
al., 2007; Flanagan et al., 2009; Jin et al., 2001). FlpA, encoded by flpA, has  a role in 
binding fibronectin and may act along with CadF during C. jejuni adhesion and invasion 
(Eucker and Konkel, 2012). Another protein with involvement in adhesion is a 42-kDa 
lipoprotein encoded by jlpA which appears to bind to a 90-kDa heat shock protein host 
cell receptor (Jin et al., 2003) . 
 
 
 
Table 1.1. Factors and genes which have been previously shown to play a role in the 
adhesion of Campylobacter to the host gut epithelia 
Adhesion Factor Encoding 
Gene 
Reference 
CadF, Outer Membrane protein cadF (Konkel et al., 1997) 
CapA, Campylobacter adhesion protein A  capA (Jin et al., 2001) 
Phopholipase A. pldA (Ziprin et al., 2001) 
Peb1, periplasmic binding protein pebA1 (Flanagan et al., 2009) 
Peb3, transport protein peb3 (Min et al., 2009) 
Peb4, chaperone involved in exporting proteins 
to the outer membrane 
peb4 (Kale, 2011) 
Lipoprotein jlpA (Jin et al., 2001) 
FlpA, fibronectin-like protein A flpA (Flanagan et al., 2009) 
1.7.3 Invasion and internalisation 
There are two proposed mechanisms currently by which C. jejuni could invade a host 
epithelial cell, the „trigger‟ and „zipper‟ ones (Figure 1.2). The „Zipper‟ mechanism 
begins with one or more bacterial surface proteins, commonly comprising surface 
adhesins and invasins such as CadF, JlpA and FlpA, which bind to specific host cell 
receptors followed by internalisation (Figure 1.2a). In contrast the „Trigger‟ mechanism 
involves type-III and type-IV secretion systems (T3SSs and T4SSs) injecting bacterial 
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proteins, such as cytolethal distending toxin (CDT) and CiaI, which can hijack or mimic 
specific host cell factors triggering the bacterial uptake process (Figure 1.2b; (O Cróinín 
and Backert, 2012). 
Initiation of the „Zipper‟ mechanism begins when bacterial pathogens adhere to the 
intestinal epithelium, the bacterial surface adhesins, such as CadF, bind to their cognate 
receptors on cells with high affinity, which then initiates the cytoskeleton-mediated 
„zippering‟ of the host cell‟s plasma membrane around the bacterium (Figure 1.2a). The 
bacterium is then internalised into a vacuole (Figure 1.2a) (O Cróinín and Backert, 
2012). Initiation of the „Trigger‟ begins with interaction with the host intestinal 
epithelium through fibronectin binding domains present  in CadF and FlpA. 
Campylobacter then use sophisticated T3SSto inject various effector proteins, such as  
Cia (Konkel et al., 1999, 2004), into the host cells cytoplasm. These effector proteins 
modulate a wide range of signalling events including the activation of small Rho 
GTPases and cytoskeletal reorganisation to induce membrane ruffling and then bacterial 
uptake (Figure 2b). As a result of the signalling, the bacteria are internalised into a 
vacuole (Figure 2b) (O Cróinín and Backert, 2012). It is unclear which mechanism C. 
jejuni employs to invade a cell; some studies have shown that it induces membrane 
ruffling in a contact-dependent manner followed by host cell entry; first with its 
flagellar tip followed by the opposite flagellar end which seems to share features of both 
the „zipper‟ and „trigger‟ mechanisms (Boehm et al., 2011; Krause-Gruszczynska et al., 
2007). 
The flagella T3SS are able to deliver the gene products of flaC and cia into the cell‟s 
cytoplasm which is very important for colonisation and invasion into epithelial cells 
(Konkel et al., 2004).  CiaC, encoded by ciaC, is required for invasion into host cells, 
while CiaI, encoded by ciaI, has been reported to be required for intracellular survival 
of C. jejuni after invasion (Table 1.2; (Buelow et al., 2011; Eucker and Konkel, 2012). 
The invasion-associated proteins are encoded by iamA, and their exact role in the 
process is still unclear (Rivera-Amill et al., 2001), while, HtrA, encoded by htrA, may 
be used as a chaperone protein which affects folding of adhesins (Bæk et al., 2011). 
C. jejuni strains with mutations in glycosylation pathways have been shown to have 
defects in their ability to adhere to and invade host cells (Kakuda and DiRita, 2006; 
Szymanski et al., 2002). Invasion by C. jejuni has also been shown to occur due to its 
ability to activate MAP kinases leading to the production of pro-inflammatory cytokine 
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Interleukin-8 (IL-8; (Hickey et al., 2000). Indeed, bacterial internalisation into intestinal 
epithelial cells is very important in C. jejuni pathogenesis (Watson and Galán, 2008). C. 
jejuni is internalised into intestinal epithelial cells in a microtubule-dependent, actin-
independent fashion which is very different from many other bacterial pathogens, such 
as Salmonella Typhimurium and Shigella flexneri, which use the host cell actin 
cytoskeleton to gain intracellular access (Watson and Galán, 2008). 
 
Table 1.2. Factors which affect invasion of C. jejuni into epithelial cells and their 
encoding genes. 
Invasion Factor Encoding 
Gene 
Reference 
CiaB, Campylobacter invasion antigen ciaB (Konkel et al., 
2004) 
CiaC, Campylobacter invasion antigen CiaC (Christensen et al., 
2009) 
CiaI, May be required for survival 
intracellularly 
CiaI (Buelow et al., 
2011) 
HtrA, chaperone protein involved in folding of 
adhesins 
htrA (Bæk et al., 2011) 
IamA, Invasion associated protein iamA (Carvalho et al., 
2001) 
FspA, role in apoptosis fspA (Poly et al., 2007) 
ABC transporter ATP-binding protein iamA (Rivera-Amill et al., 
2001) 
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Figure 1.2. Visual representation of the 'zipper' (a) and 'trigger' (b) mechanisms C. jejuni 
uses to invade a host cell 
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1.7.4 Intracellular survival 
After internalisation into epithelial cells, C. jejuni remains within the membrane bound 
compartment. With time, it becomes either oxygen sensitive or may change its 
respiratory pathway so that it can no longer grow in the presence of oxygen. The 
compartments within which C. jejuni survives are distinct from lysosomes and are 
termed vacuoles. They acquire different markers transiently such as Rab7, of the 
endocytic pathway, and survive in a compartment that is functionally separated from the 
canonical endocytic one involved in host defence (Cossart and Sansonetti, 2004). C. 
jejuni has been shown to survive within intestinal epithelial cells by preventing fusion 
of lysosomes, thus manipulating the canonical endocytic pathway to generate a unique 
intracellular compartment conducive for survival (Watson and Galán, 2008). C. jejuni 
containing vacuoles are inaccessible to endocytic tracers, which could show that they 
are functionally separate from the normal endocytic pathways leading to lysosomes. 
This suggests that C. jejuni has evolved specific adaptations to traffic in the host cell to 
avoid delivery into the lysosome and therefore survive within the cell (Watson and 
Galán, 2008). 
1.7.5. Metabolic and environmental regulation 
Campylobacter can survive under different environmental and host stressors. For 
instance, iron acquisition plays an important role in the virulence of Campylobacter 
through the use of heme compounds such as ferric iron to sustain nutrients within the 
host (Bolton, 2015; Braun, 2001; Hermans et al., 2011). Iron is very important for 
anaerobic respiration, electron transport and energy metabolism (Braun, 2001). Another 
virulence factor which plays a role in Campylobacter is superoxide dismutase which 
helps to remove the reactive oxygen species superoxide which damages cellular DNA, 
proteins and membranes (Nakajima et al., 2014; Purdy et al., 1999).   
Increasingly, antibiotic resistance has been observed in Campylobacter, with resistance 
to erythromycin, tetracycline, ciprofloxacin, kanamycin, chloramphenicol and nalidixic 
acid commonly occurring, which may help the survival and virulence of the bacteria 
within the host environment (Bolton, 2015; Silva et al., 2011).  
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1.7.6 Endotoxin and exotoxin production 
1.7.6.1 Endotoxin production  
Campylobacter also contain virulence factors based on its cell wall; lipopolysaccharides 
(LPS) and lipooligosaccharides (LOS) in the outer membrane help to contribute to 
adhesion as well as in evasion of the host immune system. Campylobacter are able to 
change the antigen composition of LOS/LPS which makes it more difficult for the host 
immune system to detect the pathogen (Ang et al., 2002; Bax et al., 2011). An important 
pathogenicity factor in Guillian-Barré syndrome is the sialic acid that is contained in the 
core oligosaccharide of Campylobacter which resembles gangliosides which can cause 
the neurological disease by initiating specific TH differentiation programs (Ang et al., 
2002; Bax et al., 2011). 
1.7.6.2 Exotoxin production 
Many strains of Campylobacter have the ability to produce toxins, which affect host 
cells in multiple ways (Wassenaar, 1997). Campylobacter has two types of toxins, 
entero- and cytotoxins (Albert et al., 2007; Lin et al., 2011; Thelestam and Frisan, 2004; 
Wassenaar, 1997). Enterotoxins such as CDT bind to cellular receptors; enter the host 
cell and are able to elevate intracellular cyclic adenosine monophosphate (AMP) levels. 
In contrast, cytotoxins are secreted proteins that kill target cells. They act intracellularly 
and form pores in the cells, showing a different mechanism of toxicity. They involve 
either inhibition of cellular protein synthesis or actin filament formation (Khan, 2005; 
Silva et al., 2011; Wassenaar, 1997).  
One of the main toxins produced by C. jejuni is CDT, which causes direct DNA damage 
leading to the activation of checkpoint pathways and eventual cell death (Lee et al., 
2003). CDT has been further classified as a genotoxin which consists of three protein 
subunits; CdtA, CdtB and CdtC encoded by the genes cdtA, cdtB and cdtC. Expression 
of all three genes is required in order to produce an active form of CDT (Gargi et al., 
2012; Lai et al., 2016; Pickett et al., 1996). CdtB is a DNase that causes DNA double-
strand breaks in the host cell nucleus resulting in cell cycle arrest at the G2/M stage of 
the cell cycle causing apoptosis (Lai et al., 2016). CdtA and CdtC bind to cholesterol-
rich micro-domains on the cytoplasmic membrane which are required for CdtB uptake 
into cells; the mechanism by which CdtA and CdtC interact with cholesterol remains 
unclear (Lai et al., 2016). Some Campylobacter strains have also been shown to have 
haemolytic properties (Wassenaar, 1997).  
15 
 
1.8 The Epithelial cell 
The surface of the gastrointestinal tract (GI) is covered by a single layer of epithelium 
that separates the intestinal tissue from the lumen of the intestine (Kunisawa and 
Kiyono, 2013). Intestinal epithelial cells (IECs), which form the barrier between the 
lumen of the gut and underlying tissues are short-lived and are renewed continuously, a 
process relying on proliferative stem cells which reside in the crypt base of the intestinal 
glands. The new cells are formed at the base and migrate upwards out of the crypt 
which eventually leads to apoptosis of the old ones and thus there is a constant number 
of epithelial cells in the gut (van der Flier and Clevers, 2009). Epithelial cells are 
responsible for apical uptake of nutrients and their transfer to the basolateral membrane 
for distribution to body tissues through the circulation (Klunder et al., 2017). IECs also 
perform another vital role in that they are the first line of defence against potential 
pathogens passing through the gastrointestinal tract while also maintaining relationships 
with commensal microbiota which play large roles in normal gut health. The defence 
against pathogens is achieved in part by the physical barriers of the epithelium including 
tight junctions (TJs) and mucus layers (Kunisawa and Kiyono, 2013). Intestinal tissues 
show intense immunological activity with IECs contributing to the intestinal immune 
system through transport and processing of antibodies and antigens, by interacting with 
immunocompetent cells, such as lymphocytes, in the intestine and by producing 
immunologically functional molecules including cytokines and antimicrobial peptides 
(Kunisawa and Kiyono, 2013).   
IECs are arranged in a monolayer of columnar shaped polarised epithelial cells and 
communicate with the environment through many receptors, transporters and channels 
on the surface, made up of an apical and a basolateral domain.  The basolateral cell-
surface can be divided further into a basal and lateral which face the basement 
membrane and neighbouring cells, respectively (Klunder et al., 2017). Claudin-based 
TJs, E-cadherin-based adherens junctions (AJs) and intercellular adhesions, are located 
on the lateral surface which give the monolayer strength and impermeability (Giepmans 
and van IJzendoorn, 2009). TJs are composed of many interacting cellular proteins, 
such as claudin and occludin. Claudin and occuldin are transmembrane proteins that 
bridge the gap and seal the space between parallel IECs. There are numerous types of 
claudins expressed in the intestinal epithelium including, claudin -1, -2, -3, -4, -5, -7, -8, 
-12, -15, -18, -20 and -23 (Tamura et al., 2008; Ulluwishewa et al., 2011).  Integrin-
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based cell matrix adhesions are found on the basal surface, by which the cells are 
attached the basement membrane (Klunder et al., 2017).  
1.9 Mucosal Immunity 
1.9.1 The human gut 
Mucosal membranes are integral part of the gut and are major sites of entry for many 
pathogens (Bamias et al., 2014; Owen et al., 2013; Perez-Lopez et al., 2016). They  are 
protected by a group of organised lymphoid tissues known as mucosa-associated 
lymphoid tissue (MALT) and specifically the gut-associated lymphoid tissue (GALT) in 
the intestinal walls (Owen et al., 2013; Zucca and Bertoni, 2016).  
Lymphoid cells are found in various regions within the intestine; such as intraepithelial 
lymphocytes (IELs), many of which are T cells, specifically in the outer mucosal 
epithelial layer. The mucus layer overlying the epithelium secreted by goblet cells 
promotes elimination of gut contents and provides first line defense against physical and 
chemical injury caused by food and microbes (Kim and Ho, 2010).  The lamina propria, 
which is under the epithelial layer, contains high quantities of B cells, and activated 
plasma cells and macrophages (Bekiaris et al., 2014; Owen et al., 2013). An example of 
the extensive MALT system in the intestine are Peyer‟s patches; made up of nodules of 
30 to 40 lymphoid follicles which extend into the muscle layers that are just below the 
lamina propria (Yasuda et al., 2002). The functional importance of MALT in the body‟s 
defence is emphasised by its large population of antibody-producing plasma cells as 
well as some activities and cellular structures which are unique to it. Delivery of small 
samples of foreign antigens from the intestinal tracts to the underlying MALT is 
achieved by specialised M cells (Kanaya and Ohno, 2014). These have „deep pockets‟ 
in the basolateral plasma membrane which contain clusters of B and T cells and 
macrophages which allow them to gain access to antigen. Antigens in the intestinal 
lumen are endocytosed into vesicles that are transported from the lumen to the 
underlying „pocket‟ where they then fuse with the membrane, delivering the antigen to 
clusters of lymphocytes and dendritic cells within the pocket (Banchereau et al., 2000). 
Antigens which are transported by M cells ultimately lead to the activation of B cells, 
which can then differentiate and secrete IgA, an antibody with a critical role against 
infection at mucosal sites (Fagarasan and Honjo, 2003). IgA has the ability to neutralise 
both toxins and pathogens, continually interacting with commensal bacteria on the 
mucosal surfaces preventing them from entering the bloodstream (Fagarasan and Honjo, 
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2003). IgA can exist either in a monomeric form, usually in circulation, or form dimers 
and polymers in mucosal tissues. The dimeric and polymeric forms can bind to 
receptors, such as TLR4 and TLR5, on epithelial cells which can trigger endocytosis 
and transportation of molecules such as antigens from the basolateral to apical side of 
the epithelial cell and into the tissue lumen (Fagarasan and Honjo, 2003). In humans, 
two subclasses of IgA exist: IgA1, found in serum and IgA2, found more commonly in 
secretions (Lavelle et al., 2010; Lim et al., 2011; Mcdermott and Huffnagle, 2014; 
Owen et al., 2013; Perez-Lopez et al., 2016).  
Paneth cells are highly specialised epithelial cells present along the small intestine in the 
crypts of Liberkuhn, tiny invaginations that line the mucosal surface. Paneth cells 
secrete antimicrobial peptides and proteins  which are key mediators of host-microbe 
interactions such as colonisation of microbiota and innate immune protection from 
enteric pathogens (Clevers and Bevins, 2013). 
1.9.2 The chicken gut 
The GI of chickens is much shorter than that of mammals relative to body length, thus 
the digesta move through it more rapidly (Pan and Yu, 2014). The short retention time 
selects for bacteria with „strong‟ adhesion properties to the mucosal layer. However, 
attached to the chicken colon are two caeca, made up of two pouches, the contents of 
which have quite slow turnover  rates, and when the animal is well provide optimal 
conditions for a diverse microbiome that can have a large impact on host health (Pan 
and Yu, 2014).  
 
The GALT in chickens consist of similar structures to those seen in mammals with 
organised tissues including single and multiple lymphoid follicles, lamina propria 
lymphocytes, Peyer‟s patches and various lymphoid aggregates across the GI tract 
(Befus et al., 1980; Brisbin et al., 2008; Casteleyn et al., 2010). The Peyer‟s patches in 
chickens have similar roles to those in mammals, which includes antigen sampling, 
although they are not as prominent in the chicken GI tract (Vaughn et al., 2006). 
Chickens also contain caecal tonsils, the largest lymphoid organ in the chicken gut 
located in the caecum-rectum junction (Figure 1.3) (Casteleyn et al., 2010; Kitagawa et 
al., 1998). 
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Chickens and other avianspecies have a unique Bursa of Fabricius and a Meckel‟s 
diverticulum. The bursa of Fabricius is located behind the cloaca and is the site of 
primary B cell development in chickens (Yasuda et al., 2002).  The organ acts as both a 
primary lymphoid organ and a secondary one, as the mucosal and submucosal regions 
of the bursal canal contain multiple lymphoid follicles (Muir et al., 2000). Meckel‟s 
diverticulum is a remnant of the yolk sac present in the small intestine and its precise 
function is still somewhat unclear although it may be an induced lymphoid organ (Muir 
et al., 2000; Oláh et al., 1984). Lymphoid aggregates, which are normally found 
scattered throughout the epithelium and the lamina propria, possess a morphologically 
distinct epithelial layer called the follicle-associated epithelium (FAE). M cells are 
found within the FAE which have a similar function of transporting antigens from the 
lumen to follicular environments, as seen in mammalian cells (Brisbin et al., 2008). The 
lamina propria contains a variety of cell types including plasma cells, effector and 
memory lymphocytes, macrophages and granulocytes.  
 
The intestinal epithelium of chickens has a similar composition to mammalian systems 
containing M cells along with intra-epithelial lymphocytes (IEL), which are distributed 
throughout the intestinal epithelium, goblet cells and paneth cells (Wang et al., 2016). 
The IEL comprise a diverse population of lymphocytes which include B cells, T cells 
and natural killer cells (Göbel et al., 2001). In chickens, IgA is present in monomeric, 
dimeric and polymeric forms in sera and intestinal and mucosal secretions. However, in 
serum the concentration of IgA is much lower than that found in secretions (Fagarasan 
and Honjo, 2003). The main structural differences between the human and chicken 
gastrointestinal tract can be seen in figure 1.3. 
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Figure 1.3. Outline of the gastrointestinal tract in human and chicken systems 
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1.10 Toll-Like Receptors and signalling 
1.10.1 Toll-like receptors and ligands  
Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs)  which 
recognise and bind pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs) leading to activation of immune cell responses 
(Takeda and Akira, 2005).  Currently, 11 TLRs have been identified in humans 
(although TLR11 may not be functional) and 10 in chickens and these are outlined in 
Table 1.3 (Kannaki et al., 2010; Keestra et al., 2013; Takeda and Akira, 2005). 
PAMP or DAMP binding to specific TLRs induces receptor dimerisation (Takeda and 
Akira, 2005). Most TLRs dimerise with themselves to form a homodimer. However, 
TLR2 forms a heterodimer by pairing with either TLR1 or TLR6. TLRs that recognise 
PAMPs on the outer surface of microbes are found on the plasma membrane. TLRs that 
bind to microbial ligands can also recognise DAMPs; endogenous components released 
by dead cells or damaged tissues. Among DAMPs recognised by plasma membrane 
TLRs are chromatin and heat shock proteins, fragments of extracellular matrix 
components and oxidised low density lipoprotein and amyloid-β (Kawasaki and Kawai, 
2014; Murphy et al., 2007). Other TLRs, such as TLR3, 7 and 9 are intracellular and 
recognise internal microbial components that have to be exposed by the degradation of 
endocytosed pathogens, such as nucleic acids, and are found in lysosomes and 
endosomes (Kawasaki and Kawai, 2014). 
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Table 1.3. List of TLRs  and ligands found in humans and chickens (Kannaki et al., 
2010; Keestra et al., 2013; Owen et al., 2013; Takeda and Akira, 2005). 
Human TLR Chicken TLR Ligand 
TLR1 TLR1LA/2A, TLR1LB/2A, 
TLR1LA,2B 
Triacylatedlipopeptides 
TLR2 TLR1LA/2A, TLR1LB/2A Diacylatedlipopeptides 
TLR3 TLR3 dsRNA 
TLR4 TLR4 LPS 
TLR5 TLR5 Flagellin 
TLR6 TLR1LA/2A, TLR1LB/2A Diacylatedlipopeptides 
TLR7 TLR7 ssRNA 
TLR8 Not Functional ssRNA 
TLR9 Absent DNA 
TLR10 Absent Unknown 
TLR11 Absent profillin/ flagellin 
Absent  TLR15 DNA 
Absent TLR21 Protease 
 
1.10.2 Toll-like receptor signalling 
The signalling pathways that occur downstream of TLRs share some common elements 
and activate expression of important genes essential for host defence. A vital shared 
component is the transcription factor nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-кB), which is needed for inducing many innate and inflammatory 
genes, including those producing defensins, chemokines and cytokines, such as tumour 
necrosis factor (TNF)-α, IL-1β and IL-6 produced by macrophages and dendritic cells. 
The exact signal transduction pathway activated by a TLR dimer following 
PAMP/DAMP binding is usually determined by the TLR and the initial protein adaptor 
that binds to the TLRs cytoplasmic domain, referred to as the Toll/interleukin-1 receptor 
(TIR) domain (Takeda and Akira, 2005). TIR domains of TLR dimers are used as 
binding sites for TIR domains of adaptors that activate downstream signalling 
pathways. The two main adaptors are myeloid differentiation factor 88 (MyD88) and 
TIR-domain-containing adaptor-inducing IFN-β factor (TRIF). All TLRs except TLR3 
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bind to MyD88 and TLR4 is unique in binding both MyD88 and TRIF (Takeda and 
Akira, 2005). 
MyD88 initiates a signalling pathway that activates the NF-кB and MAPK pathways 
after associating with a TLR dimer following ligand binding. TLRs found on the plasma 
membrane such as TLR5 use MyD88 to recruit and activate several Interleukin-1 
receptor-associated kinase (IRAK) protein kinases which can bind and activate TNF 
receptor associated factor (TRAF) such as TRAF4 or TRAF6 (TNF receptor associated 
factor 6) (Takeda and Akira, 2005) (Figure 1.4). TRAF6 leads to the activation of 
TAK1 (Transforming growth factor β-activated kinase 1) which phosphorylates the IкB 
kinase (IKK) complex. NF-кB is released once IKK phosphorylates the inhibitory IкB 
subunit, causing NF-кB to enter the nucleus and activate gene expression (Oeckinghaus 
and Ghosh, 2009). IKK is also able to activate the MAPK signalling pathways that can 
result in the activation of transcriptional factors to make up the activator protein 1 (AP-
1) dimer which is needed for differentiation, proliferation and apoptosis (Kawai and 
Akira, 2009; Kawasaki and Kawai, 2014).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. TLR Signalling caused by C. jejuni in the human immune systems 
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1.11 Cytokines 
1.11.1 Structural groups based on receptors 
Cytokines are a very broad category of small proteins that are vital for intercellular 
signalling. There are six major cytokine families: interleukin (IL) 1, hematopoietin 
(class 1 cytokine), interferon (class II cytokine), TNF family, IL-17 and the chemokine 
family (Broughton et al., 2012; Liongue et al., 2016; Owen et al., 2013). Among the 
many functions of cytokines there are a large group of inflammatory ones which are 
produced predominately by activated macrophages and are involved in the upregulation 
of inflammatory reactions (Zhang and An, 2009).   
1.11.2 Functional groups based on protective immunity 
Cytokines can be classified further into the protective immunity they generate based on 
T helper subtypes; TH1, TH2, TH17 and TREG (Al-Banna et al., 2018) . The major T 
helper cell subsets each contain polarising cytokines, which are used to induce the 
expression of master gene regulators that can subsequently regulate a number of effector 
cytokines which the T-cells can produce after they are fully differentiated (Luckheeram 
et al., 2012; Zhu et al., 2010). TH1 cytokines can be induced through many transcription 
factors such as FOXP3, T-bet and GATA3, with transcription factors T-bet, GATA3, 
RORγt inducing TH2 cytokines and T-bet and RORγ being able to induce TH17 
cytokines (Evans and Jenner, 2013). 
TH1 cytokines, such as IL-12, IFN-γ and IL-18, enhance T-cell activation and protect 
against intracellular pathogens (Luckheeram et al., 2012; Zhu et al., 2010). TH2 
cytokines, IL-4, IL-5 and IL-13, help protect against extracellular pathogens, TH17 
cytokines, IL-17A, IL-17F and IL-6, contribute to inflammation and can protect against 
bacterial infections. In contract, TREG cytokines, IL-2, IL-10 and TGF-β inhibit 
inflammation (Al-Banna et al., 2018; Luckheeram et al., 2012; Owen et al., 2013). 
1.11.3: Important pro and anti-inflammatory cytokines 
In humans and chickens, pro-inflammatory cytokines, such as IL-1, IL-6, TNF-α and 
chemokines, help to generate an immune response such as activated neutrophils 
(Dinarello, 2000). Anti-inflammatory cytokines are a group of immunoregulatory 
molecules that help control the pro-inflammatory response by acting with specific 
cytokine inhibitors and soluble cytokine receptors to help regulate the immune 
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response. The main anti-inflammatory cytokines in both animals include IL-1RA, 4, -
10, -11, -13 and IFN-α (Opal and DePalo, 2000; Reid et al., 2016; Su et al., 2012).  
 
IL-8 is an important mediator in the innate immune response which attracts neutrophils 
and other granulocytes to a site of infection. In addition, once the neutrophils have 
reached such a site, IL-8 can then induce phagocytosis (Yoshimura, 2015). IL-8 plays a 
vital role in inflammation, as its secretion is increased by oxidant stress, causing 
recruitment of inflammatory cells which leads to further oxidant stress mediators 
(Shahzad et al., 2010). IL-8 is a potent stimulator of neutrophil activation and 
chemotaxis within the intestinal mucosa and has been associated with many acute and 
chronic inflammatory reactions (Borrmann et al., 2007).  Chickens contain two 
orthologues for IL-8; IL-8like1 and IL-8like2 encoded by CXCLi1 and CXCLi2, 
respectively (Larson et al., 2008). IL-8 , in target cells, can induce migration and 
phagocytosis through increases in intracellular Ca
2+
, rapid release of reactive oxygen 
species (ROS) from the cell and through the release of histamine (Baggiolini, 2015; 
David et al., 2016a; Harada et al., 1994; Yoshimura, 2015). IL-8 is able to bind to seven 
transmembrane G-protein coupled receptors (GPCRs), CXCR1 and CXCR2 which 
mediate and regulate leukocyte accumulation and activation at sites of inflammation. 
CXCR1 interacts principally with IL-8. However, CXCR2 also interacts with CXCL 1, 
2, 4, 5 and 7 (Raghuwanshi et al., 2012).  Both monomer and homodimer versions of 
IL-8 are potent inducers of CXCR1 and CXCR2 (David et al., 2016a; Dinarello, 2000; 
Zhang and An, 2009).  
IL-10, encoded by the IL10 gene in both humans and chickens, plays a major role in the 
anti-inflammatory response. IL-10 can down regulate expression of T-helper cell 
cytokines and co-stimulatory molecules on macrophages. It can also enhance B cell 
survival, proliferation and antibody production and is involved in the regulation of the 
JAK-STAT signalling pathway (Couper et al., 2008; Walter, 2014; Zdanov, 2010). IL-
10 is a member of the interferon family of cytokines which are secreted by T, B and 
dendritic cells that regulate immune responses (Owen et al., 2013; Walter, 2014). IL-10 
can bind to two receptors, IL-10R1 and IL-10R2, with disparate affinities; each receptor 
chain has a distinct function in cellular responses when activated by IL-10 (Walter, 
2014). Binding of IL-10 to IL-10R1 has been reported to control cell specificity and 
targeting of IL-10 to macrophages that selectively express IL-10R1 signalling. In 
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contrast, IL-10R2 functions as a sensory chain, which detects IL-10 bound to IL-10R1 
and therefore is used to activate signalling based on the kinetics of the IL-10/IL-10R1 
interaction (Walter, 2014). Studies using IL-10-deficient mice have shown that they 
develop chronic inflammatory bowel disease (IBD) which may indicate that 
endogenous IL-10 is a central regulator of the mucosal immune system (Gomes-Santos 
et al., 2012; Kuhn et al., 1993; Sturlan et al., 2001). 
 
1.12 Aims and objectives  
 
The primary aim of this thesis was to understand the underlying infection biology in 
host pathogen interactions between populations of Campylobacter strains and the 
chicken. Thus, the thesis focuses on: i) using bacterial genomics to compare 
Campylobacter strains from defined sources including naturally infected chickens, ii) 
using a novel chicken intestinal epithelial cell line to study host responses, and iii) using 
industrial scale chicken infection studies to investigate host responses to infection.  The 
overarching hypothesis throughout this thesis is that Campylobacter strains 
responsible for the invasion responses generated in vitro and in vivo can be 
discriminated from other strains through differences in their genomes. 
More specifically  aims were: 
Chapter 3 
 Investigate C. jejuni diversity and population structure in 100 strains from 
difference sources 
 Investigate whether phenotypic differences exist between isolates in the C. jejuni 
population 
 Use GWAS methods to analyse the C. jejuni isolates for gene associations with 
source.  
Chapter 4 
 To characterise a novel commercially available chicken epithelial cell line, 8E11  
 To determine the inflammatory responses of chicken epithelial cells to C. jejuni 
strains 
 To investigate how the presence/absence of known virulence genes in C. jejuni 
affect the inflammatory response 
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 To investigate the signalling pathways responsible for gene expression and C. 
jejuni invasion responses  
 Associate Campylobacter virulence genes to in vitro cell responses by Scroary 
GWAS pipeline.  
 
 
 
Chapter 5 
 Characterise the genomes of bird-matched Campylobacter from different organs 
in naturally infected chickens 
 Identify genes responsible for colonisation/infection of ileum, caeca and liver in 
naturally infected chickens   
 Investigate the importance of caecal tonsils from experimentally infected 
chickens as markers of immune responses 
 Investigate in vitro cytokine and invasion responses of Campylobacter strains 
used to experimentally infect chickens 
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Chapter 2: Materials and Methods 
 
2.1 Materials 
All cell culture media, antibiotics, enzymes and other media and materials used are 
outlined in Table 2.1. 
 
Table 2.1. Cell Culture media, antibiotics and enzymes 
Media, Antibiotics and 
Enzymes 
Includes Supplier Product 
Code 
McCoy‟s 5a (Invitrogen 26600) High Glucose 
L-glutamine 
Bacto-peptone 
Phenol Red 
Gibco 16600082 
DMEM/F-12, GlutaMax
TM
 
Supplement 
GlutaMAX
TM 
Phenol Red 
Gibco 31331028 
Fetal Bovine Serum (FBS) - Gibco 11573397 
L-glutamine No Phenol Red Gibco A2916801 
Penicillin/ Streptomycin - Gibco 15140122 
Preparation Media (with 
Antibiotics) 
44ml McCoy‟s 5a or 
DMEM/F-12 
5ml FBS 
500µl Penicillin/ Streptomycin 
500µl L-Glutamine (200mM) 
- 
 
- 
Assay Media 49ml McCoy‟s 5a or 
DMEM/F-12 
500µl FBS 
500µl L-Glutamine (200mM) 
- - 
TrypLE express enzyme No Phenol Red 
EDTA 
Gibco 12604021 
Phosphate Buffered Saline 
(PBS) 
- Gibco 10010023 
Mueller-Hinton 23g/L Oxoid CM0405 
Modified Campylobacter blood-
free selective medium 
(mCCDA) 
- Oxoid CM0739 
Columbia Blood Agar (CBA) - Oxoid CM0331 
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CampyGen 3.5 Litre sachet - Oxoid CN0035 
Gentamicin (50mg/ml) - Thermo 
Scientific 
15750060 
Phorbol 12-myristate 13-acetate 
(PMA) 
- Thermo 
Scientific 
BP685-1 
AlamarBlue cell viability 
reagent 
- Thermo 
Scientific 
DAL1025 
iScript cDNA  5x iScript Reaction Mix 
iScript Reverse Transciptase 
Nuclease-free water 
Bio-Rad 1708890 
SensiMix SYBR - Bioline QT615-05 
Brilliant II QPCR Mater Mix Brilliant II master mix 
Reference Dye 
Agilent 600804 
Human IL-8/CXCL8 Duoset 
ELISA 
IL-8 Capture Antibody 
IL-8 Detection Antibody 
IL-8 Standard 
Streptavidin conjugated to 
horseradish-peroxidase (HRP) 
Bio-
Techne 
DY208 
Human IL-10 Duoset ELISA IL-10 Capture Antibody 
IL-10 Detection Antibody 
IL-10 Standard 
Streptavidin-HRP 
Bio-
Techne 
DY217B 
Tween 20 - Thermo 
Scientific 
003005 
ELISA Wash Buffer 0.05% Tween 
PBS 
- - 
SureBlue TMB 1 Component 
Microwell Peroxidase Substrate 
- KPL 5120-0075 
Hydrochloric Acid (HCI) - Thermo 
Scientific 
A508-4 
Crystal Violet (0.1% w/v) - Sigma-
Aldrich 
C0775 
Picric Acid  - Sigma-
Aldrich 
197378-
500G 
Formaldehyde - Sigma-
Aldrich 
F8775 
Bouin‟s solution Picric Acid 
40% Formaldehyde 
Acetic acid 
- - 
SV Total RNA Isolation Kit RNA Lysis Buffer 
RNA Dilution Buffer 
Promega Z3105 
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RNA Wash Solution 
DNase Stop Solution 
Yellow Core Buffer 
McCl2 0.09M 
DNase I 
Beta-Macaptoethanol 
Dynasore (80µM) - Sigma-
Aldrich 
D7693-
5MG 
Filipin - Sigma-
Aldrich 
SAE0088 
Genistein - Sigma-
Aldrich 
G6649-
5MG 
Chlorpromazine - Sigma-
Aldrich 
C8138 
LY294002 - Sigma-
Aldrich 
L9908 
InSolution
TM
 AKT Inhibitor V, 
Triciribine 
- Merck 124038 
Methyl β cyclodextrin - Sigma-
Aldrich 
C4555-1G 
Cytochalasin D - Thermo 
Scientific 
PHZ1063 
PD98059 - Invitrogen tlr-pd98 
 
2.2 In vitro Microbiology 
2.2.1 Bacterial Isolates 
All isolates used were sub-cultured from a glycerol stock stored at -80
o
C. All 
Campylobacter strains used in this study are described in Table 2.2. 
2.2.2 Bacterial growth conditions 
Bacteria were grown on Columbia blood agar (CBA; Oxoid, Basingstoke, UK) or 
Campylobacter blood free selective medium (mCCDA;Oxoid) and incubated at 42
o
C 
under microaerobic conditions (5% O2, 10% CO2, 85% N2) using a CampGen 3.5L  
sachet (Oxoid).  For broth culture, a single colony was taken from a CBA plate, 
inoculated into Muller-Hinton (MH) broth (Oxoid) and incubated at 37
o
C for 24 hours 
aerobically.  
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Table 2.2. List of all Campylobacter strains used throughout this thesis 
Number 
Isolate Species 
Clonal 
complex 
Source 
1 CAMP45 C. jejuni ST-45 chicken 
2 CAMP61 C. jejuni ST-61 cattle 
3 CampsClin11 C. jejuni ST-45 human 
4 CampsClin45 C. jejuni ST-45 human 
5 CampsClin262 C. jejuni ST-21 human 
6 CampsClin583 C. jejuni ST-45 human 
7 CampsClin266 C. jejuni ST-21 human 
8 CampsClin883 C. jejuni ST-21 human 
9 CampsClin1003 C. jejuni ST-45 human 
10 chick2219 C. jejuni ST-45 chicken 
11 chicka21 C. jejuni ST-21 chicken 
12 cow55 C. jejuni - cattle 
13 cow42 C. jejuni ST-42 cattle 
14 chick2253 C. jejuni - chicken 
15 chick594 C. jejuni ST-45 chicken 
16 cow2673 C. jejuni - cattle 
17 cow2674 C. jejuni ST-21 cattle 
18 cow206 C. jejuni ST-206 cattle 
19 cow38 C. jejuni ST-48 cattle 
20 cow190 C. jejuni - cattle 
21 cow334 C. jejuni ST-45 cattle 
22 chicka45 C. jejuni - chicken 
23 chick267 C. jejuni ST-283 chicken 
24 CampsClin230 C. jejuni ST-45 human 
25 chick2048 C. jejuni ST-45 chicken 
26 chick2197 C. jejuni ST-354 chicken 
27 chick607 C. jejuni - chicken 
28 chick2223 C. jejuni ST-45 chicken 
29 cow3583 C. jejuni ST-42 cattle 
30 cow618 C. jejuni ST-61 cattle 
31 cow237 C. jejuni ST-206 cattle 
32 cow270 C. jejuni ST-403 cattle 
33 cowb21 C. jejuni ST-21 cattle 
34 cowb45 C. jejuni ST-45 cattle 
35 cowc45 C. jejuni ST-45 cattle 
36 cowd45 C. jejuni ST-45 cattle 
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37 cow53 C. jejuni ST-21 cattle 
38 cow104 C. jejuni ST-21 cattle 
39 cow3189 C. jejuni - cattle 
40 cow3201 C. jejuni ST-21 cattle 
41 cow3205 C. jejuni ST-206 cattle 
42 cow137 C. jejuni ST-45 cattle 
43 cow230 C. jejuni - cattle 
44 cow583 C. jejuni ST-45 cattle 
45 cow3207 C. jejuni ST-45 cattle 
46 cow3214 C. jejuni ST-45 cattle 
47 chick354 C. jejuni ST-257 chicken 
48 chick51 C. jejuni ST-443 chicken 
49 chick1079 C. jejuni ST-573 chicken 
50 chick574 C. jejuni ST-574 chicken 
51 cowa45 C. jejuni ST-45 chicken 
52 chick2213 C. jejuni ST-45 chicken 
53 cow518 C. jejuni ST-21 cattle 
54 CampsClin53 C. jejuni ST-21 human 
55 cow58 C. jejuni - cattle 
56 cowa21 C. jejuni ST-21 cattle 
57 chickc21 C. jejuni ST-21 chicken 
58 chick25 C. jejuni ST-661 chicken 
59 chick104 C. jejuni ST-21 chicken 
60 chick353 C. jejuni ST-353 chicken 
61 chickb354 C. jejuni ST-354 chicken 
62 chick573 C. jejuni ST-573 chicken 
63 chick2568 C. jejuni ST-661 chicken 
64 chickc45 C. jejuni ST-45 chicken 
65 chick19 C. jejuni ST-21 chicken 
66 chick50 C. jejuni ST-21 chicken 
67 chick53 C. jejuni ST-21 chicken 
68 chick262 C. jejuni ST-21 chicken 
69 chick266 C. jejuni ST-21 chicken 
70 chick861 C. jejuni - chicken 
71 chick1086 C. jejuni ST-21 chicken 
72 chick1360 C. jejuni ST-21 chicken 
73 chick11 C. jejuni ST-45 chicken 
74 chick137 C. jejuni ST-257 chicken 
75 chick1003 C. jejuni ST-45 chicken 
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76 chick814 C. jejuni ST-661 chicken 
77 chickb21 C. jejuni ST-21 chicken 
78 chickb45 C. jejuni ST-45 chicken 
79 chickd45 C. jejuni ST-45 chicken 
80 chick883 C. jejuni ST-21 chicken 
81 chick230 C. jejuni ST-45 chicken 
82 chick2663 C. jejuni ST-45 chicken 
83 CampsClin21 C. jejuni - human 
84 OxClina21 C. jejuni ST-21 human 
85 OxClinb21 C. jejuni ST-45 human 
86 OxClina45 C. jejuni ST-45 human 
87 OxClinb45 C. jejuni ST-21 human 
88 starling177 C. jejuni ST-177 starling 
89 starling682 C. jejuni ST-682 starling 
90 starling45 C. jejuni ST-45 starling 
91 starling1020 C. jejuni ST-682 starling 
92 goose1033 C. jejuni ST-1034 goose 
93 goose702 C. jejuni - goose 
94 goose137 C. jejuni ST-45 goose 
95 goose696 C. jejuni ST-1332 goose 
96 duck702 C. jejuni ST-702 duck  
97 duck45 C. jejuni ST-45 duck  
98 
CAMP2381 C. jejuni - 
environmental 
waters 
99 NCTC11168 C. jejuni ST-21 human 
100 M1 C. jejuni ST-45 human 
101 C7 C. coli 828 Chicken Caeca 
102 C8 C. coli - Chicken Caeca 
103 
C11 
C.coli/ 
C. jejuni 
828/464 Chicken Caeca 
104 C12 C. coli 828 Chicken Caeca 
105 
C14 
C.coli/ 
C. jejuni 
828/354 Chicken Caeca 
106 C15 C. coli 828 Chicken Caeca 
107 C18 C. coli 828 Chicken Caeca 
108 C20 - - Chicken Caeca 
109 C23 C. coli 828 Chicken Caeca 
110 C24 C. jejuni 353 Chicken Caeca 
111 C25 C. jejuni 353 Chicken Caeca 
112 C26 - - Chicken Caeca 
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113 C28 C. jejuni 353 Chicken Caeca 
114 C29 C. jejuni 353 Chicken Caeca 
115 I4/G7 C. coli - Chicken Ileum 
116 I7/G7 C. jejuni 464 Chicken Ileum 
117 I11/G11 C. jejuni 464 Chicken Ileum 
118 I12/G12 C. coli 828 Chicken Ileum 
119 I14/G14 C. jejuni 464 Chicken Ileum 
120 I15/G15 C. jejuni 464 Chicken Ileum 
121 I18/G18 C. jejuni 353 Chicken Ileum 
122 I20/G20 C. jejuni 353 Chicken Ileum 
123 I23/G23 C. coli 828 Chicken Ileum 
124 I24/G24 C. jejuni 353 Chicken Ileum 
125 I25/G25 C. jejuni 353 Chicken Ileum 
126 I26/G26 C. jejuni 353 Chicken Ileum 
127 I28/G28 C. coli 828 Chicken Ileum 
128 I29/G29 C. coli 828 Chicken Ileum 
129 L4 C. coli - Chicken Liver 
130 L7 C. jejuni 5136 Chicken Liver 
131 L11 C. jejuni 464 Chicken Liver 
132 L12 C. jejuni 464 Chicken Liver 
133 
L14 
C.coli/ 
C. jejuni 
828/257 Chicken Liver 
134 L15 C. jejuni 464 Chicken Liver 
135 L18 - - Chicken Liver 
136 L20 C. coli 828 Chicken Liver 
137 L23 C. jejuni 464 Chicken Liver 
138 L24 C. coli 828 Chicken Liver 
139 L25 C. jejuni 353 Chicken Liver 
140 
L26 
C.coli/ 
C. jejuni 
828/464 Chicken Liver 
141 L28 C. coli 828 Chicken Liver 
142 L29 C. coli 828 Chicken Liver 
143 CJ12662 C. jejuni -   
144 CJ13126 C. jejuni -   
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2.2.3 Culture of human and chicken intestinal epithelial cells 
Human colon adenocarcinoma (HT-29) cells were maintained in McCoy‟s 5A 
(modified) Medium with L-Glutamine (5mM), Penicillin (10,000 I.U/ml) Streptomycin 
(10,000µg/ml) (P/S) and supplemented with 10% foetal bovine serum (FBS) 
(ThermoFisher-scientific, Loughborough, UK). MM-CHiC clone 8E11 chicken 
intestinal cells (Micromol, Germany) were maintained in Dulbecco‟s modified eagle 
medium/nutrient mixture F-12 (DMEM/F-12) (ThermoFisher-scientific, Loughborough, 
UK) with L-Glutamine, Penicillin Streptomycin (P/S) and 10% FBS. Human epithelial 
colorectal adenocarcinoma cells (Caco-2) were maintained in Dulbecco‟s modified 
eagle medium/nutrient mixture F-12 (DMEM/F-12) (ThermoFisher-scientific, 
Loughborough, UK) with L-Glutamine, Penicillin Streptomycin (P/S) and 10% FBS. 
All cell lines were grown routinely in a 175cm
2
 flask at 37
o
C in a 5% CO2 humidified 
incubator. Cell lines were grown until confluent and then were trypsinized (TrypLE 
Express) and counted using trypan blue. Cultures were routinely sub-cultured into new 
flasks when confluent. 
2.2.4 Infection studies: co-culture of epithelial cells and Campylobacter 
Campylobacter, grown overnight in MH broth, to a concentration of approximately 
1x10
8
c.f.u/ml, was standardised by measuring the optical density (OD 600nm) of the 
bacterial suspension during experiments, ensuring that the same number of bacteria was 
added each time by diluting to an OD of 0.1 (1 x 10
7
/ml). New epithelial cell cultures 
from section 2.2.3 were seeded at approximately 4x10
4
 cells per cm
2
 in 24-well plates 
and incubated until confluent. Then, the epithelial cell monolayers were infected with 
50µl of bacterial suspension, containing approximately 3.5x10
5
c.f.u. per well. The 
infected monolayers were incubated for 4, 6 and 24 hours at 37
o
C in a 5% CO2 
atmosphere to allow the bacteria to adhere and invade the epithelial cells. Uninfected 
cells and cells treated with phorbol 12-myristate 13-acetate (PMA) (10mM) were 
included in the experiments as negative and positive controls respectively. At the end of 
each time point the cell supernatants were collected into 1.5ml microcentrifuge tubes 
and placed into a centrifuge at 300g for 5 min, to remove any particulate material by 
centrifugation; the samples were then aliquoted and stored at -20
o
C until ready to assay 
by cytokine ELISA. Total RNA from the cells was extracted and stored at -80
o
C until 
ready to be converted to cDNA for qPCR described in section 2.2.6. 
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2.2.5 IL-8/IL-10 Enzyme linked immunosorbent assay (ELISA) 
The Human CXCL8/IL-8 DuoSet kit and Human IL-10 DuoSet kit (Bio-Techne, 
Abingdon, UK) was used to measure IL-8/IL-10 secretion from infected and uninfected 
human cell lines. Briefly, 50µl of a monoclonal antibody specific (10µg/ml) for IL-8 / 
IL-10 was pre-coated onto a 96-well half area microplate overnight. Then, 50µl of 
standards (0-2000pg/ml IL-8 / 1L-10) and samples were pipetted into the wells for 2 
hours. Wells were washed 3 times with wash buffer (0.05% tween (Sigma-Aldrich), 
PBS) before 50µl of an enzyme-linked polyclonal antibody specific (5µg/ml) for IL-8 / 
IL-10 was added to the wells for 2 hours. Wells were washed 3 times before a 
streptavidin HRP reagent was added for 20 minutes. Three further washes were 
completed before 50µl of a SureBlue
TM
 substrate solution (Milford, UK) was added to 
the microplate wells to cause a colour development in proportion to the amount of IL-8 
bound in the earlier step. The colour development was stopped and the intensity of the 
colour was measured at 450nm using the FLUOstar Omega plate reader (BMG-labtech, 
Aylesbury, UK). Unknowns were calculated from the standard curve. 
2.2.6 RNA Isolation 
Total RNA was isolated from infected HT-29 human or 8E11 chicken intestinal 
epithelial cells, from section 2.2.4, grown in a 24 well plate using a Promega SV total 
RNA isolation kit (Promega, Southampton, UK) according to manufacturers‟ 
instructions. Total RNA was quantified using a NanoDrop (Thermo scientific, 
Loughborough, UK) and integrity confirmed by agarose gel electrophoresis (0.7% 
agarose gel using a 1kb and 100bp ladders at 100V for 1 hour). 
2.2.7 Quantitative PCR of RNA transcripts using SYBR green and probe based 
method 
One microgram of total RNA was converted to cDNA using an iScript kit (Biorad, 
Watford, UK).  Quantitative PCR using SYBR green was used to amplify the gene of 
interest and the housekeeping gene. Each reaction (25µl) contained 12.5µl 2X Sensimix 
SYBR buffer (Bioline, London, UK), 0.5µl each primer (25µM), 9.5ul purified water 
and 2µl cDNA. The qPCR conditions were as follows; 10min at 95°C, then 50 cycles 
with denaturing for 15sec at 95°C, annealing for 15 sec at temperatures specific to 
primers sets (Table 2.3) and synthesis at 72°C. Reactions were performed in an iCycler 
(Biorad). Primer efficiency was measured using total RNA from epithelial cells infected 
with a reference C. jejuni isolate (NCTC11168) and a dilution series up to 1/10,000. 
The log values of the Cycle threshold (CT) values were then taken and plotted 
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graphically and the slopes used to calculate the efficiency using the equation ((1-
Slope)/(Log10(2)))*100. Relative transcriptional levels in distinct experiments were 
determined by using the 2
-ΔΔ
Ct method and β-actin as the reference housekeeping gene, 
where 
ΔΔ
Ct = (Ct Infected – Ct Housekeeping)time x - (Ct uninfected – Ct 
Housekeeping)time 0. Time x relates to gene of interest whereas time 0 relates to the 
untreated (Livak and Schmittgen, 2001). Primer sequences for human IL-8, IL-10 and 
β-actin and chicken CXCLi1/2 and β-actin were used to create primers for qPCR (Table 
2.3). Target sequences were identified from the NCBI database and then the coding 
sequence (CDS) was used to generate forward and reverse primers using Primer3, 
selecting for amplicon sizes of 50-150 bases. 
Quantitative PCR using the probe-based method was used to amplify the gene of 
interest and the housekeeping one, 28S ribosomal RNA. Each reaction (25µl) contained 
12.5µl Brilliant II QPCR mastermix (Agilent, Stockport UK), 0.625µl each primer 
(25µM), 0.25µl of each probe, 9.5µl purified water and 2µl cDNA. The qPCR 
conditions were as follows; 10min at 95°C, then 50 cycles with denaturing for 15sec at 
95°C, annealing for 15 sec at temperatures specific to primers sets (Table 2.3) and 
synthesis at 72°C. Reactions were performed with use of the AriaMx Real time PCR 
system (Agilent). Primer efficiency was measured using total RNA from epithelial cells 
infected with a reference C. jejuni isolate (NCTC11168) and a dilution series up to 
1/10,000. The log values of the Cycle threshold (CT) values were then taken and plotted 
graphically and the slopes used to calculate the efficiency. Relative transcriptional 
levels within distinct experiments were determined using the Pfaffl method with Agilent 
AiraMx software (Pfaffl, 2001) using the equation (ETarget)
 ΔCt
target
(Uninfected-
Infected)
/(EHousekeeping)
 ΔCt
Housekeeping
(Untreated-infected)
, where E represents the efficiency of the 
target gene transcript.  
2.2.8 cDNA Synthesis Conditions 
Step 1: Priming at 25
o
C for 5 min 
Step 2: Reverse transcription (RT) at 46
o
C for 20 min 
Step 3: RT inactivation at 95
o
C for 1 min 
Step 4: Hold at 4
o
C 
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2.2.9 PCR Conditions 
Step 1: Inactivate at 95
o
C for 10 min 
Step 2: Denature at 95
o
C for 1 min 
Step 3: Anneal at 55-60
o
C for 1 min (Primer dependent, Table 2.3) 
Step 4: Extend at 72
o
C for 1 min 
Step 5: Repeat steps 2, 3 and 4 for 50 cycles 
Step 6 (SYBR only): Final extension/blunt ending at 72
o
C for 5 min (John et al., 2017) 
Table 2.3. Primers used throughout the experiments 
cDNA Primer Sequence 5’-3’ Annealing  
Temperature 
(
o
C) 
Reference/ 
Genbank 
Chicken 
28S 
gcgaagccagaggaaact 
gacgaccgatttgcacgtc 
55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-1β 
gctctacatgtgtgtgtgatgag 
tgtcgatgtcccgcatga 
55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-6 
gctcgccggcttcga 
ggtaggtctgaaaggcgaacag 
55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-8 
tggcaccgcagctcatt 
tctttaccagcgtcctaccttgcgaca 
55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-10 
catgctgctgctgggccttgaa 
cgtctccttgatctgcttgatg 
55 (Shini and 
Kaiser, 2009) 
Chicken 
IFNγ 
gtgaagaaggtgaaagatatcatgga 
gctttgcgctggattctca 
55 (Shini and 
Kaiser, 2009) 
Chicken 
TNF-α 
cttctgaggcatttggaagc 
actgggcggtcatagaacag 
55 (Shini and 
Kaiser, 2009) 
Chicken 
28S probe 
[FAM]aggaccgctacggacctccacca[TAM] 55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-1β 
probe 
[FAM]ccacactgcagctggaggaagcc[TAM] 55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-6 
probe 
[HEX]aggagaaatgcctgacgaagctctcca[BHQ1] 55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-8 
probe 
[HEX]gccctcctcctggtttgag[BHQ1] 55 (Shini and 
Kaiser, 2009) 
Chicken 
IL-10 
probe 
[HEX]cgacgattcggcgctgtcacc[BHQ1] 55 (Shini and 
Kaiser, 2009) 
Chicken [FAM]tggccaagctcccgatgaacga[TAM] 55 (Shini and 
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IFNγ 
probe 
Kaiser, 2009) 
Human 
IL-8 
cagttttgccaaggagtgct 
ttggggtggaaaggtttgga 
57 BC013615.1 
Chicken 
IL-8-1 
cgattgaactccgatgccag 
cattcttgcagtgaggtccg 
59 NM_205018.1 
Chicken 
IL-8-2 
ggatggaagagaggtgtgct 
ctgagccttggccataagtg 
59 NM_205498.1 
Human 
IL-10 
ggcgctgtcatcgatttctt 
cattcttcacctgctccacg 
58 NM_000572 
Chicken 
IL-10 
acatccaactgctcagctct 
cgtacaggtctttgcggatg 
57 AJ621254.1 
Human β-
actin 
tggcatccacgaaactacct 
cgtacaggtctttgcggatg 
59 X00351.1 
Chicken 
β-actin 
aagatcattgccccacctga 
cctgcttgctgatccacatc 
59 L08165.1 
Human 
GAPDH 
caaattccatggcaccgtca 
atctcgctcctggaagatgg 
57 NM_002046.5 
Chicken 
GAPDH 
tgggaagctgtggagagatg 
cttcccattcagctcaggga 
57 NM_204305.1 
Chicken 
MHC 1 
cttccacccacccaagatct 
tcgttgaaggacatgtcgga 
58 M84767.1 
Human 
MHC 1 
ctctctctttctggcctgga 
tctctgctggatgacgtgag 
58 AB021288.1 
 
2.2.10 Motility Assay 
All C. jejuni strains were grown for 48 hours on CBA at 42
o
C under microaerobic 
conditions (5% O2, 10% CO2, 85% N2) using CampGen 3.5L (Oxoid). A 10µl loop of 
bacteria was then re-suspended in 3ml of MH and incubated at 37
o
C overnight with 
shaking at 250rpm. The OD of each sample was measured (~0.2-0.6) and it was diluted 
1:10. Two millilitres of MH medium supplemented with 0.4% agar was aliquoted to 
each well of a 6-well plate and allowed to solidify. Then 2µl of C. jejuni suspensions 
(0.1 OD600) were added to the centre of a well and the plate incubated at 37
o
C under 
microaerobic conditions for 48h. Relative motility of each bacterial strain was 
determined by measuring the diameter (mm) of the migration zone with a ruler.   
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2.2.11 Invasion Assay and Adhesion 
Bacterial strains (from glycerol stocks) were inoculated onto agar plates and grown in a 
microaerobic environment for 48 hours at 42
o
C. A colony  from a freshly grown culture 
was sub-cultured in MH broth for 24h, as described previously in section 2.2.2. Then, 
1x10
7 
CFU of bacterial suspension was added to the wells containing monolayers of 
cells in assay medium (modified McCoy‟s 5A/DMEM/F-12 with L-glutamine (5mM) 
and supplemented with 5% FBS) for 6h. The remaining broth was serially diluted in 
PBS and plated out onto CBA plates for enumeration of Campylobacter. Monolayers of 
cells were grown in a 24-well tissue culture plate as previously stated (section 2.2.3). 
For the adhesion assay, the cell monolayers incubated with bacteria were washed three 
times with PBS and then incubated at 37
o
C with maximum recovery diluent for 10min 
(1.5g peptone, 8.5g sodium chloride, per litre; final pH 7.0) to remove unbound 
bacteria. Plates were shaken and adhering Campylobacter cells were removed and 
serially diluted in maximum recovery diluent and plated out onto CBA for enumeration. 
For the invasion assay, the cell monolayer incubated with bacteria were washed twice 
with PBS before 100µl gentamicin (Sigma, Poole, Dorset UK) in assay media 
(100µg/ml) was added to each well and incubated at 37
o
C in 5% CO2 for 90 min. Cells 
infected with Campylobacter were analysed to investigate the appropriate incubation 
time with gentamicin and to confirm it did not affect cell integrity (Appendix Figure 
8.3). Cells were washed twice with PBS before 2ml 0.1% Triton X-100 in PBS was 
added to each well in order to lyse the cells. After 5 minutes, cell lysates were serially 
diluted in PBS and plated out on CBA plates for enumeration of the invasive bacteria. 
This experiment was performed four times. The limit of detection was 50 CFU/ml. 
2.2.12 Cell Viability 
Cell viability was assessed using the AlamarBlue Reagent (Thermo Fisher Scientific) 
according to manufacturer‟s instructions. Briefly, 5µl of AlamarBlue reagent was added 
to each well of a 96-well plate containing HT-29 or 8E11 cells infected with C. jejuni in 
50µl of medium. Plates were incubated for 4h at 37
o
C and absorbance was measured at 
OD570, and OD600. AlamarBlue cell viability reagent functions as a cell health indicator 
using the reducing power of living cells to quantitatively measure the proliferation of 
cell lines. Viable cells can convert resazurin continuously, the active ingredient in 
alamarblue, to resorufin and so increasing the overall absorbance at OD570 and OD600 
and colour of the media. 
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2.2.13 Growth and Biofilm assay.  
Growth and biofilm formation were measured using a semi-quantitative assay on Nunc 
96-well tissue culture plates (Mack et al., 1992; Pascoe et al., 2015). Briefly, C. jejuni 
strains were grown overnight in MH at 42
o
C under microaerobic conditions as 
described in section 2.2.1, and diluted using MH to 0.1 OD600. Five microlitres of 
bacterial suspension from an overnight culture (corrected to OD600 = 0.1) grown in MH 
was used to inoculate 200µl of fresh MH-medium in a 96-well tissue culture plate. 
Cultures were grown and monitored in real-time over 48 hours at 37
o
C or 42
o
C in a 
BMG Omega plate reader using an atmospheric control unit to generate a microaerobic 
atmosphere. Spectrophotometric measurements were taken at OD600 every 60 mins and 
the average of at least three replicates was calculated. For the measurement of biofilm 
formation, culture medium was removed and the wells washed gently three times with 
PBS. Adhered bacteria were fixed with 150µl of bouin‟s solution (7.5ml picric acid; 
2.5ml 40% formaldehyde; 0.5ml acetic acid) for 15 min and washed again with PBS. 
Plates were air-dried and then stained with 0.1% (w/v) crystal violet for 5 min. Excess 
stain was removed, adhered bacteria were air dried and spectrophotometric 
measurements were taken at OD600 in a BMG Omega 96-well plate reader and the 
average of at least three replicates was calculated. 
2.2.14 Inhibition Assays 
A series of known endocytosis and signalling inhibitors was used to block cellular 
processes (Table 2.1). HT-29 and 8E11 cells were cultured as described earlier in 
section 2.2.2. Cells were treated with each inhibitor separately for 30min and bacterial 
strains were added with subsequent invasion assays and RNA isolation/qPCR carried 
out as previously described in section 2.2.6. 
2.3 Bioinformatics, genomics and Campylobacter genomes 
2.3.1 Campylobacter-BIGSdb 
The Campylobacter bacterial isolate genome sequence database (BIGsdb), (Sheppard et 
al., 2012) containing data from over 3000 isolates was used to identify and select strains 
from a variety of different sequence types and niches (human, cattle, chicken and wild 
bird). BIGSdb is a scalable web-database that stores contiguous sequences or whole 
genome data, and the corresponding origin and phenotype data for the isolates from 
which the sequence was derived (Jolley and Maiden, 2010; Maiden et al., 2013). 
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Campylobacter BIGSdb was used to identify and characterise Campylobacter 
population structure for host pathogen studies in vitro and to produce gene alignments 
of any loci that vary in all the different strains used in this study to produce 
phylogenetic trees using MEGA 6 (Tamura et al., 2013).  
2.3.2 Generation of Pan-Genomes 
Genome sequences were annotated with Prokka (Seemann, 2014) and the output then 
used to create the pan-genome using „Roary the pan genome pipeline‟ (Page et al., 
2015). The resulting pan-genome was used to produce maximum likelihood 
phylogenetic trees using MEGA 6, iTol and phandango (Hadfield et al., 2018; Letunic 
and Bork, 2016; Tamura et al., 2013).  
Prokka was run using the following command: 
Prokka --kingdom Bacteria --outdir prokka_11168 –genus Campylobacter --
locustag 11168 11168.fas 
Roary was run using the following command: 
 roary -f ./PanGenome -e -n -v ./gff/*.gff 
 
2.3.3 GWAS using Scoary 
Scoary microbial pan-GWAS (Brynildsrud et al., 2016) was used to compare and 
analyse gene association using the „gene_presence_absence.csv‟ file output from Roary 
along with a new „traits‟ file describing the required analysis. 
Scoary was run using the following command: 
 scoary –g gene_presence_absence.csv –t traits.csv 
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2.3.4 SNP analysis and Recombination 
Sequence outputs from Roary were taken and the gaps in them removed using Geneious 
(Kearse et al., 2012b, 2012a), where the sequences were then used in Gubbins 
(Croucher et al., 2015) to determine recombination events within the sequences as well 
as single nucleotide polymorphisms (SNPs). 
Gubbins was run using the following command: 
 run_gubbins.py [FASTA alignment] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assembled 
Genomes 
Roary 
Pan-genome 
Prokka 
Gubbins 
SNP and  
Recombination 
Annotated 
Genomes 
Scoary 
GWAS 
Figure 2.1. Genomic pipeline using Prokka, Roary, Scroary and Gubbins to analyse sequences 
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2.4 Programmes 
 
Several programmes for genomic and statistical anaylsis were used in this study, these 
are outlined in Table 2.4. 
 
Table 2.4. Programs used during this study 
Programs Version Manufacturer 
Prokka 1.12 
Open Source 
http://www.vicbioinformatics.com/software.prokka.shtml  
Roary 3.6.1 
Open Source 
https://sanger-pathogens.github.io/Roary/  
Gubbins 2.0.0 
Open Source 
https://www.sanger.ac.uk/science/tools/gubbins  
Geneious 10.2.3 Biomatters (Auckland, New Zeland) 
BioPerl 1.007 
Open Source 
https://bioperl.org/  
BLAST+ 2.6.0 
Open Source 
ftp://ftp.ncbi.nlm.nih.gov/blast/executables/blast+/LATEST/  
HMMER 3.1b2 
Open Source 
http://hmmer.org/  
Aragorn 1.2.36 
Open Source 
http://mbio-serv2.mbioekol.lu.se/ARAGORN/  
Prodigal 2.6.2 
Open Source 
https://github.com/hyattpd/Prodigal  
tbl2asn 23 Open Source 
GNU 
Parallel 
20170922 
Open Source 
https://www.gnu.org/software/parallel/  
Infernal 1.1 
Open Source 
http://eddylab.org/infernal/  
MEGA 6 
Open source 
https://www.megasoftware.net/  
iTOL 4.2.3 
Biobyte solutions 
https://itol.embl.de/  
Phandango 1.1.0 
Open Source 
https://jameshadfield.github.io/phandango/#/  
Prism 6 GraphPad Software Inc (San Diego, USA) 
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2.5 In vivo Experiments 
2.5.1 Industrial scale Campylobacter infection study of broiler Chickens 
2.5.1.1: Ethics 
An in vivo Campylobacter infection study as part of a BBSRC funded project entitled 
„Broiler gut health and C. jejuni infection: impacts of harvest management‟ 
(BB/M009610/1) was carried out at Scotland‟s Rural University College (SRUC). All 
work was conducted in accordance with the UK legislation governing experimental 
animals under Home Office project licence and approved by the SRUC ethical review 
process.  
2.5.1.2: Campylobacter infection protocol 
Birds were infected with a cocktail of six Campylobacter strains (Appendix Table 8.2) 
using a litter seeding method (Sandilands et al., 2018) at a concentration of 1x10
5 
cfu of 
each Campylobacter. The birds were infected by members of SRUC and Drs Williams 
and Wilkinson of Swansea University 
2.5.1.3: Harvest of tissues 
For results generated in this thesis, the caecal tonsils were removed at the time of cull 
from Campylobacter infected and uninfected chickens. They were placed immediately 
into RNAlater (Ambicon, UK) and stored at -20
o
C until needed. 
2.5.1.4 RNA isolation from caecal tonsils 
Approximately thirty µg of caecal tonsil was placed in 600µl of RNA lysis buffer with 
one 5mm stainless steel bead (Qiagen, Crawley UK) and was disrupted using the 
FastPrep FP120 (Thermo scientific, Loughborough, UK) at 4 m/sec for 1 minute. RNA 
was extracted using the QIAGEN RNeasy mini kit according to manufacturer‟s 
instructions, eluted in 50µl nuclease free water and stored at -20
o
C until needed. The 
total RNA was quantified using a NanoDrop (Thermo scientific, Loughborough, UK). 
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2.6 Statistics 
Normality was assessed using D‟agostino-Pearson test. For data that were distributed 
normally a two-way ANOVA was used. For data that were not distributed normally, 
non-parametric tests were used. To compare two groups a Mann-Whitney U test was 
used and for 3 or more groups a Krustal-Wallis test with a post hoc Dunns test was 
applied.  
Correlations were assessed using linear regression of log transformed data with a p 
value related to the slope. Significance differences were accepted if p≤0.05 in all tests. 
Graphpad Prism 6.0 (San Diego, USA) was used to analyse and assess differences 
between treatment groups. 
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Chapter 3: Characterisation of Campylobacter jejuni strains from four different 
hosts 
 
3.1 Introduction 
3.1.1 C. jejuni Genomics 
C. jejuni are distributed widely and found in the microbiota of many wild and 
domesticated birds and mammals and are genetically highly diverse (Killiny and 
Almeida, 2011). Campylobacter populations are highly structured into clusters of 
related lineages which include deep branching clades and clonal complexes of isolates 
that share four or more alleles at seven MLST loci (Dingle et al., 2001; Sheppard et al., 
2008). MLST data have shown that C. jejuni populations are subject to high levels of 
horizontal gene transfer within and between species and  display partial clonality where 
strains with similar genotypes form clusters, known as clonal complexes, which contain 
related STs (Sheppard et al., 2008; Smith et al., 1993).  Analysis of C. jejuni 
populations has shown that certain clusters may be differentiated by their host sources 
(Colles et al., 2008; McCarthy et al., 2007; Sheppard et al., 2010b, 2010a). Studies of 
large collections  from diverse sources and locations have identified certain STs 
associated with defined hosts; wild birds are often associated with their own C. jejuni 
strains (Griekspoor et al., 2013; Sheppard et al., 2011) and certain sequence types (such 
as ST403) are not found in  birds (Morley et al., 2015). 
C. jejuni is a rapidly evolving species which is subject to an intense purifying selection 
that can purge most novel variation while still possessing a large evolutionary potential. 
Recombination has a vital role in generating diversity and facilitating gene flow 
between C. jejuni (Wilson et al., 2009). In addition, the genetic basis for antimicrobial 
drug resistance is spread through recombination in C. jeuni  (De Boer et al., 2002). 
Characterisation of thousands of C. jejuni isolates from PubMLST 
(http://pubmlst.org/Campylobacter/) identified clonal complexes and STs that usually 
only come from the gut of a single host species and can be termed as „host specialists‟; 
which include chicken specialists such as STs-661,573, -574, -607, -443, -460, -283 and 
-257 and cattle specialists such as ST-61 and ST-42. STs-45 and -21 are found in 
multiple host species (Dearlove et al., 2016; Pascoe et al., 2015; Sheppard et al., 2011). 
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Analysis of the genome of C. jejuni has identified many virulence genes which are 
shown in Table 3.1. Among these are ones linked to motility, toxicity, adhesion, 
invasion, antigen peptides, transporters and signal transduction kinases (Ashgar et al., 
2007; Bæk et al., 2011; Brøndsted et al., 2005; Faber et al., 2015; Fernando et al., 2007; 
Joslin and Hendrixson, 2008, 2009; Kale, 2011; Khan, 2005; Koolman et al., 2016; Lee 
et al., 2003; Min et al., 2009; Neal-McKinney and Konkel, 2012; Pei and Blaser, 1993; 
Poly et al., 2007). 
Table 3.1. Known virulence genes in C. jejuni 
Gene Name/Function 
flaA Flagellin A 
flaB Flagellin B 
flaC Flagellin C 
cdtA Cytolethal distending toxin A 
cdtB Cytolethal distending toxin B 
cdtC Cytolethal distending toxin C 
peb1a Bi-functional adhesion/ABC transporter aspartate/ glutamate-binding protein 
peb3 Major antigenic peptide PEB3 
peb4 Peptidyl-prolyl cis-trans isomerase 
pldA phospholipase A 
jlpA Surface exposed lipoprotein 
ciaB Campylobacter invasion antigen B 
ciaC Campylobacter invasion antigen C 
ciaI Campylobacter invasion antigen I 
cadF Outer membrane fibronectin-binding protein 
capA Auto-transporter protein 
fliA Flagellar biosynthesis RNA polymerase sigma factor 
porA Major outer membrane protein 
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htrA Serine Protease 
flgR Sigma-54 associated transcriptional activator 
flgS Signal transduction histidine kinase 
fspA flagellum-secreted non flagellar protein 
iamA ABC transporter ATP-binding protein 
htrA Serine protease 
 
3.1.3 Pan-Genomes 
Microbial pan-genomes were first studied in 2005 and this work showed that  bacteria 
can contain more genes than a single genome (Medini et al., 2005). The pan-genome 
approach to analysing bacterial genomes gives a much wider view of a bacterial 
population and defines the entire genomic repertoire of a  species which is made up of 
the core genome, genes shared in all isolates, and the accessory genome, genes shared 
by a subset of isolates, which contribute to species diversity and to niche lineages, 
which have adaptations for a new host or antibiotic resistance (Vernikos et al., 2015). 
Increasingly, there are more software options available in which to analyse sequences 
obtained from bacterial isolates. This has improved knowledge and made results more 
reliable thus shedding more light and obtaining a clearer picture of the relationship 
between sequences within a bacterial species. 
3.1.4 Recombination 
Recombination in relation to genetics is the rearrangement of DNA and has a strong 
impact on genetic diversity (Bishop and Schiestl, 2002; Helleday, 2010; Posada et al., 
2002). The relative recombination rate of a gene shows the frequency by which a new 
mutation in a single gene can occur (Fearnhead et al., 2015).  Recombination in bacteria 
is influenced by physical proximity and may lead to adaption to selective pressures, 
production of a new species and the exchange of DNA between distantly related 
bacterial strains (Chaguza et al., 2015; Fearnhead et al., 2015; Méric et al., 2015; 
Sheppard et al., 2008).  
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3.1.5 C. jejuni Survival 
There are many stresses that C. jejuni must cope with to survive in both the 
environment and host. These include oxidative stress, osmotic pressure, starvation, 
nitrosative stress, low pH and heat shock (Bronowski et al., 2014). However, C. jejuni 
has the ability to survive in a wide range of environments through many mechanisms 
such as the ability to form biofilms, undergo morphological changes and during periods 
of unfavourable conditions, such as a low nutrient environment, entering a purportedly 
viable but nonculturable (VBNC) state (Bronowski et al., 2014; Magajna and Schraft, 
2015; Murphy et al., 2006; Teh et al., 2014). 
Campylobacter needs to defend itself against atmospheric levels of oxygen and reactive 
oxygen species (ROS). Exposure of C. jejuni to light does not induce superoxide 
dismutase (SOD), the major defence against oxidative stress, instead catalase, encoded 
by katA, is induced but basal activity of SOD still occurs in C. jejuni  and may play a 
role in defence (Bronowski et al., 2014). For optimum growth, C. jejuni require 
microaerobic growth conditions with 85% N2, 10% CO2 and 5% O2 (Bolton, 2015; 
Davis and DiRita, 2008). 
3.1.6 Biofilm Formation 
The formation of multicellular biofilms is an ancient adaption shared by many bacteria 
and archaea (Pascoe et al., 2015). A biofilm is an aggregate of multiple bacterial layers 
encased in a polymeric substance. Biofilm is produced by C. jejuni  and helps 
attachment to the surface of a biomaterial,  aggregation of bacterial cells to each other 
and helps the survival of bacteria under stressful conditions (Joshua et al., 2006; Pascoe 
et al., 2015; Tolker-Neilsen, 2015). C. jejuni requires microaerobic conditions to grow 
and are thought not multiply in aerobic environment. However, the bacteria are found in 
such environments like natural waters but this may just be survival. It has been 
suggested that C. jejuni can survive in aerobic environments by forming biofilms 
(Joshua et al., 2006). Prevention of biofilm formation and degradation in C. jejuni has 
been observed through the use of DNase enzymes (Brown et al., 2015). In human 
infections, bacteria in biofilms are generally  more resistant to antibiotics compared to 
planktonic bacteria (Joshua et al., 2006). 
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3.1.7 Aims 
In this chapter an established collection of C. jejuni strains (Sheppard et al., 2008, 2013) 
from a variety of niches and STs were used to study population structure. This study 
used novel genomic tools, published in the last 3 years (Brynildsrud et al., 2016; 
Croucher et al., 2015; Page et al., 2015), to create a pan-genome of strains along with 
phenotypic experiments to analyse their motility, growth and biofilm assays, to give an 
overall view of population behaviour. Specifically the  aims were to: 
 Investigate C. jejuni diversity and population structure in 100 strains from 
difference sources using novel genomic tools to create a pan-genome of strains 
which can then be used to analysis recombination and gene presence/absence 
analysis  
 Investigate whether certain phenotypic differences in survival mechanisms exist 
between isolates in the C. jejuni population 
 Use GWAS methods to analyse the C. jejuni isolates from different sources for 
gene associations.  
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3.2 Materials and Methods 
 
3.2.1 C. jejuni isolates 
A collection of 100 fully sequenced isolates (Table 2.2 1-100) of C. jejuni from a 
variety of sources including 16 human, 42 chicken, 31 cattle, 10 wild birds and 1 
environmental strain was used in this study. These had been characterised previously to 
the genomic level (Sheppard et al., 2008, 2013). 
3.2.2 Campylobacter-BIGsdb 
Campylobacter-BIGsdb (Sheppard et al., 2012)  was used as described in section 2.3.1.  
3.2.3 Pan-Genome creation 
The pan-genome was created using Prokka (Seemann, 2014) and Roary (Page et al., 
2015) as described in section 2.3.  
3.2.4 GWAS using Scoary 
Scoary microbial pan-GWAS (Brynildsrud et al., 2016) was performed as described in 
section 2.3.3. Scoary was used to identify genes that were related to the different 
sources of the C. jejuni isolates (human, chicken, cattle and wild bird). 
3.2.5 SNP analysis and Recombination 
 Analysis of SNP and recombination using Geneious (Kearse et al., 2012b, 2012a) and 
Gubbins (Croucher et al., 2015) was performed as described in section 2.3.4. 
3.2.6 Growth and Biofilm assay 
The growth and biofilm assay was performed as described in section 2.2.15.  
3.2.7 Motility Assay 
The motility assay was performed as described in section 2.2.  
3.2.8 Statistics   
The two-way ANOVA with multiple comparisons and a Krustal-Wallis test with a post 
hoc Dunn‟s test for multiple comparisons were used with significance differences 
accepted if p≤0.05. Graphpad Prism 6.0 (San Diego, USA) was used to analyse and 
assess differences between treatment groups. 
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3.3 Results 
 
3.3.1 MLST Analysis of C. jejuni populations  
We selected C. jejuni strains that have been described previously (Sheppard et al., 2008, 
2013) . Isolates were chosen based on the availbility of  the „genome‟ and the „isolate‟. 
The MLST neighbour-joining tree was constructed with the 100 isolates (Table 2.2) 
used throughout this study. These were chosen from the laboratory‟s archived collection 
based on clonal complex and the source of C. jejuni (Figure 3.1).  
The MLST tree (Figure 3.1) revealed three areas with two distinctive clusters which 
match the two main sequence types, ST-45 and -21. Both STs contain isolates from a 
variety of sources. In addition, a third area between these two clusters may be identified, 
where lineages exist for isolates from unique sources.  Many of the wild bird isolates 
had their own unique STs, including 1034, 1332 and 702. However,  some of them 
showed close lineage with isolates obtained from chickens such as STs-702 and -1332.  
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Figure 3.1. MLST tree of 100 C. jejuni strains labelled by ST (colour), with clear points 
denoting strains from unqiue STs, and source (shape). Human, chicken, cattle and wild 
bird isolates are represented by a square, circle, triangle and diamond, respectively 
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3.3.2 Pan-genome Approach 
A pan-genome approach applying Prokka and Roary was used to construct a pan-
genome matrix (Figures 3.2 and 3.3). It contained 2715 genes, made up of 435 core 
genes (99% <= gene presence <= 100%), with an additional 700 in the soft core (95% 
<= gene presence < 99%) totalling 1135 present in the core.  There were 1580 genes in 
the accessory genome made up of 547 shell genes (15% <= gene presence < 95%) and 
1033 cloud genes (0% <= gene presence < 15%) (Figure 3.3). The maximum likelihood 
phylogenetic tree generated using Roary and MEGA6 (Figure 3.2) displayed two 
distinct clusters (32 strains within CC-45 and 28 strains within CC-21) both containing 
a mix of isolates from human and chicken sources (5 human and 18 chicken strains 
within CC-45 and 7 human and 14 chicken strains within CC-25). NCTC 11168 
clustered with the CC-21 isolates, whereas M1, another strain used as a reference 
isolate, clustered with the CC-45 isolates as expected and reported previously in Figure 
3.1 (Figure 3.2). 
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Figure 3.2. Phylogenetic tree of the pan genome of the C. jejuni from 100 isolates taken 
from a variety of sources with two reference strains, 11168 and M1 included. 11168 and M1 
cluster within the two main clonal complexes CC-21 and CC-45, respectively. 
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Figure 3.3. Representation of the pan-genome showing the core and accessory genome with relation to the phylogenetic tree. The core 
genome is made up of the Core (99% <= gene presence <= 100%), and the soft core (95% <= gene presence <= 99%) whereas the 
accessory genome is made up of the shell (15% <= gene presence <=95%) and the cloud genes (0% <= gene presence <= 15%). 
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3.3.3 Core vs. Accessory Genome 
The core genome of the 100 C. jejuni isolates analysed totalled 1135 genes which 
included core and soft-core ones. Of these genes, 246 were found to be hypothetical 
proteins and were removed from further analysis, as no credible information could be 
drawn from them. The accessory genome totalled 1580 genes in both the shell and 
cloud, of which 808 were hypothetical proteins and removed from further analysis 
(Figure 3.3). 
Analysis of known virulence genes (Table 3.1) demonstrated the presence of the 
motility genes flgS and flgR in the core genome with flaC located in the accessory 
genome. Two adhesion linked genes; pebA1 and pldA, were found in the core genome 
with all others being present in the accessory genome (Table 3.2). All cdt toxicity genes 
were in the accessory genome whereas the invasion linked genes ciaB, ciaC and ciaI 
were all found within the core. The remaining invasion-linked genes, htrA, iamA and 
fspA, were within the accessory genome (Table 3.2). All known antimicrobial resistance 
genes were in the accessory genome including cmeB, aadE, tet(O), blaOXA-61 and aph-3-
I.  
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Table 3.2. Presence of known virulence linked genes in the core and accessory genome 
Gene Name/Function Core Accessory 
flaA Flagellin A  x 
flaB Flagellin B  x 
flaC Flagellin C  x 
flgS Signal transduction histidine kinase x  
flgR Sigma-54 associated transcriptional 
activator 
x  
cadF Outer membrane fibronectin-binding 
protein 
 x 
capA Auto-transporter protein  x 
pebA1 Bi-functional adhesion/ABC transporter 
aspartate/ glutamate-binding protein 
x  
peb3 Major antigenic peptide PEB3  x 
peb4 Peptidyl-prolyl cis-trans isomerase  x 
pldA phospholipase A x  
jlpA Surface exposed lipoprotein  x 
ciaB Campylobacter invasion antigen B x  
ciaC Campylobacter invasion antigen C x  
ciaI Campylobacter invasion antigen I x  
htrA Serine protease  x 
iamA ABC transporter ATP-binding protein  x 
fspA flagellum-secreted non flagellar protein  x 
cdtA Cytolethal distending toxin A  x 
cdtB Cytolethal distending toxin B  x 
cdtC Cytolethal distending toxin C  x 
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3.3.4 Analysis of C. jejuni virulence factors in the accessory genome 
The presence of known virulence genes found in the accessory genome (Table 3.2) of 
the C. jejuni strains were analysed using gene-by-gene analysis (Figure 3.4 and Table 
3.3). The flaA/B genes showed the lowest presence across the 100 isolates, compared to 
all other genes investigated, with only 23% of all genomes containing flaA/B. All three 
cdt genes were present in almost all human, chicken and cattle strains. Isolates from 
wild birds had a lower presence of cdtA, with it only being present in 60% of strains 
compared to 90% with both cdtB and cdtC. No association was found when comparing 
genes present in the accessory genome and source of C. jejuni isolate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Presence of known virulence genes from the accessory genome in strains isolated from 
human, chicken, cattle and wild bird sources. 
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Table 3.3. Presence of known virulence genes in the core and accessory genome of  C. 
jejuni populations 
Gene Gene Presence (%) Presence within core genome 
(%) Human Chicken Cattle  Wild Bird 
flgS 100.00 100.00 100.00 100.00 100.00 
flgR 100.00 100.00 100.00 100.00 100.00 
pebA1 100.00 100.00 100.00 100.00 100.00 
pldA 100.00 100.00 100.00 100.00 100.00 
ciaB 100.00 100.00 100.00 100.00 100.00 
ciaC 100.00 100.00 100.00 100.00 100.00 
ciaI 100.00 100.00 100.00 100.00 100.00 
 Presence within accessory 
genome (%) 
flaA/B 21.43 17.95 34.62 40.00 23 
flaC 100.00 62.50 40.54 70.00 66 
cadF 100.00 87.18 80.77 90.00 78 
capA 56.25 33.33 34.62 20.00 33 
peb3 87.50 82.05 76.92 70.00 71 
peb4 100.00 94.87 84.62 50.00 78 
jlpA  100.00 76.92 73.08 90.00 72 
flpA  100.00 74.36 76.92 100.00 73 
htrA 100.00 64.10 76.92 100.00 69 
iamA 71.43 79.49 92.31 100.00 75 
fspA 57.14 33.33 34.62 60.00 36 
cdtA 100.00 95.83 94.59 70.00 86 
cdtB 100.00 95.83 91.83 90.00 91 
cdtC 87.50 85.42 91.89 90.00 88 
 
3.3.5 GWAS of C. jejuni strains by source 
Scoary was used to investigate association between gene presence/absence and source 
of the C jejuni isolates. Scoary compared isolates from one particular source to every 
other source. For example, human isolates were compared to chicken, cattle and wild 
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bird ones. Scoary found 22 genes linked specifically to human isolates, excluding 15 
hypothetical proteins. Genes related to human isolates had a variety of characteristics 
including lipoproteins (nlpA), heme related (hemH), flagellar (flgE), RNA degradation 
(rppH) and transporter proteins (proP) (Table 3.4).  The genes rppH and hemH were 
significantly related to human isolates being found to be trait positive in 13 of the 16 
human strains, both yielding p values of 0.02 (Table 3.4). All 22 genes found were 
significantly related to human isolates (Appendix Table 8.3). 
Scoary identified 27 genes linked to chicken isolates, excluding 23 hypothetical 
proteins. Among those related to chicken sources were genes encoding for Sigma factor 
54 transcriptional activator (flgR), drug resistance proteins (Cj1375), iron transporters 
(feoB), exporters (ymfD) and transferases (murG) (Table 3.5). The gene murG was trait-
positive in 40 of the 42 chicken isolates and significantly related with (p = 0.01). The 
genes ntrC and ykkC were trait positive in 39 and 34 chicken isolates, respectively. All 
27 genes found were significantly related to the chicken trait (Appendix, Table 8.4).  
Table 3.4. Top genes (highest trait positive scores) found to be associated with strains 
isolated from humans. 
Gene Locus Tag Annotation Trait Positive 
Isolates 
p Value 
rppH Cj0581 RNA pyrophosphohydrolase 13 0.026217 
hemH Cj0503c Ferrochelatase 13 0.026217 
nlpA Cj0771c Lipoprotein 28 12 0.031127 
patA Cj0639 Peptidoglycan O-
acetyltransferase 
11 0.006454 
dsbL Cj0865 Thiol:disulfide interchange 
protein DsbL 
11 0.024205 
clpA Cj1108 ATP-dependent Clp protease 
ATP-binding subunit ClpA 
11 0.024205 
proP Cj0339 Proline/betaine transporter 10 0.010203 
flgE Cj0043 Flagellar hook protein FlgE 8 0.005657 
aldA Cj1548c Lactaldehyde dehydrogenase 7 0.006670416 
 
hddC Cj1431c D-glycero-alpha-D-manno-
heptose 1-phosphate 
guanylyltransferase 
 
7 0.035565058 
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Table 3.5. Top genes (highest trait positive scores) found to be associated with strains 
isolated from chickens. 
Gene Locus Tag Annotation Trait Positive 
Isolates 
p Value 
murG Cj1039 UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol 
N-acetylglucosamine transferase 
40 0.015864 
flgR Cj024c Sigma-54 associated 
transcriptional activator 
39 0.039786 
Cj1375 Cj1375 Multidrug efflux transporter 34 0.041552 
grpE Cj0758 Protein GrpE 32 0.000992 
ymfD Cj1687 Bacillibactin exporter 31 0.015862 
feoB Cj1398 Ferrous iron transport protein B 29 0.000442 
torC Cj0265c Cytochrome c-type protein TorC 21 0.006902 
metC Cj1392 Cystathionine beta-luase 15 0.001326 
porA Cj1259 Major outer membrane protein 9 0.004334 
 
Scoary identified 41 genes related to cattle isolates, excluding 30 hypothetical proteins. 
Among those from cattle sources were genes encoding for flagellar associated gene 
(fldD), iron transporter (feoB), and a histidine binding (hisJ) (Table 3.6). The genes flgD 
and feoB were found to be trait positive in 25 of the 31 cattle isolates and significantly 
related with p values of 0.03. All 41 genes found were significantly related to the cattle 
trait (Appendix, Table 8.5). 
Scoary revealed 90 genes related to wild bird isolates, excluding 82 hypothetical 
proteins. The genes found to be trait positive with the highest frequency included ones 
encoding for a DNA ligase (ligA), bacterial haemoglobin (cgb) and sensor proteins 
(cj1492c). Within 9 of the 10 wild bird isolates the genes hrcA and hydA were found to 
be trait positive with significant associations (p values of 0.002 and 0.004, respectively; 
Table 3.7). All 90 genes found were significantly related to the wild bird trait 
(Appendix Table 8.6).  
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Table 3.6. Top genes (highest trait positive scores) found to be associated with strains 
isolated from cattle. 
Gene Locus Tag Annotation Trait Positive 
Isolates 
p Value 
flgD Cj0042 Basal-body rod modification 
protein FlgD 
25 0.030579 
pyrC Cj0259 Dihydroorotase 25 0.030579 
feoB Cj1398 Ferrous iron transport protein B 25 0.032227 
panB Cj0298c 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
24 0.000306 
dgkA Cj0257 Diacylglycerol kinase 24 0.005679 
panC Cj0297c Pantothenate synthetase 23 0.002187 
panD Cj0296c Aspartate 1-decarboxylase 23 0.002187 
hisJ Cj0734c Histidine-binding protein 22 0.011435 
fabD Cj0116 Malonyl CoA-acyl carrier 
protein transacylase 
22 0.019578 
 
 
Table 3.7. Top genes (highest trait positive scores) found to be associated with strains 
isolated from wild birds. 
Gene Locus Tag Annotation Trait Positive 
Isolates 
p Value 
hrcA Cj0757 Heat-inducible transcription 
repressor HrcA 
9 0.002728 
hydA Cj1267c Quinone-reactive Ni/Fe-
hydrogenase small chain 
9 0.004608 
 
cj1492c 
Cj1492c Sensor protein  8 0.009051 
 
ligA 
Cj0586 DNA ligase 8 0.029978 
hddA Cj1425c D-glycero-alpha-D-manno-
heptose 7-phosphate kinase 
8 0.033468 
gmhA Cj1149c Phosphoheptose isomerase 8 0.036215 
yajR Cj1241 Inner membrane transport 
protein YajR 
7 0.025536 
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cgb Cj1586 Bacterial hemoglobin 7 0.025536 
fdhC Cj1509c Formate dehydrogenase, 
cytochrome b556(fdo) 
subunit 
7 0.025536 
CarB Cj0279 Carbmoyl-phosphate 
sythase large chain 
7 0.04836 
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3.3.6 Recombination in C. jejuni isolates  
Through the use of Gubbins (Croucher et al., 2015) a total of 39,916 SNPs were 
detected in the isolates and 25,091 of these were outside recombination regions and so 
excluded from further analysis. A total of 14,825 SNPs were detected within 
recombination regions. Most of the regions detected were shared by multiple isolates 
(red regions) (Figure 3.5). However, there were unique recombination sites identified in 
many isolates (blue regions) (Figure 3.5).  Using Gubbins, the rate of nucleotide change 
caused by recombination was measured, relative mutation in ST-45 strains (r/m= 2.82) 
occurred at a higher rate compared to relative mutation in ST-21 strains (r/m= 1.47). 
Variation was also observed in recombination estimated from different sources of C. 
jejuni. Relative mutation rate in isolates taken from human sources (r/m= 5.97) occurred 
at a much higher rate compared to chicken (r/m= 3.86), cattle (r/m= 4.92) and wild bird 
isolates (r/m= 2.48).
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Figure 3.5. Representation of recombination regions present within the 100 Campylobacter genomes analysed. Red regions represent recombination 
regions shared with two or more isolates while blue regions denote unique recombination regions to an individual isolate. 
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3.3.7 Growth of C. jejuni  
The 100 C. jejuni isolates were subjected to growth assays under varying conditions. 
They were grown at 37 and 42
o
C in a microaerobic environment (Figure 3.6a), where 
strains grown at 42
o
C grew at a significantly (p <0.05) faster rate and to a significantly 
(p <0.05) higher population density than ones grown at 37
o
C. A similar trend was 
observed when strains were grown under normal atmospheric conditions albeit to a 
lower extent (Figure 3.6b) and no significant difference (p >0.05) between strains 
grown at 37 and 42
o
C was observed. All 100 strains from the various sources grew at 
similar rates. 
 
Figure 3.6. Growth of Campylobacter jejuni (n=100) strains under varying conditions. 
a) Strains subjected to a microaerophilic environment at 37
o
C   and 42
o
C; b) strains 
subjected to normal atmospheric conditions at 37
o
C and 42
o
C. 
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3.3.8 Biofilm Formation  
A 25% sub-group of C. jejuni isolates categorised by presence of the genes flaA/B as 
well as strains from a variety of STs (Appendix table 8.1) were used to test the ability of 
the strains to form biofilm using analysis with crystal violet, with an absorbance 
(570nm) of greater than 0.1 defined as biofilm positive. The C. jejuni strains grown at 
42
o
C were shown to form the strongest biofilms in a microaerobic atmosphere (Figure 
3.7a) with a significant difference (p≤0.01) shown between strains grown at this 
temperature and at 37
o
C. Under normal atmospheric conditions strains grown at 42
o
C 
displayed a trend towards stronger biofilms but results did not reach significance 
(Figure 3.7b). C. jejuni strains grown in a microaerobic atmosphere produced stronger 
biofilms at both temperatures (Figure 3.7); with significantly stronger biofilms formed 
at 42
o
C under microaerobic conditions (p≤0.01). No differences were observed between 
biofilms formed by strains from difference sources at either temperature (Figure 13cd). 
 
Figure 3.7. Effect of growth atmosphere and temperature on C. jejuni biofilm formation 
analysed through crsytal violet. C. jejuni strains were grown at 37 and 42
o
C under 
microaerophilic conditions (a) and under normal atmospheric conditions (b), with 
biofilm organised by source of C. jejuni strain at 42
 
 (c) and 37
 o
C (d). Results are also 
expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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3.3.9 Motility of C. jejuni strains  
The motility of a 25% sub group of C. jejuni isolates categorised by presence of the 
genes flaA/B as well as strains from a variety of STs (Appendix table 8.1) was measured 
with isolates from human sources found to have the greatest motility compared to 
strains from chickens, cattle and wild birds. Isolates from chickens showed the lowest 
motility overall; a significant difference was observed between human and chicken 
isolates (p≤0.05;Figure 3.8). Isolates that were flaA/B positive (shown in green on 
Figure 3.8) usually had the highest rates of motility compared to isolates which were 
flaA/B negative; with a significant difference (p≤0.05) seen when flaA/B positive 
isolates were compared to the flaA/B negative isolates (Figure 3.8). 
 
Figure 3.8. Motility assay performed on a 25% sub-group of C. jejuni isolates from (a) 
different sources and (b) motility in regards to the presence of flaA and flaB genes . 
Isolates coloured green represent isolates which are flaA/B positive. Results are also 
expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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3.4 Discussion 
A population of C. jejuni isolates from a variety of different sources and sequence types 
was analysed. MLST analysis of the 100 C. jejuni strains displayed two distinct clusters 
of clonal complexes ST-21 and -45 in the neighbour joining tree. These are the two 
most common C. jejuni clonal complexes reported and this grouping is to be expected 
and supports previous publications (Méric et al., 2014; Sheppard et al., 2008).  MLST 
analysis of C. jejuni isolates provided a good initial phylogenetic analysis of the dataset 
in conjunction with the Campylobacter MLST database 
(http://pubmlst.org/campylobacter/) which contains over 60,000 isolates as of June 2018 
and is widely used by Campylobacter researchers (Dingle et al., 2001; Jolley and 
Maiden, 2010; Jorgensen et al., 2011; Kittl et al., 2013; Sheppard et al., 2008).  Whilst 
MLST characterised the phylogeny it could not answer questions on the presence or 
absence of key virulence genes amongst the strains and so further genomic 
identification was necessary.  
Creation of the C. jejuni pan-genome which used C. jejuni NCTC 11168 as a reference 
strain resulted in one containing 2715 genes; of which 1135 were present in the core 
genome. Roary was run with a 95% cut off for the core genome to create a pan-genome 
of only the most essential genes found in C. jejuni. C. jejuni NCTC 11168 was used, as 
it remains a well-characterised and widely used reference strain in Campylobacter 
studies (Dingle et al., 2001; Hall et al., 2010; Koolman et al., 2016; Sheppard et al., 
2012) and was the first C. jejuni strain to have its whole genome sequenced and 
annotated (Parkhill et al., 2000). The pan-genome consisted of C. jejuni isolates only 
and so is relatively small compared to other Campylobacter pan-genomes previously 
created using both C. jejuni and C. coli (Lefebure et al., 2010; Méric et al., 2014). 
Creation of a maximum likelihood tree from the pan-genome resulted in a similar 
phylogenetic tree to the one created using MLST data with the characteristic clusters of 
clonal complexes ST- 45 and -21 on either end of the tree. Pan-genome approaches to 
genome analysis provide a much higher strain typing resolution than MLST, allowing 
discrimination among many bacterial strains within a species (Hall et al., 2010). The 
pan-genome was created using Prokka and Roary (Page et al., 2015; Seemann, 2014), 
and through the use of this software a more up to date view of the population of C. 
jejuni has been created and thus provides a clearer and more in-depth analysis of the 
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population as the software has been demonstrated  high speed applications to construct 
pan genomes with many third party analysis tools using Roary results which can be 
integrated for further analysis and visualisation  (Yu et al., 2017). 
Gene by gene analysis of known virulence genes in the sequences yielded large 
differences in flaA/B, flaC and cdtA. The flaA/B genes were absent in 71.05% of the 
strains analysed which led to the phenotypic analysis of the motility of the isolates 
however this lack of flaA/B could be due to variation within the genes and further 
analysis of the allelic differences of the fla genes could provide invauable insight. The 
apparent absence of flaA/B did not seem to affect motility with all strains being motile. 
However, the absence of these genes may affect the ability of C. jejuni to invade into 
epithelial cells as flaA is essential for invasion into such cells and responsible for 
adherence to them (Jain et al., 2008).  The absence of flaC  may also effect invasion and 
adhesion as Faber et al., found that flaC is a secreted effector flagellin which may help 
to modulate the immune response and invasion into epithelial cells (Faber et al., 2015).  
The cdtA gene was present in almost all strains isolated from humans, chickens and 
cattle; however, there was a marked decrease of cdtA presence in the strains isolated 
from wild birds, which warranted more attention. This gene encodes for cytolethal 
distending toxin A, one part of three subunits of CDT which causes DNA damage and 
leads to cell death (Lee et al., 2003). The lack of cdtA could prevent the correct 
formation of CDT in these strains resulting in lower toxicity to host cells. Indeed this 
was investigated in later work described in Chapter 4 with human and chicken epithelial 
cells. All CDT genes, cdtA, cdtB and cdtC, were found in the accessory genome. The 
presence of these genes throughout the isolates may contribute to the overall severity of 
C. jejuni strains during infection with strains lacking cdt genes being less harmful to a 
host compared to strains with the ability to produce CDT and cause toxicity in a host 
which supports work by Jain et al where CDT
+
 strains of C. jejuni were more effectively 
adhered and invaded into epithelial cells compared to CDT
-
 ones (Jain et al., 2008). 
Analysis of genes present in the core and accessory genome yielded the presence of 
some interesting known virulence genes. The motility genes flaA and flaB were  present 
within the accessory genes, both fla genes being present in the same genome is to be 
expected as flaA and flaB are gene duplications that have specialised. This is a good 
example of one of the major mechanism of gene evolution (Meinersmann and Hiett, 
2000). The flgS and flgR genes which are responsible for flagellar biosynthesis were 
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also present in the core genome which form Campylobacter flagellin. It is no surprise 
that these genes were present in most C. jejuni strains as they provide functional 
motility and promote colonisation and survival as mutational studies of flagella have 
found that flagella appear to be required for maximal biofilm formation (Guerry, 2007; 
Joslin and Hendrixson, 2009; Reeser et al., 2007). The Campylobacter invasion antigen-
associated genes, ciaB, ciaC and ciaI, were all present within the core genome. The cia 
genes have been known to help invasiveness and intraceullular survival of C. jejuni 
(Buelow et al., 2011; Koolman et al., 2016; Neal-McKinney and Konkel, 2012). The 
Cia proteins also use flagellar export apparatus and so the presence of these genes and 
the fla and flg genes in the core genome may help C. jejuni to survive and invade into 
host cells (Konkel et al., 2004). All antimicrobial resistance genes were found in the 
accessory genome; suggesting strains with unique resistance profiles.  This is consistent 
with studies confirming that resistance is on the rise over the last decade (Bardoň et al., 
2017; Guévremont et al., 2006; Obeng et al., 2012; Ruiz-Palacios, 2007).  
Using Scoary, differences in genes related to the source of the isolate were identified. 
Wild bird isolates had 90 genes closely related to the trait. The cause of such a high 
number of genes being linked to this trait could be due to wild birds having less contact 
with other reservoirs of C. jejuni compared to cattle and poultry and so have evolved 
into a separate niche (Griekspoor et al., 2013; Sheppard et al., 2011). Another possible 
explanation could be due to the wild bird isolates encompassing many different species 
including geese, ducks and starling. We might speculate that each of these birds will 
have different gut environments and Campylobacter found in them may have their own 
specific genes essential for niche adaption.  
The 22 genes were related to human isolates including: hddC, a heptose transferase, 
which is related to the polysaccharide capsule an interface between the bacteria and the 
environment and so may contribute to the virulence of human strains (Poly et al., 2011). 
Another gene, flgE, which encodes for the flagellar hook protein FlgE was also found to 
be related to human isolates which may contribute to motility and thus their virulence . 
Matsunami et al (2016) showed that the protein FlgE in C. jejuni provides stability and 
robustness of the hook which helps survival of C. jejuni thus the human isolates may 
have a better chance of survival compared to strains from chickens, cattle and wild birds 
(Matsunami et al., 2016).  
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Strains from chickens had 27 genes related to the chicken source including flgR, a 
sigma-54 associated transcriptional activator and Cj1375, a multidrug efflux transporter, 
which could aid the persistence of C. jejuni in chickens, particulalry if they are treated 
with antibiotics. The motility linked flgR, a NtrC-like protein which are a family of 
transcriptional activators and Joslin et al (2008) found that flagellar motility, 
specifically FlgR activation mechanisms, are utilised to control the transcription of 
target genes.  Multiple studies have shown that non-motile isolates are less invasive and 
thus the ability to control flagella more efficiently could give a large advantage to C. 
jejuni isolates (Baldvinsson et al., 2014; Golden and Acheson, 2002; O Cróinín and 
Backert, 2012). Thus, I might suggest that strains isolated from chicken  may be able to 
utilise  FlgR activation mechanisms to control flagellar motility more efficiently, and 
this could help C. jejuni migration from the gut and enter other organs such as the liver 
(Jagannathan et al., 2000; Joslin and Hendrixson, 2008; Reid et al., 2016). 
Scoary identified 41 genes related to strains isolated from cattle. Among these was gene 
feoB, which encodes for a ferrous iron transporter protein which Naikare et al (2006) 
showed to have a major role in the acquisition, gut colonisation and persistence, which 
may help to explain the ability of C. jejuni to persist in cattle. These animals possess a 
complex four compartment stomach, small intestine and large intestine and so 
acquisition and regulation of iron by C. jejuni may help contribute to survival (Palyada 
et al., 2004). 
High rates of recombination due to mutations were found in the isolates analysed.  
Interestingly, the normal rate of recombination in C. jejuni has been estimated to be r/m 
= 2.2 (Vos and Didelot, 2009).  Recombination rates between the different sources may 
help to explain the differences seen between different source lineages when a 
Campylobacter lineage transfers to a new animal host it could acquire DNA from the 
resident population through horizontal gene transfer. This has been observed by 
McCarthy et al (2007) and Wilson et al (2008) where C. jejuni lineages isolated from 
chicken contained alleles that originated in chicken specialist genotypes.  These 
recombination rates are much higher than those of other bacteria such as Staphylococcus 
aureus and Escherichia coli which have very low rates of r/m = 0.1 and 0.7, 
respectively. This could help C. jejuni to adapt and survive within their environment  
(Vos and Didelot, 2009). However, there are also many bacteria which have much 
larger rates of recombination such as Helicobacter pylori and Salmonella enterica 
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which have recombination rates of r/m = 13.6 and 30.2, respectively (Vos and Didelot, 
2009).  The higher rate of recombination found in human strains may be due to higher 
selective pressures within such a  host. 
A total of 25,091 SNPs were detected outside of recombination regions and were 
excluded as mutations found in single isolates provide very little information about the 
shared ancestry between lineages. They are specific to single isolates and could be 
caused by a number of different factors such as a single mutation (Posada et al., 2002). 
SNPs found in recombination regions shared between two or more isolates, reveal 
ancestry and evolution between isolates. A total of 14,825 SNPs were detected within 
recombination regions which could form the basis for further analysis into what changes 
have occured. 
All C. jejuni strains tested were able to grow at both 37 and 42
o
C as shown previously  
(Davis and DiRita, 2008; Silva et al., 2011).  Overall the optimal growth was  at 42
o
C at 
both high and low oxygen concentrations, irrespective of the source of the isolate.  This 
supports work published previously by Zanetti et al (1996).  The optimal growth at 42
o
C 
with a low oxygen concentration also linked to optimal biofilm formation with the 
strongest biofilms also seen at this temperature with a low oxygen concentration. 
A sub-group of C. jejuni strains was chosen to perform biofilm and motility assays 
based on a number of criteria; i) ST to select representative strains on the 
Campylobacter phylogenetic tree; ii)  presence / absence of motility and biofilm linked 
genes and iii) the source of the C. jejuni strain (Appendix table 8.1).  Biofilm 
production was measured in a variety of different environments and conditions, 
including under micoaerobic conditions and under normal atmospheric conditions at 37 
and 42
o
C to analyse the ability of the C. jejuni strains to survive in different conditions 
that the bacteria could be exposed to in an environmental, industrial or clinical setting 
(Bolton, 2015; Garénaux et al., 2008; Teh et al., 2014). The strongest biofilms were 
formed under microaerobic conditions at 42
o
C, as shown  previously (Davis and DiRita, 
2008; Joshua et al., 2006; Pascoe et al., 2015). The strongest biofilms are formed when 
the strains can grow and proliferate (Davis and DiRita, 2008). All the strains tested were 
able to form a biofilm with the cut off being set at above OD600 = 0.1 (Pascoe et al., 
2015), although most biofilms formed were weak when compared to those created by 
bacteria such as Staphylococcus spp. (Archer et al., 2011; Harris et al., 2016).  
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The motility of the sub-group of strains was tested later; every C. jejuni strain was 
motile but with a large range of motility. C. jejuni strains that were isolated from human 
sources were the most motile. Interestingly, C. jejuni from clinical samples are more 
pathogenic and identified as hyper-invasive by Fearnley er al (2008) (Fearnley et al., 
2008).  
This chapter has provided evidence identifying numerous genes in C. jejuni that may 
provide a survival advantage in the environment and in the host through flagellar 
motility and transferase genes such as hddC which relate to an interface between the 
bacteria and the environment. In the next chapter the role of the host is investigated 
further by investigating the human and chicken immune responses produced by the 100  
C. jejuni strains in a high-throughput in vitro epithelial cell system. 
3.5 Conclusion 
This work adds to the growing number of studies showing the diverse population 
structure of C. jejuni.  Irrespective of the source of the isolates, there were differences 
genomically and phenotypically, which shows that no one strain of Campylobacter can 
represent how the entire population may act in difference circumstances.A pan-genome 
approach was applied to a population of C. jejuni strains to better understand the spread 
of virulence genes in the core and accessory genome with GWAS used to identify 
association between genes and the source animal of a strain.  High levels of 
recombination within the population may also contribute to its survival through rapid 
evolution via mutations with high recombination rates observed compared to other 
bacterial species. Scoary was also able to find many genes related to particular sources 
of C. jejuni which could be used for potential markers. To conclude, Campylobacter is 
highly variable with a diverse population which contains large strain to strain variation 
and thus there is no one C. jejuni isolate that can represent the population. 
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Chapter 4: Diverse responses of Campylobacter jejuni strains in human and 
chicken intestinal epithelial cells  
4.1 Introduction 
4.1.1 Campylobacter jejuni pathogenesis in humans and chickens 
C. jejuni is pathogenic to humans and chickens. Studies confirm that C. jejuni behaves 
as a pathogen in chicken hosts although mechanistic understanding is incomplete 
(Figure 4.1; (Byrne et al., 2007; Humphrey et al., 2014; Jennings et al., 2011; Ruiz-
palacios et al., 1981; Williams et al., 2013). C. jejuni was first shown to be able to 
adhere and invade into chicken epithelial cells in vitro by Byrne et al, (2007) with 
invasion into chicken cells showing an efficiency that was comparable to primary 
human cells in vitro (Byrne et al., 2007). Later, Jennings et al (2011) discovered a link 
between C. jejuni and the development of vibrionic hepatitis, also known as spotty liver 
disease which is characterised by the presence of focal lesions that are greyish-white in 
colour. Chickens with spotty livers contained predominately Campylobacter, thus 
showing the ability of C. jejuni to leave the gastrointestinal tract (Jennings et al., 2011). 
Further research by Williams et al., (2013) discovered that broiler chickens infected 
with C. jejuni had increased incidence of hock marks and pododermatitis. Thus 
infection by this bacterium affects the health and welfare of such animals as shown 
almost 30 years earlier (Williams et al., 2013).  Then, Humphrey et al (2014) also 
showed that C. jejuni is not a commensal in broiler chickens and affects bird welfare. 
Infection led to a large pro-inflammatory innate immune response in some chicken 
breeds with intestinal inflammation  and damage to gut mucosa causing the animals to 
suffer from diarrhoea. In other broiler types, infection caused much less damage to the 
gut mucosa and the animals remained largely well Humphrey et al (2014). 
Campylobacter jejuni strains also differ in virulence in chickens. 
4.1.2 Role of epithelial cells in Campylobacter pathogenesis  
C. jejuni has been shown to adhere efficiently to and enter chicken intestinal epithelial 
cells. in vitro and in vivo mice models confirm consistent roles for pathogen recognition 
by the host through TLRs-2, -4, -5 and -9 following Campylobacter infection (Friis et 
al., 2009; Hara et al., 2012; Rathinam et al., 2009). However, a recent study suggests 
that there may well be differential activation between human and chicken receptors 
adding to the complexity of responses (De Zoete et al., 2010). 
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Figure 4.1. Interaction of Campylobacter with host epithelial cells in human and 
chicken derived cells 
4.1.3 Campylobacter induced signalling pathways in epithelial cells 
Early host cell responses to Campylobacter are better understood in human than with 
chicken intestinal epithelial cells (Figure 4.1).  Thus, Campylobacter flagellin stimulates 
TLR5 found on the apical surface of intestinal epithelial cells to initiate signalling for 
CXCL8, the gene encoding for IL-8 in humans (Borrmann et al., 2007) and CXCLi1 and 
CXCLi2 chickens (Larson et al., 2008). 
In human intestinal epithelial cells, Campylobacter activates signalling pathways such 
as phosphoinositide 3-kinase/protein kinase B/Akt (PI3K/Akt) and the mitogen 
activated protein kinase (MAPK) pathways resulting in the induction of IL-8 and IL-10. 
In addition, adhesion and invasion by C. jejuni, along with its secreted toxin CDT, are 
thought to be the main factors driving IL-8 production (Li et al., 2011). Interestingly, 
inhibition of the PI3K/Akt signalling pathway in human epithelial cells infected with C. 
jejuni resulted in a reduction of IL-10 and an increase in IL-8 production which may 
help C. jejuni survive intracellularly suggesting that pro and anti-inflammatory 
pathways exist in human intestinal cells (Li et al., 2011). In contrast, there has been a 
lack of work regarding the action of Campylobacter in chicken epithelial cells lines 
compared to the vast research into responses in human cell lines (Hickey et al., 1999, 
2000; Jin et al., 2003; Jones et al., 2003). In addition, in the chicken macrophage cell 
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line (HD11) there is evidence that there is a robust inflammatory response to 
Campylobacter spp. (Smith et al., 2005). Therefore, there is increasing evidence that 
Campylobacter is not merely a commensal in chickens and causes an immune response 
as discussed in previously (Humphrey et al., 2014). Further understanding the response 
of chicken cells to Campylobacter forms the basis for the work in this chapter. 
 
4.1.8 Aims 
Using the 100 C. jejuni strains characterised in chapter 3 the inflammatory (cytokine), 
adhesion, invasion, toxicity and signalling responses induced in HT-29 (human) and 
8E11 (chicken) intestinal epithelial cells were investigated to:  
 Characterise a novel commercially available chicken epithelial cell line, 8E11  
 Determine the inflammatory responses of chicken epithelial cells to C. jejuni 
strains 
 Investigate how the presence/absence of known virulence genes in C. jejuni 
affect the inflammatory response 
 Investigate the signalling pathways responsible for gene expression and C. jejuni 
invasion responses  
 Associate Campylobacter virulence genes to in vitro cell responses by Scroary 
GWAS pipeline.  
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4.2 Materials and Methods 
4.2.1 Bacterial isolates 
Bacteria were grown on either Oxoid CBA (Thermo-scientific) or on mCCDA (Oxoid) 
plates and incubated at 42
o
C under microaerobic conditions using CampyGen
TM
 3.5L 
sachets (Thermo-scientific). C. jejuni strains were cultured under microaerobic 
conditions (5% O2, 10% CO2, 85% N2).  A single colony was inoculated into Muller-
Hinton broth (Oxoid) and incubated at 37
o
C for 24 hours. All isolates used were 
subcultured from a stock stored at -80
o
C. All C. jejuni strains used in this study can be 
seen in Appendix, Table 8.2.  
4.2.2 Culture of human and chicken intestinal epithelial cells 
The culture of both human and chicken lines was performed as described in section 
2.2.3 
4.2.3 Infection studies 
Cell monolayers were infected with 50µl of bacterial suspension, containing 
approximately 3.5x10
5 
CFU per well. The infected monolayers were incubated for 4, 6 
and 24 hours at 37
o
C in a 5% CO2 atmosphere to allow the bacteria to adhere and invade 
the host cells. Uninfected cells and ones treated with PMA were included in the 
experiments as a negative and positive control.  
4.2.4 Human cytokine antibody array assay 
The human cytokine antibody array membrane with 42 targets (Appendix Table 8.10) 
(Abcam, Cambridge, UK) was used to measure and detect 42 human cytokines from 
human cell lines infected or uninfected with two typed C. jejuni strains, 11168 and M1 
(Table 2.2). Assays were performed according to the manufacturer‟s instructions; 
briefly, the membranes were treated with 2ml of the blocking buffer provided. Then, 
1ml of the culture supernatants from infection studies and from an uninfected control 
sample were added for 2 hours at room temperature. Membranes were washed three 
times using the wash buffers I and II, provided. Then, 1ml of the biotin-conjugated anti-
cytokine antibody conjugate was added to each membrane and incubated overnight at 
4°C. Membranes were washed again before 2ml of HRP-conjugated Streptavidin was 
added to each well and incubated at room temperature for 2 hours. The membranes were 
washed again prior to chemiluminescence detection. The membranes were treated with 
500µl of the detection buffers provided and incubated for 2 minutes at room 
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temperature. They were then imaged using BioRad ChemiDoc XRS+ (BioRad, UK). 
The images were analysed using ImageJ to plot mean pixel density. 
4.2.5 Enzyme linked immunosorbant assay (ELISA) 
The ELISAs were performed as described in section 2.2.5. 
4.2.6 RNA Isolation 
Total RNA was isolated from HT-29 human or 8E11 chicken intestinal epithelial as 
described in section 2.2.6. 
4.2.7 Quantitative PCR of RNA transcripts 
Quantitative PCR was performed using SYBR green as described in section 2.2.7. 
Primer efficiency was measured using total RNA from epithelial cells infected with a 
reference C. jejuni isolate (NCTC11168) and a dilution series up to 1/10,000. Target 
sequences were identified from the NCBI database and then the coding sequence (CDS) 
was used to generate forward and reverse primers using Primer3, selecting for amplicon 
sizes of 50-150 bases. 
4.2.8 PCR Conditions 
The BioRad iCycler was run using conditions described in section 2.2.9. 
4.2.9 Invasion Assay and Adhesion 
The invasion and adhesion assay was performed as described in section 2.2.11. 
4.2.10 Cell Viability 
The cell viability assay was performed as described in section 2.2.12. 
4.2.11 Signal Inhibition Assays 
The signal inhibition assays were performed as described in section 2.2.14. The 
inhibitors and their working concentrations used are summarsed in Table 4.1. 
4.2.12 GWAS using Scoary 
Scoary microbial pan-GWAS (Brynildsrud et al., 2016) was performed as described in 
section 2.3.3. Scoary was used to identify genes that were related to the different 
phenotypes identified throughout the chapter (including IL-8, IL-10 expression, and 
invasion response). 
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Table 4.1. List of inhibitors and their respective pathways used during this study. 
Inhibitor Pathway Reference 
Dynasore (80µM) Dynamin – Endocytosis, 
Dynamin GTPase activity 
(Macia et al., 2006) 
Filipin (1µg/ml) Lipid raft Caveolin pathway 
Endocytosis 
(Bonneau et al., 2010) 
Genistein (1µg/ml) Caveolin Endocytosis, tyrosine 
kinase inhibitor 
(Akiyama et al., 1987) 
Chlorpromazine (5µg/ml) Clathrin Endocytosis, clathrin 
misassembly 
(Lee et al., 2007) 
LY294002 (10µM) P-I3 Kinase (Chaussade et al., 2007) 
InSolution
TM
 AKT Inhibitor V, 
Triciribine (10µM) 
AKT  (Karst et al., 2006) 
Methyl β cyclodextrin (5µg/ml) Lipid raft disruption by 
cholesterol extraction 
(Stella and He, 2008) 
Cytochalasin D (5µg/ml) Actin polymerisation (May et al., 1998) 
PD98059 (10µg/ml) ERK/MEK  (Alessi et al., 1995) 
 
4.2.13 Statistics 
The non-parametric Krustal-Wallis test, with a post hoc Dunns test for multiple 
comparisons was used. Correlations were assessed using linear regression of log 
transformed data with a p value related to the slope. Significance differences were 
accepted if p≤0.05. Graphpad Prism 6.0 (San Diego, USA) was used to analyse and 
assess differences between treatment groups. 
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4.3 Results 
 
4.3.1 C. jejuni strains used in this study 
To investigate the diversity of human and chicken epithelial cell innate immune 
responses, the 100 strains of C. jejuni used in chapter 3 were investigated (Figure 3.2, 
Table 2.2). Isolates were from a variety of STs, and the major clonal complexes CC-45 
and CC-21 (Figure 3.2). In addition, strains were selected based on the source of the 
isolate and included, human, chicken, cattle and from wild-bird (Figure 3.2).  
4.3.2 Identification of potential immune markers from cytokine panel array assays 
A human cytokine antibody array assay was performed using the two reference strains 
for C. jejuni; 11168 and M1 (Figure 4.2a). Samples taken from uninfected HT-29 cells 
showed very little to no expression of all cytokines measured, with the positive controls 
in the top left corner and bottom right corner being the only signals present on the 
membrane (Figure 4.2a). The major cytokine induced in response to  11168 and M1 was 
IL-8 (CXCL8). Other cytokines also found to be expressed included IP-10 (CXCL10), 
MIP-1δ (CCL15), RANTES (CCL5), TNF RI (TNFRSF1A) and TIMP-2 (Figure 4.2). 
A list of all cytokines measured during this assay is shown in appendix table 8.10. 
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Figure 4.2. Human cytokine array assay performed on uninfected cells, cell infected by 
11168 and cells infected by M1. Red box indicates the IL-8 cytokine expression in 
11168 and M1; blue box indicates the control wells (a), with markers with the overall 
largest mean pixel density in the infected samples plotted (b).  
4.3.3 IL-8 secretion from human epithelial cells 
The cytokine membrane identified IL-8 as an important early gene induced by C. jejuni. 
To investigate the epithelial response further, the 100 C. jejuni strains from chapter 3 
were used to infect HT-29, human intestinal epithelial cells. IL-8 secretion from HT-29 
cells increased over the 24 hours of co-culture with the C. jejuni strains (Figure 4.3). 
Uninfected cells produced little or no IL-8 whereas the positive control (PMA) treated 
wells had significantly increased output of this cytokine. Comparison between time 
points demonstrated highly significant differences between IL-8 production at 4-24 
hours (4 vs 24 hours, P<0.0001). Large variations in IL-8 production were observed in 
response to the different C. jejuni strains with the highest and lowest IL-8 production 
being isolate 79 with an average IL-8 secretion of 2234.5pg/ml and isolate 56 with an 
average IL-8 secretion of 40.75pg/ml resulting in a 50-fold difference in production. 
Comparison of IL-8 secretion from HT-29 cells in response to C. jejuni strains from 
different sources over the same time course (Figure 4.3) was also assessed. After 4 
hours (Figure 4.3b) of infection very little IL-8 was produced in response to all strains 
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with no significant differences being shown between them (Fig 4.3b). After 6 hours of 
infection, IL-8 production had increased compared to controls (Figure 4.3c) and to 
secretion after 4 hours; with strains isolated from wild birds beginning to emerge with 
the highest overall IL-8 secretion, although no significant difference was detected at 
these time points. 
After 24 hours of infection, very large differences were observed in IL-8 secretion 
compared to control (Figure 4.3d). In addition, IL-8 secretion in response to isolates 
from wild birds showed the highest levels with a significant difference when compared 
to the strains isolated from humans (P>0.001), chickens (P>0.01) and cattle (P>0.0001). 
Large differences were also observed between strains from the same source, such as in 
strains from chickens where differences in IL-8 secretion as large as 2200 pg/ml (Figure 
4.3d) were observed. Distributions were assessed for „normality‟ by the D‟agostino-
Pearson test which confirmed that the results obtained were not normally distributed. 
When these results were grouped by C, jejuni clonal complex (Figure 4.4) strains from 
ST-45 show a higher overall IL-8 secretion (by approximately 250pg/ml) than ones 
from ST-21 (Figure 4.4). However, there was no significant difference (P>0.05) 
between the two clonal complexes or when these ST were then compared to isolates 
from unique and other clonal complexes (Figure 4.4). 
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Figure 4.3 Mean IL-8 secretion induced by C. jejuni at (a) over all time points 
measured, (b) 4h of infection, (c) 6h of infection and (d) 24h of infection categorised by 
source of Campylobacter strain and d) Mean IL-8 secretion induced by C. jejuni at 24h, 
categorised by source of Campylobacter strain. Results are also expressed as mean +/- 
SD of all strains measured. Differences were considered significant if p≤0.05. 
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Figure 4.4. Mean IL-8 secretion induced by C. jejuni at (a) 4h of infection (b) 6h of 
infection (c) 24h of infection categorised by sequence type the of Campylobacter strain. 
Results are also expressed as mean +/- SD of all strains measured. Differences were 
considered significant if p≤0.05. 
 
4.3.4 Confirmation of the species of the chicken cell line using MHC expression 
MHC Class 1 (β-macroglobulin) expression was used to measure the cell lines 
capability to present foreign molecules and to speciate the cells. MHC class 1 was 
investigated after 24 hours of co-culture of the cell lines with the C. jejuni isolates. 
Overall expression was greater in human cells than in chicken ones with a significant 
difference (p=≤0.001) between the two (Figure 4.5). 
Expression in the HT-29 cells (Figure 4.5b) displayed large variations between isolates 
from different sources, with those from chickens showing the largest expression and 
significant differences were found between human and chicken isolates (p≤0.001) and 
human and cattle isolates (p≤0.01). The HT-29 cells displayed very similar expression 
levels of MHC with all the isolates from human sources. Similar expression patterns 
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were observed within expression from the 8E11 chicken cells (figure 4.5c). However, 
the highest level of expression was seen in isolates from cattle. Significant differences 
between the human isolates and the chicken isolates (p≤0.01) and cattle isolates 
(p≤0.001) were seen. The results also confirm the „chicken‟ nature of the 8E11 cells. 
 
Figure 4.5. Expression of MHC induced by C.jejuni after 24h of infection on (a) HT-29 
and 8E11 cell lines; with (b,c) the breakdown of responses by source in HT-29 
(b)/8E11(c) cells and (d,e) by sequence type of Campylobacter in HT-29(d) and 
8E11(e) cells.  Results are also expressed as mean +/- SD of all strains measured. 
Differences were considered significant if p≤0.05. 
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4.3.5 C. jejuni strains produce a large variation in inflammatory cytokine 
responses 
Inflammatory phenotype was investigated by infecting human and chicken epithelial 
cells with the C. jejuni strain collection (n=100). IL-8 or CXCLi1 and CXCLi2 
expression in these cells showed dramatic changes compared to uninfected controls with 
up to 100,000-fold increases in both human and chicken cells (Figure 4.6a). Despite the 
large variation, human IL-8 and chicken CXCLi2 expression were significantly 
increased (p≤0.01 and p≤0.01 respectively) compared to CXCLi1. There was no 
difference between IL-8 and CXCLi2 expression. The reference strains NCTC11168 
and M1 produced IL-8 and CXCLi1 responses similar to the average for the whole C. 
jejuni study population. The average C. jejuni induced CXCLi2 response was similar to 
that of the M1 but the 11168 strain induced response was 11-fold higher (p≤0.01). The 
positive control, PMA, produced similar high levels of expression with both cell lines 
and with each cytokine measured. There were no differences seen when comparing the 
two most common sequence types of C. jejuni; ST-21 and ST-45.   
The anti-inflammatory cytokine IL-10 also displayed an infection-induced increase in 
expression and variability compared to uninfected controls (p≤0.001) in both HT-29 and 
8E11 cells.  In addition, IL-10 expression was significantly increased (p<0.001) in 8E11 
cells compared to that in HT-29 cells (Figure 4.6b).  The reference strains NCTC11168 
and M1 produced IL-10 responses similar to the average for the whole C. jejuni study 
population.  
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Figure 4.6 Expression of pro- and anti- inflammatory cytokines and chemokines in HT-
29 human and 8E11 chicken epithelial cells after infection with C. jejuni for 24 hours 
before isolation of total RNA and quantification of specific mRNA by qPCR. (a) 
Expression of IL-8/CXCLi1/CXCLi2 in both HT-29 and 8E11 cell lines (b) Expression 
of IL-10 in HT-29 and 8E11 cell lines. Results are also expressed as mean +/- SD of all 
strains measured. Differences were considered significant if p≤0.05. 
 
4.3.6 Inhibition of C. jejuni cytokine response 
Following on from the cytokine expression work, eight strains of C. jejuni that produced 
the strongest cytokine responses were chosen to investigate whether they had an  effect 
on common signalling pathways (PI 3-kinase/Akt and ERK) in human and chicken 
epithelial cells (Figure 4.7 a, b and c). Inhibition of signalling pathways showed that IL-
8 expression in HT-29 cells and CXCLi1 and CXCLi2 in 8E11 cells were all ERK-
dependent (p≤0.001, p≤0.01 and p≤0.05 respectively).  Furthermore, PI 3-kinase and 
Akt pathways did not appear to be required for IL-8 or CXCLi1/2 production. In 
contrast, IL-10 expression in human and chicken cells was dependent on PI 3-Kinase 
and its downstream target Akt but was independent of ERK (Figure 4.7d and e).  These 
results confirm that similar signalling pathways are responsible for IL-8 and IL-10 
expression in human and chicken epithelial cells. 
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Figure 4.7. Prior to infection with C. jejuni, cells were incubated with signalling 
inhibitors for up to 30 minutes. Then specific mRNA for IL-8 / CXCLi1 / CXCLi2 (a, b, 
c) and IL-10 (d, e) were measured. Each dot represents three biological replicates in one 
strain.  Results are also expressed as mean +/- SD of all strains measured. Differences 
were considered significant if p≤0.05. 
4.3.7 The cdtA gene has an important role in C. jejuni-induced epithelial cell 
toxicity 
The influence of invasion by all C. jejuni strains (n=100) on epithelial cell viability and 
toxicity responses was investigated (Figure 4.8). The toxicity of C. jejuni on both 
human and chicken cells showed unique profiles for each strain tested. Epithelial cells 
infected with any C. jejuni strain showed increased toxicity compared to untreated cells 
but only a few C. jejuni strains induced high toxicity responses (over 50% reduction in 
viability, Figure 4.8a). There were no differences between sources and sequence types. 
cdtA-positive strains were significantly more toxic than -negative ones in both human 
(Figure 4.8b, p=≤0.0001) and chicken epithelial cells (Figure 4.8c, p=≤0.001). 
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Figure 4.8. Reduction of cell viability after infection with C. jejuni. HT-29 and 8E11 
cells were infected with C. jejuni for 24 hours before isolation of cell supernatants for 
alamar blue viability assay. (a) Toxicity responses in HT-29 and 8E11 epithelial cells. 
(b and c) Toxicity responses organised by the presence and absence of the cdtA gene. 
Each dot represents three biological replicates in one strain.  Results are also expressed 
as mean +/- SD of all strains measured. Differences were considered significant if 
p≤0.05. 
 
4.3.8 Measurement of C. jejuni adhesion and invasion in human and chicken 
epithelial cells 
The ability of high and low IL-8 (or CXCLi1/2)-inducing C. jejuni strains (n=35) to 
adhere to and invade human and chicken epithelial cells was investigated. No 
significant difference (P>0.05) was detected in adherence to human and chicken 
epithelial cells (Figure 4.9a) although adhesion levels to chicken cells had a wider 
distribution. Gentamicin protection assays with both cell lines showed that all strains 
tested were able to invade cell lines (Figure 4.9b), ranging from 1-3% of the starting 
inoculum. While each strain produced a unique invasion response no significant 
difference  (P >0.05) in the invasion was observed between human and chicken cells. 
Inhibition of epithelial cell signalling pathways following invasion with „high‟ invasive 
strains (n=8) confirmed the role of ERK in C. jejuni invasion of human (Figure 4.9c) 
and chicken (Figure 4.9d) epithelial cells (p=≤0.001 in both cases). These results 
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confirm the unique invasion properties of individual C. jejuni strains despite all 
requiring ERK for a full invasion response.  
 
 
Figure 4.9 HT-29 and 8E11 cells were infected with C. jejuni for 6 hours before 
isolation and quantification of adherent and invasive C. jejuni. (a) Adhesion of C. jejuni 
strains to HT-29 and 8E11 cells. (b) Invasion of C. jejuni into HT-29 and 8E11 cells. 
(c,d) Treatment of HT-29 and 8E11 cells with signalling inhibitors for 30 minutes prior 
to invasion assays. Each dot represents three biological replicates in one strain.  Results 
are also expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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Figure 4.10. Relationships between C.jejuni-induced cellular invasion, toxicity and 
cytokine production; phenotypic data was subjected to regression analysis. (a) IL-8 (b) 
CXCLi1and (c) CXCLi2 correlations with C. jejuni invasion. (d) IL-8, (e) CXCLi1, (f) 
CXCLi2 correlations with toxicity. (g) HT29 cell viability correlation with invasion (h) 
8E11 cell viability correlation with invasion. 
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4.3.9 C. jejuni induced IL-8 production, toxicity and invasion of epithelial cells are 
more closely correlated in chicken than human cells 
Given that both IL-8 production and invasion were ERK-dependent across the 
collection of C. jejuni strains, correlations between the measured phenotypes of IL-8 
production, invasion and toxicity were performed. IL-8 expression and invasion were 
not correlated (Figure 4.10a, p<0.4) whereas both CXCLi1 (Figure 4.10b, p<0.023) and 
CXCLi2 (Figure 4.11c, p<0.03) expression showed strong positive correlations with 
invasion. IL-8 (p<0.007), CXCLi1 (p<0.0082) and CXCLi2 (p<0.0339) all positively 
correlated with cell toxicity (Figures 4.10d-f). Finally, invasion and toxicity were 
strongly correlated in human cells (p<0.0078) but did not reach significance in chicken 
ones (Figure 4.10 g and h).  These correlations confirm the close interrelationship 
between C. jejuni-induced IL-8 expression, toxicity and cellular invasion. 
4.3.10 Endocytosis of C. jejuni is dynamin- and clathrin-dependent in both human 
and chicken epithelial cells  
Having confirmed the importance of ERK in downstream signalling for invasion, 
upstream pathways at the cell surface important for endocytosis were analysed (Figure 
4.11). Both Methyl-β-cyclodextrin and cytochalasin D completely abrogated C. jejuni 
invasion into both cell lines providing more evidence for the role of lipid rafts and the 
actin cytoskeleton respectively. Pre-treatment of epithelial cells with a dynamin 
inhibitor (Dynasore) and a clathrin inhibitor (chlorpromazine) reduced significantly C. 
jejuni invasion in human (Figure 4.11a) and chicken (Figure 4.11b) cells compared to 
the „no‟ inhibitor control. This is confirmed by concomitant reduction in cellular 
toxicity in the relevant cultures (Figure 4.12). In addition, caveolin-dependent 
endocytosis was tested using filipin and genistein with no consistent effect observed 
over triplicate experiments. These results confirm the importance of clathrin and 
dynamin in C. jejuni invasion. The inhibitors Methyl-β-cyclodextrin and cytochalasin D 
were able to completely block invasion of C. jejuni (Figure 4.11). However, they were 
also very toxic to both cell lines (Figure 4.12). 
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Figure 4.11 The effect of inhibition of cellular endocytosis on C. jejuni invasion into 
epithelial cells; (a) HT-29 and (b) 8E11 cells were pre-treated with endocytosis 
inhibitors prior to infection with C. jejuni for 6 hours and then C. jejuni invasion was 
assessed. Each dot represents three biological replicates in one strain.  Results are also 
expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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Figure 4.12 The effect of inhibition in the reduction of cell viability of epithelial cells 
after infection with C. jejuni; (a) HT-29 and (b) 8E11 cells were pre-treated with 
endocytosis inhibitors prior to infection with C. jejuni for 6 hours and then C. jejuni 
invasion was assessed. Each dot represents three biological replicates in one strain.  
Results are also expressed as mean +/- SD of all strains measured. Differences were 
considered significant if p≤0.05. 
 
4.3.11 C. jejuni-induced IL-8 and CXCLi1/2 expression is dynamin- and clathrin-
dependent in human and chicken epithelial cells 
Cytokine expression was also determined following manipulation of endocytosis 
pathways. Consistent with invasion responses (Figure 4.11), IL-8 expression (Figure 
4.13a) in human cells and CXCLi1 (Figure 4.13b) and CXCLi2 (Figure 4.13c) 
expression in chicken cells was dependent on dynamin and clathrin (Figure 4.13). In 
contrast to invasion responses, inhibition of caveolin pathways also significantly 
reduced IL-8, CXCLi1 and 2 expression. Cytokine expression could be detected in the 
absence of toxicity and with minimal invasion responses (Figures 4.11 and 4.13). These 
results confirm the importance of clathrin, caveolin and dynamin for C. jejuni-induced 
IL-8 production.  
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Figure 4.13 The effect of inhibition of endocytosis of cytokines cytokine expression in 
epithelial cell;.  (a) HT-29 and (b, c) 8E11 cells were treated with endocytosis inhibitors 
prior to infection with C. jejuni for 24 hours. Then total RNA was isolated and specific 
mRNA was quantified by qPCR. Expression of (a) IL-8, (b) CXCLi1 and (c) CXCLi2 
in epithelial cells. Each dot represents three biological replicates in one strain.  Results 
are also expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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4.3.12 GWAS analysis of strains with high and low invasion and expression of 
immune markers 
Scoary analysis (as outlined in chapter 3) was used to investigate genes associated with 
in vitro responses in this chapter. Responses were categorised into „high‟, „intermediate‟ 
and „low‟ and then GWAS was performed. A total of 7 genes were found to be 
associated with high expression of IL-8/CXCLi1/2 from human and chicken epithelial 
cells including motility linked flagellar hook protein, flgE. A further 5 genes were found 
to be associated with the average, intermediate expression and 8 with low expression 
(Table 4.14). Scoary identified 2 genes which were associated with high expression of 
IL-10 with a further 11 related to intermediate level of expression and 10 genes 
associated with low level expression (Table 4.15). The genes hddA and gmhA were 
associated with both the high and intermediate expression of IL-10, with porA, a major 
outer membrane protein also found associated. 
Scoary was next used to investigate genes associated with the invasion response in both 
human and chicken epithelial cells (Table 4.16).  A total of 4 genes were associated 
with the highest levels of invasion into epithelial cells including an anaerobic 
transporter. Another 4 genes were associated with intermediate levels of invasion and 9 
associated with the lowest levels of invasion (Table 4.16). 
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Table 4.24. Genes found to be related to expression of IL-8/CXCLi1/2. 
Gene Locus Tag Annotation Trait 
Positive 
Isolates 
p Value 
High IL-8/CXCLi1/2 
upp Cj1286c Uracil phosphoribosyltransferase 13 0.026 
mnmA Cj0053c Bacteriohemerythrin 7 0.029 
flgE Cj1729c Flagellar hook protein FlgE 7 0.038 
selU Cj0500 tRNA 2-selenouridine synthase 2 0.026 
mcp4 Cj0262c Methyl-accepting chemotaxis protein 4 1 0.034 
kdpB Cj0677 Potassium-transporting ATPase ATP-
binding subunit 
0 0.034 
rfbC Cj1430c dTDP-4-dehydrorhamnose 3,5-epimerase 0 0.035 
Intermediate IL-8/CXCLi1/2 
sbp Cj0256 Sulfate-binding protein 15 0.010 
yagU Cj0014c Inner membrane protein YagU 8 0.038 
kdpB Cj0677 Potassium-transporting ATPase ATP-
binding subunit 
4 0.023 
cstA Cj0917c Carbon starvation protein A 3 0.030 
mnmA Cj0053c tRNA-specific 2-thiouridylase MnmA 0 0.034 
Low IL-8/CXCLi1/2 
yedZ Cj0379c Sulfoxide reductase heme-binding subunit 
YedZ 
13 0.026 
fliY Cj0059c L-cystine-binding protein FliY 12 0.012 
metF Cj1202 5,10-methylenetetrahydrofolate reductase 12 0.030 
mdaB Cj1545c Modulator of drug activity B 12 0.030 
selB Cj1379 Selenocysteine-specific elongation factor 12 0.030 
 
flgS 
Cj0793 Signal transduction histidine-protein kinase 
BaeS 
11 0.002 
folP Cj0585 Bifunctional dihydropteroate 
synthase/dihydropteroate reductase 
11 0.006 
cysA Cj0300c Sulfate/thiosulfate import ATP-binding 
protein CysA 
11 0.023 
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Table 4.35. Genes found to be related to expression of IL-10. 
Gene Locus Tag Annotation Trait 
Positive 
Isolates 
p Value 
High IL-10 
gmhA Cj1149c Phosphoheptose isomerase 1 0.00433 
hddA Cj1425c D-glycero-alpha-D-manno-heptose 7-
phosphate kinase 
1 0.00463 
Intermediate IL-10 
mnmA Cj0053c Bacteriohemerythrin 11 0.02991 
hddA Cj1425c D-glycero-alpha-D-manno-heptose 7-
phosphate kinase 
10 0.00952 
gmhA Cj1149c Phosphoheptose isomerase 10 0.01094 
ymfD Cj1241 Bacillibactin exporter 8 0.01706 
porA Cj1259 Major outer membrane protein 8 0.04972 
rfbC Cj1264c dTDP-4-dehydrorhamnose 3,5-epimerase 7 0.00175 
hyaD Cj1264c Hyaluronan synthase 5 0.04761 
fcl Cj1428c GDP-L-fucose synthase 4 0.03544 
hddC Cj1431c D-glycero-alpha-D-manno-heptose 1-
phosphate guanylyltransferase 
2 0.03758 
argO Cj1715 Arginine exporter protein ArgO 0 0.03116 
Low IL-10 
ribF Cj0589 Riboflavin transporter 8 0.01099 
alsT Cj0905c Amino-acid carrier protein AlsT 8 0.03099 
carB Cj0279 Carbamoyl-phosphate synthase large chain 7 0.00372 
mdaB Cj1545 Modulator of drug activity B 7 0.00873 
proB Cj0097 Glutamate 5-kinase 7 0.02698 
ldh Cj1167 L-lactate dehydrogenase 7 0.02698 
pyrC Cj0259 Dihydroorotase 6 0.01728 
ubiE Cj0324 Ubiquinone/menaquinone biosynthesis C-
methyltransferase UbiE 
4 0.00437 
tupB Cj1540 Tungstate uptake system permease protein 
TupB 
4 0.02367 
cobB Cj1050c NAD-dependent protein deacylase 2 0.03099 
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Table 4.46. Genes found to be related to the level of invasion into both human and 
chicken epithelial cells. 
Gene Locus 
Tag 
Annotation Trait 
Positive 
Isolates 
p Value 
High Invasion 
dcuA Cj0088 Anaerobic C4-dicarboxylate transporter 
DcuA 
6 0.033 
hyaD Cj1264c Hyaluronan synthase 5 0.030 
flgR Cj1024c Sigma 54 associated transcriptional 
activator 
2 0.031 
arsB Cj1187c Arsenical pump membrane protein 2 0.031 
purH Cj0953c Bifunctional purine biosynthesis protein 
PurH 
2 0.040 
Intermediate Invasion 
ribF Cj0589 Riboflavin transporter 8 0.011 
cdtA Cj0079c Cytolethal distending toxin subunit A 8 0.031 
mcrB Cj0139 5-methylcytosine-specific restriction 
enzyme B 
3 0.041 
upp Cj1286c Uracil phosphoribosyltransferase 2 0.011 
Low Invasion 
hisS Cj0765c Histidine--tRNA ligase 9 0.044 
tgt Cj1010 Queuine tRNA-ribosyltransferase 8 0.011 
hypA Cj0627 Hydrogenase/urease nickel incorporation 
protein HypA 
8 0.011 
cgb Cj1586 Bacterial hemoglobin 8 0.031 
fdhC Cj1509c Formate dehydrogenase, cytochrome 
b556(fdo) subunit 
8 0.031 
nrfA Cj1357c Cytochrome c-552 8 0.031 
murG Cj1039 UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
7 0.027 
cydB Cj0082 2-oxoglutarate-dependent 
ethylene/succinate-forming enzyme 
2 0.011 
selU Cj0500 tRNA 2-selenouridine synthase 2 0.031 
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4.4 Discussion 
The data in this chapter add to the growing body of evidence that C. jejuni is a pathogen 
in chickens (Byrne et al., 2007; Humphrey et al., 2014; Jennings et al., 2011; Neill et 
al., 1984; Ruiz-palacios et al., 1981; Sanyal et al., 1984; Williams et al., 2013). C. jejuni 
induce inflammatory and toxicity responses and can also invade human and chicken 
epithelial cell lines. While there was little difference between human and chicken cell 
responses, there was a wide range across all bacterial strains studied. The 100 strains of 
C. jejuni analysed were deliberately chosen from a variety of sources (including 
chicken, human, cattle and wild birds) and across sequence types to give a good 
representation of strains studied previously at the genomic level although we did not 
detect differences between these groups (Sheppard et al., 2011, 2013). Coincidentally, 
the reference strains M1 and NCTC11168 produced responses equivalent to the average 
for the whole study population. The question remains as to the source of the variation 
across the whole population. Individual virulence factor expression was not measured in 
this study but previous work on the transcriptome of a variety of Campylobacter strains 
showed that they are subject to complex regulation (Dugar et al., 2013).    
Epithelial-derived IL-8 production is vital for early neutrophil infiltration into the gut in 
humans (Bennett  Jr. et al., 2010) and chickens (Humphrey et al., 2014). This study 
confirms the importance of human IL-8 and identifies both CXCLi1 and CXCLi2 as 
important early chemokines induced in chicken epithelial cells following C. jejuni 
infection. This is consistent with studies in chicken LMH epithelial cells (Larson et al., 
2008). Interestingly, CXCLi2 (like human IL-8) was significantly higher than CXCLi1. 
This is the first time that a study using a large collection of C. jejuni strains has found 
differences in these two chicken IL-8 homologues. Other studies found no differences 
(Kogut et al., 2005) but on a smaller scale (n=6 strains) and Larson et al., (2008) found 
the opposite effect. It is interesting to speculate that CXCLi2 (and not CXCLi1) may be 
the functional equivalent to IL-8 in humans. This is supported by structural data on 
amino acid similarity where CXCLi1 and CXCLi2 are 48 and 67%, respectively, 
identical to human IL-8 (Gupta et al., 2008; Sick et al., 2000). Expression of IL-8 
mRNA and IL-8 protein yielded different patterns. Expression of mRNA does not 
always correlate with protein expression with not all mRNA converted into protein with 
work by (Shebl et al., 2010).  
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The three cellular responses defined by „IL-8 production‟, „cellular toxicity‟ and 
„Campylobacter invasion‟ are inextricably linked, as demonstrated by the correlation 
curves (Figure 4.10). Clear links were demonstrated between increased cytokine output 
(IL-8, CXCLi1 and 2) and „toxicity‟ suggesting similar mechanisms of induction. 
Indeed, Hickey and co-workers suggested two mechanisms of Campylobacter-induced 
IL-8 production involving; i) adherence and or invasion; and ii) cdt expression (Hickey 
et al., 1999, 2000). While this known link between IL-8 and invasion was demonstrated 
in INT407 cells, we did not find a significant correlation between them in HT-29 cells. 
In contrast, strong positive correlations were made in chicken cells between both 
CXCLi1/2 and invasion, again supporting an important role for these cytokines in early 
Campylobacter responses in chickens.  
Numerous human cell lines have been used to study Campylobacter pathogenesis, 
including T84 (Zheng et al., 2008), INT407 (Borrmann et al., 2007), HT-29 (Bahrami et 
al., 2011), and Caco-2 (Man et al., 2010) intestinal epithelial cells. There are very few 
data on chicken intestinal cell systems, due to the lack of commercially available  cell 
lines until recently when one company (MicroMol) produced several clones. These cell 
lines are particularly useful for high throughput studies with many strains such as the 
use of them for this purpose in the current study. When considering the three cellular 
endpoints of IL-8 expression, cellular toxicity, and Campylobacter invasion none of 
these cells mimic equivalent in vivo responses exactly.  Campylobacter invasion into 
Caco-2 cells show very good correlation to in vivo invasive potential in chickens (Hanel 
et al., 2004) and humans (Everest et al., 1992) but produce limited cytokine responses 
(MacCallum et al., 2006) whereas HT-29 and T84 produce robust cytokine responses 
but no good evidence of relevance to in vivo invasion responses (MacCallum et al., 
2006). In the present study, cellular invasion in both HT-29 cells and the 8E11 chicken 
cells at a level of 1-3% of the initial inoculum with sufficient robustness to differentiate 
strains and for consistency over three replicate experiments was detected. This is in 
keeping with levels of invasion of up to 4% in Caco-2 cells shown previously (Hanel et 
al., 2004). This suggests great potential in the chicken cell line used in this study for 
investigating the diversity of C. jejuni responses in vitro.      
This study confirmed the importance of canonical pro- (ERK) and anti-inflammatory 
(PI 3-Kinase -Akt) pathways for the C.jejuni-induced production of IL-8 and IL-10 in 
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human epithelial cells (Li et al., 2011; Watson and Galan, 2005). Furthermore, ERK-
dependent Campylobacter invasion is also supported by previous studies (Hu et al., 
2006a; Jin et al., 2003; Samuelson et al., 2013; Samuelson and Konkel, 2013). The 
importance of these pathways in chicken cells is a novel result of this study and 
confirms that the underlying mechanisms are similar between human and chicken cells. 
In addition, the significantly higher IL-10 responses in the chicken cells suggest that the 
chicken gut may produce IL-10 as a method to tolerate large doses of Campylobacter 
and is supported by previous in vivo studies showing that some breeds of chicken 
produce more „regulated‟ responses (Humphrey et al., 2014). While the chicken cells 
used here are derived from leghorn chickens it would be interesting to speculate on the 
breeds used previously (Humphrey et al., 2014) as there is evidence using Bayesian 
structural modelling of in vivo responses in chickens that IL-10 profiles are indeed 
different between breeds and this needs exploring further through cell line models 
derived from broiler chickens (Reid et al., 2016; Williams et al., 2013). 
Campylobacter uptake by endocytic pathways confirmed the requirement of lipid rafts 
(Lin et al., 2011) in human cells and extended this role to chicken epithelial cells. This 
study also found that microfilaments were required for invasion of both HT-29 cells and 
the chicken ones. Interestingly, at least two mechanisms exist as INT407 (Konkel and 
Cieplak  Jr., 1992) and Caco-2 (Russell and Blake, 1994) cells show 
microfilaments/microtubules-dependent and -independent mechanisms, respectively, 
suggesting that the role of cytoskeleton may be strongly cell dependent. Further work 
into mechanisms of uptake, in the present study, confirmed roles for dynamin and 
clathrin which has not been documented to date. Interestingly Cdt uptake into cells does 
involve clathrin coated pits (Thelestam and Frisan, 2004) and may be the mechanisms 
observed here. A consistent role for caveolins (using filipin and genistein) in the uptake 
process could not be confirmed during this study. Indeed, this is consistent with a recent 
publication which suggests that C. jejuni invasion is independent of caveolins (Konkel 
et al., 2013).  
Throughout this chapter many of the unknown mechanisms highlighted in figures 1.4 
and 4.1 have been identified (Figure 4.14). C. jejuni has been shown to effectively 
invade into host cells causing inflammatory markers to be expressed and disrupt the 
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immune response in the host with C. jejuni shown to use similar signalling pathways to 
the human host (Figure 4.14). 
 
 
Figure 4.14 Identified aspects of the chicken system during this chapter 
One interesting consequence of inhibiting endocytic pathways was the concurrent 
reduction in cell toxicity confirming that Campylobacter is responsible for the toxicity 
and the endocytic inhibitors have negligible effects on cell viability, however;  
inhibitors such as Methyl-β-cyclodextrin and cytochalasin D were shown to be very 
toxic to both cell lines and so lower doses in future experiments would be needed to 
confirm that the differences observed are not due to the viability of the cells being 
reduced. Another consequence of inhibiting endocytosis was the „extra‟ effect of 
inhibiting cytokine production. Previously, de Zoeta and co-workers (De Zoete et al., 
2010) established that live Campylobacter are very weak stimulators of both human and 
chicken TLR-2, -4 and -5. In striking contrast, lysed Campylobacter induce strong NF-
kappaB activation through human TLR1/2/6 and TLR4 and chicken TLR2t2/16 and 
TLR4 but not via TLR5 of either species (De Zoete et al., 2010). The results of the 
current study, support the concept that „invasion‟ or „internalisation‟ of some kind is 
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necessary for cytokine production. Indeed, Hickey et al also suggest an „invasion‟ 
dependent pathway for IL-8 induction (Hickey et al., 2000). Preliminary TLR 
expression data displayed the presence of many TLRs on both the human and chicken 
cell lines, however further work is needed to expand the TLR profiles of the novel 8E11 
chicken cells (Figure 4.15). 
 
Figure 4.15 Preliminary experiment where HT-29 and 8E11 cells were cultured with 
ligands to show expression of TLRs in both systems. 
 
These results are novel because of the number and diversity of relevant C. jejuni strains 
used with an chicken cell line to determine pathogenic mechanisms. However, there are 
certain limitations that provide an opportunity to improve the work in the future. Firstly, 
chicken 8E11 cells are derived from s intestines of embryonic white leghorn chickens 
and are positive for enterocyte markers, villin, E-cadherin and cytokeratin. Sequencing 
of the 8E11 cells found a small amount of quail DNA within the cells, thus expression 
of the chicken specific MHCs was used as a marker due in part to work by Shiina et al 
(2004) who found that quail and chickens have different MHCs led us to confidently 
call the MM-ChiC clone 8E11 cells chicken intestinal cells (Shiina et al., 2004). 
Previous studies have confirmed the importance of broiler breed to the final 
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inflammatory response and suggest that cells from commercial fast and slower growing 
breeds may be more relevant to study chicken gut responses (Kaiser et al., 2016).  
Indeed, recent technologies point to the precision modelling of chicken intestinal slices 
(Punyadarsaniya et al., 2015). Secondly, we focused our attention on using C. jejuni 
strains that define the species, from a variety of sources and sequence types, as 
published previously (Sheppard et al., 2013).  Recent Campylobacter outbreaks have 
highlighted the importance of invasion from the gut (e.g. to the liver) suggesting the 
importance of focussing on groups of invasive and non-invasive Campylobacter in 
future studies. Under-cooked chicken muscle is also a highly important vehicle for 
human infection internationally. 
In this chapter a new commercially avaiable  chicken cell line was used to determine the 
inflammatory responses in chickens while also investigating the signalling pathways C. 
jejuni uses during infection into host cells. In the next chapter, methods from chapters 3 
and 4 will be used to analyse Campylobacter strains from naturally and experimentally 
infected chickens to investigate genomic and phenotypic differences in strains from 
different sections of the chicken gut and also investigate potential biomarkers in 
chickens. 
GWAS analysis to find association between C. jejuni genes and expression of immune 
markers or invasion responses in human and chicken epithelial cells identified many 
potential genomic markers including flgE, a motility linked gene, which was associated 
with high levels of IL-8/CXCLi1/2 expression which was also found to be related to 
strains from human sources in chapter 3.  The gene upp,was found to be associated with 
high level of of IL-8/CXCLi1/2 expression and also intermediate level of invasion into 
epithelial cells which could help to support the link between IL-8 production and the 
invasiveness of Campylobacter (Hickey et al., 1999; Zheng et al., 2008). The genes 
gmhA and hddA were found to be related to high levels of IL-10 expression, these genes 
are required for the synthesis of heptose (Guerry et al., 2012). Wong et al (2015) 
suggested that a modified heptose may lead to bacterial resistance against 
gastrointestinal host defenses and can support the persistence of Campylobacter and 
thus the genes gmhA and hddA being associated to IL-10 may be due to the modified 
heptose triggering IL-10 expression to form an anti-inflammatory response to 
counteract gut inflammation (Wong et al., 2015). 
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4.5 Conclusion 
In conclusion, these novel data suggest that chicken systems are likely to use similar 
host defence pathways to humans in response to Campylobacter spp. Strong correlation 
was found between IL-8 with invasion and toxicity in the human cells. However, the 
diversity and range of responses suggests that „a one strain fits all approach‟ to in vivo 
experimental infection would not give meaningful data for the study of Campylobacter 
pathogenesis. The novel chicken cell line, 8E11, was demonstrated to be a good 
candidate for a model to investigate the chicken system with the host responses 
measured suggesting that chicken and human epithelial cells share common 
mechanisms to combat C. jejuni with exceptional phenotypic diversity. GWAS analysis 
was able to find genes assocated with expression of IL-8, IL-10 and level of invasion. 
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Chapter 5 – Host responses to Campylobacter strains from naturally and 
experimentally infected chickens   
5.1 Introduction 
5.1.1 Campylobacter and chicken production 
Poultry, in commercial terms, includes chicken, turkey, duck and laying hens.  Chicken 
is the predominant species used in the meat production industry comprising 70-80% of 
the animals used (Skarp et al., 2016). Chicken is thus a very important source of 
relatively cheap but nutritionally high quality protein worldwide; with production now 
being industrialised in many developing countries, particularly in SE Asia. In the UK 
alone, approximately one billion chickens are reared for meat consumption annually, 
with around 75% of them being positive for Campylobacter at point of sale (PHE, 
2016). Estimates suggest that chickens account, either directly and indirectly, for up to 
80% of human Campylobacter infections (Skarp et al., 2016).  
Poultry production has a pyramid structure. There are a few breeding companies at the 
top and they supply producers with birds for breeding flocks. These provide chicks for 
primary production at rearing farms. When the animals reach slaughter weight, usually 
2.2Kg,  they are transported to the abattoir. The chickens are either left as carcasses or 
processed into products, which are sold at retail and/or enter the catering industry. 
These stages play a part in the transmission of Campylobacter from farm to fork. The  
prevalence of Campylobacter-positive broiler flocks in the EU varies between countries 
and regions. It is low in Scandinavia and ranges from 0.6 - 13.1% in Norway, Sweden 
and Finland,. In other countries such as France and the UK up to 74-80% of flocks are 
positive (EFSA, 2010; Skarp et al., 2016). Flocks in commercial production usually 
consist of approximately 10,000 to 50,000 birds per house; with several houses often 
present on a farm potentially facilitating the spread of Campylobacter from house to 
house for rapid spread through the farm.  Flocks can be infected by one or  multiple 
strains simultaneously. At the retail end of the processing chain there are various 
products on sale from whole carcasses to different cuts and portions, as well as fresh 
and frozen products which pose different infection risks. Campylobacter can be found 
on skin (Hansson et al., 2015; Marotta et al., 2015), in muscle (Hansson et al., 2015; 
Scherer et al., 2006) and in liver tissues (Barot et al., 1983; Humphrey et al., 2015; 
Lahti et al., 2017; Whyte et al., 2006).  
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5.1.3 Campylobacter in chickens 
Past dogma suggested that Campylobacter behaved as a commensal in chicken hosts 
(Brisbin et al., 2008; Connell et al., 2012). However, work going back to the 1980s and 
more recent studies (Humphrey et al., 2014; John et al., 2017; Ruiz-palacios et al., 
1981; Sanyal et al., 1984; Williams et al., 2014), as well as work conducted in vitro in 
Chapter 4 of this thesis, have demonstrated that Campylobacter can behave as a 
pathogen in chickens. However, the virulence mechanisms responsible for such 
behavioiurs of  Campylobacter strains  are not yet understood completely (Byrne et al., 
2007; Humphrey et al., 2014; Jennings et al., 2011; Williams et al., 2013). 
5.1.4 Campylobacter extra-intestinal spread 
In recent years, epidemiological evidence has suggested strongly that the greater human 
health threat is the contamination/infection of liver and muscle tissues (Lahti et al., 
2017; Rosner et al., 2017) compared to Campylobacter on chicken carcass surfaces. In 
the UK, an industry-wide campaign to reduce the percentage of carcasses entering the 
food chain, which has been very successful, has had no significant impact on the 
number of human cases (PHE and FSA data 2018). Campylobacter have been shown to 
be highly heat resistant when attached to chicken muscle tissues, contributing to an 
infection risk in undercooked chicken muscle, and infected chicken liver is also a major 
source of  infections in humans (De Jong et al., 2012; Lahti et al., 2017; Rosenquist et 
al., 2009; Rosner et al., 2017; Whyte et al., 2006). Despite isolation from edible tissues 
the mechanism by which Campylobacter can transmigrate from the chicken gut to liver 
and muscle tissues is not well defined (Berntson et al., 1992; Hansson et al., 2015; 
Humphrey et al., 1993; Luber and Bartelt, 2007; Scherer et al., 2006). 
5.1.5 Caecal Tonsils 
The caecal tonsils are an important component of the chicken GALT, which plays a 
significant role in inducing and regulating immune responses locally and systemically 
(Oláh et al., 2013). Caecal tonsils are a cluster of aggregated lymphoid tissue, which is 
located within the medial wall of caeca at its transition to the rectum (Casteleyn et al., 
2010; Gómez Del Moral et al., 1998). Caecal tonsils are composed of several subunits 
made up of secondary lymphoid follicles with interspersed T cell regions which are 
located around a central fossula (Kitagawa et al., 1998). The fossula itself branches into 
several crypts, which connect directly to the caecal lumen, with M cells scattered 
between columnar epithelial cells that are present on a lympho-epithelium which lines 
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the crypts (Casteleyn et al., 2010; Kitagawa et al., 1998). The subunits of the tonsils are 
separated from each other by septa of connective tissue (Kitagawa et al., 1998).  Caecal 
tonsils appear late in the embryonic stage of development. However, only after hatching 
does their first major development occur. The first day after the chick has hatched; both 
B and T lymphocytes are formed. After 6 weeks post-hatching the number of B cells far 
exceeds those of T lymphocytes  (Gómez Del Moral et al., 1998). When the chicken is 
fully matured, the caecal tonsils are large and so represent a major component of its  
GALT. As a result of their large size caecal tonsils can be extracted easily and used to 
investigate the local immune responses in the chicken gut (Haghighi et al., 2008; 
Janardhana et al., 2009; Yurong et al., 2005).  
The exact function of the chicken caecal tonsil is not certain. However, some authors 
suggest that they may neutralise antigens that enter the caeca due to reflux of urates 
(Kitagawa et al., 1998).  Other investigators suggest that the caecal tonsils and other 
chicken GALTs might play a role in the differentiation of stem cells into B lymphocytes 
(Befus et al., 1980). 
5.1.6 Immune biomarkers in chickens 
Important inflammatory markers in the chicken immune response include ILs-8, -10, -
1β and TNFα. IL-8 is an important mediator in the innate immune response, which 
attracts neutrophils and other granulocytes to a site of infection and can induce 
phagocytosis (Yoshimura, 2015). In the chicken system, there are two orthologues for 
CXCLi1 and CXCLi2 (Larson et al., 2008). Studies have shown that C. jejuni can 
stimulate the production of both CXCLi1 and CXCLi2 (Larson et al., 2008; Taha-
abdelaziz et al., 2016). Another pro-inflammatory cytokine, tumour necrosis factor 
alpha (TNF-α), is also involved in the innate immune response and is produced 
primarily by macrophages but also by many other cell types including neutrophils, 
CD4+ lymphocytes, mast cells and natural killer (NK) cells. The primary role of TNF-α 
is regulation of immune cells (Olmos and Lladó, 2014) with Campylobacter being able 
to induce activation of TNF- α, which may subsequently activate NF-kβ (Namin et al., 
2015; Olmos and Lladó, 2014; Rohde et al., 2018). 
Aquired immunity in chickens offers protection against the development of bloody 
diarrhoea in response to infection with C. jejuni. T lymphocytes such as the CD4
+
 act as 
T helper (TH) cells which recognise antigens associated with MHC II, which can be 
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further divided into Th1, Th2, Th17 and Th22 responses. Th1 cells develop in response to 
the innate immunity and activate macrophages to produce IgG antibodies to promote 
phagocytosis and also produce TNF to promote leukocyte recruitment and 
inflammation. Th2 cells provide helper functions for B cells, stimulating production of 
antibodies and inhibit macrophage activity thus are considered anti-inflammatory and 
regulatory to control Th1 pro-inflammatory responses. Th17 cells contribute to 
propagation of an inflammatory response and provide mucosal immunity. Th22 cells are 
linked to pro-inflammatory responses in the gut and wound healing (Al-Banna et al., 
2018). 
An important cytokine, which has a function in stimulating the immune response is IL-6 
produced in response to infection as well as tissue injuries and contributes to host 
defence through stimulation of acute phase responses and immune reactions. IL-6 is 
secreted by macrophages and T cells, with C. jejuni recognition activating a MyD88-
independent secretion via TLR-2 in Caco-2 cells and is expressed  by chickens (Friis et 
al., 2009; Pielsticker et al., 2012; Tanaka et al., 2014).   
Another important mediator of the inflammatory response is IL-1β; produced by 
macrophages as a proprotein. It is involved in various cellular activities such as cell 
proliferation, differentiation and apoptosis (Palomo et al., 2015). C. jejuni increases IL-
1β gene transcription in chickens, with elevated levels of IL-1β, -6 and -8 transcription 
in chicken cells infected with C. jejuni having the ability to activate innate immunity 
signalling pathways in chicken ileum explants (Fonseca et al., 2016; Li et al., 2008; 
Smith et al., 2005). 
IL-10 plays an important role in the anti-inflammatory response in chickens by down 
regulating expression of T-helper cell cytokines and co-stimulatory molecules on 
macrophages (Couper et al., 2008; Walter, 2014). IL-10 expression in chickens 
increases immediately following infection with C. jejuni (Barjesteh et al., 2013). 
Interferon gamma (IFNγ) has an important role in both innate and adaptive immunity 
against some bacterial infections and is an activator of macrophages and induces class II 
major histocompatibility complex (MHC) molecule expression, IFNγ is produced 
primarily by NK cells and natural killer T cells (Schoenborn and Wilson, 2007). The 
importance of IFNγ comes from its immunostimulatory and immunomodulatory effects 
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(Schoenborn and Wilson, 2007).  IL-1β, -6, -10 and IFNγ play a role in the Th17 
pathway which has been observed in birds infected with C. jejuni (Reid et al., 2016). 
 
5.1.7 Aim  
This chapter focuses on Campylobacter strains from naturally and experimentally 
infected chickens. Methods and results used in both Chapters 3 and 4 were used to 
investigate and discover any new potential biomarkers of infection using a collection of 
Campyloabacter strains from the chicken environment. This chapter will also:  
 Characterise the genomes of bird-matched Campylobacter from different organs 
in naturally infected chickens 
 Identify genes responsible for colonisation/infection of ileum, caeca and liver in 
naturally infected chickens   
 Measure the immune response in caecal tonsils from experimentally infected 
chickens as a potential biomarker for Campylobacter infection 
 Investigate the in vitro cytokine and invasion responses of Campylobacter 
strains used to experimentally infect chickens 
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5.2 Methods 
 
5.2.1 Campylobacter strains from naturally infected chickens 
A collection of 96 Campylobacter strains, from a BBSRC project entitled „Broiler gut 
health and C. jejuni infection: impacts of harvest management‟ (BB/M009610/1) were 
isolated from different anatomical locations of naturally infected chickens; the caeca, 
ileum and liver. A total of 42 of these „bird-matched‟ Campylobacter strains were used 
during this study; 14 each from caeca, ileum and liver were used to infect human (Caco-
2) and chicken (8E11) epithelial cell lines. A full list of bacterial strains is in table 2.2 
strains 101-142.  
5.2.2 Pan-Genome creation 
The pan-genome was created using Prokka (Seemann, 2014) and Roary (Page et al., 
2015) as described in section 2.3. C. jejuni and C. coli strains were analysed in Prokka 
against species specific gene sets. Strains comprising a mix of C. jejuni and C. coli were 
ran against all Campylobacter genes. The resulting pan-genome was used to produce 
maximum likelihood phylogenetic trees using iTol and phandango (Hadfield et al., 
2018; Letunic and Bork, 2016). 
5.2.3 GWAS using Scoary 
Scoary microbial pan-GWAS (Brynildsrud et al., 2016) was performed as described in 
section 2.3.3. Scoary was used to identify genes that were related to the different 
sources of the C. jejuni isolates (caeca, ileum, liver). 
5.2.4 Culture of Human and Chicken Intestinal epithelial cells 
Human and chicken cells were maintained and cultured as described in Chapter 2.2.3 
5.2.5 Infection studies 
The infection studies were performed as described in section 2.2.4 
5.2.6 Invasion Assay  
An invasion assay was performed on the „bird-matched‟ strains listed in section 5.2.1, 
as described in section 2.2.13. During the invasion assay all six Campylobacter strains 
were also combined and added to the cell lines at a total of 1x10
7
 cfu to mimic the strain 
cocktail given in vivo.  
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5.2.7 RNA Isolation 
Total RNA was isolated from Caco-2 human or 8E11 chicken intestinal epithelial as 
described in section 2.2.6. 
5.2.8 Quantitative PCR of RNA transcripts 
Quantitative PCR was performed using the probe based method as described in section 
2.2.7.  
5.2.9 PCR Conditions 
The AriaMX was run using conditions described in section 2.2.9. 
5.2.10 Chicken Study 
An in vivo chicken infection study was carried out as described in Chapter 2. Birds were 
infected with a cocktail of six Campylobacter (CJ13126, CJ12662, L4, I4, C8 and C15) 
strains using a litter seeding method (Sandilands et al., 2018) at a concentration of 
1x10
5 
c.f.u Campylobacter. The birds were infected by members of SRUC and Drs 
Williams and Wilkinson of Swansea Universty. 
5.2.11 Experimental infection 
For chicken infection, four strains; one isolated from the liver (L4), one from the Ileum 
(I4) and two from the caecum of infected chickens (C8 and C15) along with two known 
C. jejuni isolates (CJ13126 and CJ12662) were used to infect chickens during an in vivo 
chicken study described in section 2.5.1. 
5.2.12 RNA extraction from Caecal Tonsils 
Thirty µg of caecal tonsil was placed in 600µl of RNA lysis buffer with one 5mm 
stainless steel bead (Qiagen, Crawley UK) and the tonsil disrupted using the FastPrep 
FP120 (Thermo scientific, Loughborough, UK) at 4 metres/sec for 1 minute. RNA was 
extracted subsequently using the QIAGEN RNeasy mini kit according to 
manufacturer‟s instructions. RNA was eluted in 50µl nuclease free water and stored at -
20
o
C until needed and quantified using a NanoDrop (Thermo scientific, Loughborough, 
UK). 
 
 
116 
 
5.2.13 Statistics 
Normality was assessed using D‟agostino-Pearson test. The two-way ANOVA with 
multiple comparisons and non-parametric Krustal-Wallis test, for multiple comparisons 
with post hoc Dunns test were used. Significance differences were accepted if p≤0.05. 
Graphpad Prism 6.0 (San Diego, USA) was used to analyse and assess differences 
between treatment groups. 
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5.3 Results 
 
5.3.1 Campylobacter strains from naturally infected chickens 
Forty two Campylobacter strains were isolated from the caeca, ileum and liver of 
commercial chickens sampled during the BBSRC project entitled „Broiler gut health 
and C. jejuni infection: impacts of harvest management‟ (BB/M009610/1). The strains 
used in the studies described below came from 14 birds where each had Campylobacter 
in the caeca, ileum and liver; with common numbered birds taken from the same bird 
(Table 2.2; Strains 101-114). 
5.3.2 Genomic analysis of isolates from naturally infected chickens 
Roary was used to construct a pan-genome of the „bird-matched‟ Campylobacter strains 
from naturally infected chickens (Figure 5.1 and 5.2). The phylogenetic tree created 
from the pan-genome displayed no clear pattern between isolates from the same bird 
and G11 and L11 and G7 and L7 were only isolates from the same bird to cluster 
together (Figure 5.1). Both reference isolates, M1 and 11168, clustered together (Figure 
5.1). The resulting pan-genome contained 10446 genes, made up of 73 core ones (99% 
<= gene presence <= 100%), with an additional 156 in the soft core (95% <= gene 
presence < 99%) totalling 226 genes present in the core genome and 10217 in the 
accessory genome. In total this comprised 3093 shell genes (15% <= gene presence < 
95%) and 7124 cloud ones (0% <= gene presence < 15%) (Figure 5.2).  
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Figure 5.1. Maximum likelihood tree of the pan genome of Campylobacter isolates 
from the ceaca (C), ileum (G) and liver (L) from naturally infected chickens with 11168 
and M1 included as reference strains.
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Figure 5.2. Representation of the pan-genome displaying the core and accessory genome with relation the phylogenetic tree. The core genome is 
made up of the core genes (present in 99-100% of isolates) and soft core ones (present in 95-99% of isolates), with the accessory genome 
comprising shell genes (present in 15-95% of isolates) and the cloud genes (present in 0-15% of isolates). 
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5.3.3 Core Vs Accessory genome 
Analysis of the 42 isolates using the pan genome pipeline generated in Chapter 3 
showed that the core genome totalled 226 genes. Of these, 38 were hypothetical proteins 
and so were removed from further analysis. The accessory genome contained 10217 
genes from the shell and cloud, of which 4158 were hypothetical proteins and so were 
removed from further analysis (Figure 5.2). 
Analysis of the known virulence genes from Chapter 3 (Table 3.1) showed the presence 
of two adhesion linked genes; pebA1 and pldA, as the only known virulence linked 
genes in the core genome. All other genes were in the accessory genome (Table 5.1.) 
All known antimicrobial resistance linked genes were found in the accessory genome 
including; cmeB, aadE, tet(O), blaOXA-61 and aph-3-I.  
Table 5.1. Presence of known virulence linked genes in the core and accessory genome 
Gene Gene Name Core Accessory 
flaA Flagellin A  x 
flaB Flagellin B  x 
flaC Flagellin C  x 
flgS Signal transduction histidine kinase  x 
flgR Sigma-54 associated transcriptional activator  x 
cadF Outer membrane fibronectin-binding protein  x 
capA Auto-transporter protein  x 
pebA1 Bi-functional adhesion/ABC transporter 
aspartate/ glutamate-binding protein 
x  
peb3 Major antigenic peptide PEB3  x 
peb4 Peptidyl-prolyl cis-trans isomerase  x 
pldA phospholipase A x  
jlpA Surface exposed lipoprotein  x 
ciaB Campylobacter invasion antigen B  x 
ciaC Campylobacter invasion antigen C  x 
ciaI Campylobacter invasion antigen I  x 
htrA Serine protease  x 
iamA ABC transporter ATP-binding protein  x 
fspA flagellum-secreted non flagellar protein  x 
cdtA Cytolethal distending toxin A  x 
cdtB Cytolethal distending toxin B  x 
cdtC Cytolethal distending toxin C  x 
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5.3.4 GWAS of isolates from caeca, ileum and liver 
We applied the GWAS methods successfully performed in Chapter 3 (100 strain 
collection) and in Chapter 4 (in vitro pathogenesis in section 4.3.12) to investigate the 
association of genomic markers with „organ / body compartment‟ in naturally infected 
chickens. 
Scoary was used to investigate association between isolates from the caeca, ileum and 
liver. Scoary linked 60 genes to isolates from the caeca, excluding 137 hypothetical 
proteins. Among the most trait-positive isolates were three tRNA ligases (leuS, argS 
and valS), an outer membrane protein (ompA) and a macrolide export protein (macB) 
(Table 5.1). All 60 genes were significantly associated to caecal isolates (Appendix 
Table 8.7).  
With isolates from the ileum, Scoary identified 41 genes linked with this site, excluding 
50 hypothetical proteins.  A wide variety of genes were found to be related to isolates 
from the ileum including a major exporter protein (chuA), an RNA polymerase subunit 
(rpoBC), an actin cross-linking toxin (vgrG1) and a tyrosine recombinase (xerH) (Table 
5.2). The genes vgrG, xerH, rpoB, chuA, fusA, rpsL and bcr were all found to be trait-
positive in 12 of the 14 isolates from the ileum. All 41 genes were significantly related 
to presence in the ileum (Appendix Table 8.8). 
Scoary found 178 genes linked to isolates extracted from the liver, excluding 173 
hypothetical proteins. Genes related to isolates from the liver included: a heat shock 
protein (hspR), a transporter protein (feoA), an arsenical resistance protein (asrB) and a 
ribosomal protein methyltransferase (prmA) (Table 5.3). The genes acpS, arsB and arsC 
were found to be trait-positive in 12 of the 14 isolates, all yielding a p number of 
0.013019. All 178 genes linked to the liver were found to be significant (Appendix 
Table 8.9). 
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Table 5.2. Top genes found to be related to caeca isolates with the highest trait positive 
scores. 
Gene Locus Tag Annotation C. 
jejun
i or 
C. 
coli 
gene 
Trait 
Positiv
e 
Isolate
s 
p Value 
leuS Cj1091c Leucine tRNA ligase C. 
jejun
i 
11 0.00869 
argS Cj1175c Arginine tRNA ligase C. 
jejun
i 
11 0.017179 
macB ATE51_RS0
5905 
Macrolide export protein MacB C. 
coli 
11 0.037322 
gatA Cj1059c Glutamyl-tRNA(Gln) 
amidotransferase subunit A 
C. 
jejun
i 
11 0.040346 
ompA Cj0599 Outer membrane protein A C. 
jejun
i 
8 0.032929 
pseC Cj1294 UDP-4-amino-4,6-dideoxy-N-
acetyl-beta-L-altrosamine 
transaminase 
C. 
jejun
i 
7 0.04234 
valS Cj0775c Valine tRNA ligase C. 
jejun
i 
5 0.012217 
kefC Cj1231 Glutathione-regulated potassium-
efflux system protein KefC 
C. 
jejun
i 
5 0.012217 
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Table 5.3. Top genes found to be related to ileum isolates with the highest trait positive 
scores 
Gene Locus Tag Annotation C. 
jejuni 
or C. 
coli 
gene 
Trait 
Positive 
Isolates 
p Value 
vgrG1 ATE51_RS07040 Actin cross-linking toxin VgrG1 C. 
coli 
12 0.006097 
xerD Cj0863c Tyrosine recombinase XerH C. 
jejuni 
12 0.013019 
rpoB Cj0478 Bifunctional DNA-directed RNA 
polymerase subunit beta-beta' 
C. 
jejuni 
12 0.033572 
fusA Cj0493 Elongation factor G C. 
jejuni 
12 0.033572 
rpsL Cj0491 30S ribosomal protein S12 C. 
jejuni 
12 0.033572 
bcr ATE51_RS00200 Bicyclomycin resistance protein C. 
coli 
12 0.033572 
capA 
 
Cj0628 Lipoprotein C. 
jejuni 
11 0.037139 
chuA Cj1614 Outer membrance receptor C. 
jejuni 
11 0.037139 
rpmB Cj0450c 50S ribosomal protein L28 C. 
jejuni 
11 0.044913 
metF Cj1202 5,10-methylenetetrahydrofolate 
reductase 
C. 
jejuni 
10 0.031294 
 
Table 5.4. Top genes found to be related to liver isolates with the highest trait positive 
scores 
Gene Locus Tag Annotation C. jejuni 
or C. coli 
gene 
Trait 
Positive 
Isolates 
p value 
acpS Cj1409 Holo-[acyl-carrier-protein] 
synthase 
C. jejuni 12 0.013019 
arsB Cj1187c Arsenical-resistance protein Acr3 C. jejuni 12 0.013019 
arsC Cj0717 Glutaredoxin arsenate reductase C. jejuni 12 0.013019 
feoA Cj1397 Putative Fe(2 ) transport protein 
A 
C. jejuni 11 0.005736 
galE Cj1131c UDP-glucose 4-epimerase C. jejuni 11 0.044913 
prmA Cj1117c Ribosomal protein L11 
methyltransferase 
C. jejuni 10 0.031294 
purU Cj0790 Formyltetrahydrofolate 
deformylase 
C. jejuni 10 0.031294 
hspR Cj1230 Putative heat shock protein HspR C. jejuni 10 0.031294 
ribA Cj0996 GTP cyclohydrolase-2 C. jejuni 10 0.031294 
fabD Cj0116 Malonyl CoA-acyl carrier protein 
transacylase 
C. jejuni 10 0.031294 
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5.3.5 Invasive capability of Campylobacter strains isolated from different sections 
of the chicken gut and liver from naturally infected chickens 
Fourty two Campylobacter strains were used in total with 14 strains each from the 
caeca, ileum and liver. The invasive capability of these strains was measured using a 
gentamicin protection assay on two cell lines; one human (Caco-2) and one chicken 
(8E11) (Figure 5.3). The majority of Campylobacter strains (12/14 from caeca, 13/14 
from ileum and 14/14 from liver) could effectively invade both cell lines with a slight 
trend of higher invasion in the chicken 8E11 cells. However, there was no significant 
difference between the two cell lines (Figure 5.3a). 
Comparison of the strains isolated from the caeca and ileum found no significance 
between levels of invasion (Figure 5.3bc), however strains isolated from the liver 
demonstrated a higher invasive capability in the chicken 8E11 cells compared to the 
Caco-2 ones with a significant (p≤0.05) difference between the two groups. All liver 
isolates were able to invade into both cell lines (Figure 5.3d). 
Sub-group analysis of Campylobacter isolates from caeca, ileum or liver produced 
important significant differences (p<0.05) (Figure 5.3ef). In the chicken 8E11 cells,  the 
liver isolates had the highest overall invasive capability with significant differences seen 
when comparing the liver and caeca (p≤0.001) or liver and ileum (p≤0.001) (Figure 
5.1e). A similar pattern was observed in the human Caco-2 cells with strains isolated 
from the liver again demonstrating the highest overall invasion ability with a significant 
difference seen when comparing them to the caecal isolates (p≤0.01). There was no 
significant difference between strains from liver and ileum (Figure 5.3f).  
Further sub-group analysis of Campylobacter from caeca, ileum and liver from the same 
bird confirmed that invasion was less dependent on „bird‟ and more dependent on 
anatomical site within it (Figure 5.4) and the genes identified in the individual strains 
(Tables 5.2 - 5.4).  In the 8E11 cell line, there was a much greater level of invasion by 
the liver isolates compared to those from the caeca and ileum from the same birds 
(Figure 5.4a). One of the birds had strains of Campylobacter which displayed no 
invasion in the caeca and ileum, however; the strain isolated from the liver was very 
highly invasive, producing the joint highest invasive response recorded (Figure 5.4a).  
Invasion responses in Caco-2 cells displayed a similar pattern as in the 8E11 cells 
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except for isolates from one bird in which the strain isolated from the caeca produced 
the highest invasive response recorded. The strain from the liver was also high, whereas 
that from the ileum was much less invasive (Figure 5.4b). Another strain isolated from 
caeca was unable to invade into the Caco-2 cells; whereas, ones from the ileum and 
liver of the same bird produced very high invasive responses (Figure 5.4b). 
 
 
 
Figure 5.3. Gentamicin protection assay of 42 Campylobacter strains from caeca, ileum 
and liver in 8E11 and Caco-2 cells (a), with comparison of strains from the (b) caeca, 
(c), ileum and (d) liver in both cell lines, with the breakdown of invasive responses by 
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group in (e) 8E11 and (f) Caco-2. Results are also expressed as mean +/- SD of all 
strains measured. Differences were considered significant if p≤0.05. 
 
Figure 5.4. Gentamicin protection assay results with strains isolated from the same bird 
joined across each anatomical location (a) 8E11 and (b) Caco-2 cells. Individual results 
are presented in the table.  
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5.3.6 Analysis of the invasive capability of Campylobacter strains in vitro   
Gentamicin protection assays were used to measure the invasive capabilities of the six 
Campylobacter strains used during in vivo infection studies. The strains were added to 
three epithelail cell lines: the HT-29 and Caco-2 human lines and 8E11 chicken line. All 
strains were able to invade each cell line to a similar degree with 0.9-1.8% of original 
inocula of each of the six strains being invasive (Figure 5.5a), and no differences seen 
between the cell lines. L4, a strain isolated from the liver of a naturally infected chicken 
produced the largest invasion response in  the 8E11 and Caco-3 cell lines (Figure 5.5b), 
while a typed strain, CJ12662, was the least invasive. Each strain demonstrated 
consistent responses between cell lines, displaying a similar level of invasion in each 
(Figure 5.5b). Both strains isolated from the caeca, C8 and C15, had similar levels of 
invasion in all cell lines. No significance difference was found between cell lines or 
Campylobacter strain. All six strains were combined to infect the cells, which resulted 
in invasion rates of around 1.4-1.6% (Figure 5.5, grey points). 
 
Figure 5.5. Gentamicin protection assay performed on three cell lines, HT-29, 8E11 
and Caco-2 displaying overall invasive capability of the strains with invasion of all six 
strains combined included in grey  (a). The individual results are presented in the table  
through each cell line (b). Results are also expressed as mean +/- SD of all strains 
measured. Differences were considered significant if p≤0.05.  
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5.3.7 In vitro expression of pro-inflammatory cytokines in human and chicken cell 
lines  
RNA was isolated from human and chicken epithelial cells after being treated with the 
six Campylobacter strains for 24 hours. The cDNA generated from the total RNA was 
subsequently used for quantitative PCR to measure pro- and anti- inflammatory 
responses (including IL-8 as a marker for the pro- inflammatory response and IL-10 as 
the marker for the anti-inflammatory response).  Results of the pro-inflammatory 
response displayed slightly higher expression of IL-8/CXCLi2 compared to CXCLi1. 
However, there was no significant difference between expression of IL-8/CXCLi1/2 in 
each cell line (Figure 5.6a). C. jejuni strain CJ12662 caused the lowest overall level of 
expression in every cell line tested. In contrast,  L4, a strain isolated from the liver, 
caused the highest overall expression of IL-8, in the HT-29 and Caco-2, and CXCLi2 in 
the 8E11 cells (Figure 5.6b). C. jejuni strain CJ13126 produced the highest expression 
of CXCLi1 in the 8E11 cells (Figure 5.6b). The two strains isolated from the caeca of a 
chicken, C8 and C15, invoked similar patterns of expression in the cell lines with that in 
HT-29 and Caco-2, yielding almost identical results for each isolate. When the six 
strains were combined and used to infect the cells lines, the expression of IL-8 and 
CXCLi1/2 were observed to be higher than the average expression of the individual 
strains (Figure 5.6, grey points). 
 
Figure 5.6. Expression of IL-8 and CXCLi1/2 in the three cell lines tested; HT-29, 
8E11 and Caco-2 with all six strains combined seen in grey (a), Theindividual results 
are presented within the table (b). Results are also expressed as mean +/- SD of all 
strains measured. Differences were considered significant if p≤0.05. 
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5.3.8 In vitro expression of anti-inflammatory IL-10 in human and chicken cell 
lines  
Results for the anti-inflammatory marker IL-10 showed that there was no significant 
difference in its expression by different cell lines (Figure 5.7a). Similar to expression of 
IL-8; Campylobacter strain CJ12662 produced the lowest level of expression in all three 
cell lines, with the strain isolated from the liver of an infected chicken, L4, invoking the 
highest anti-inflammatory response in all lines (Figure 5.7b). Expression invoked by the 
two strains from caeca were similar, and greater than that invoked by the strain isolated 
from the ileum (Figure 5.7b). When six strains were used together to infect cells lines 
expression of IL-10 was observed to express at the average rate of expression of the 
individual strains (Figure 5.7, grey points). 
 
Figure 5.7. Expression of IL-10 in the three cell lines tested; HT-29, 8E11 and Caco-2 
with all six strains combined shown in grey(a). The individual results are presented in 
the table(b). Invasion with all six strains combined can be seen in grey. Results are also 
expressed as mean +/- SD of all strains measured. Differences were considered 
significant if p≤0.05. 
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5.3.9 Expression of immune biomarkers in caecal tonsils extracted from 
Campylobacter-infected chickens  
The in vivo chicken immune response to Campylobacter was measured in the caecal 
tonsils extracted at post-mortem (PM) of uninfected and infected birds. The two groups 
of chickens were kept in separate chicken houses and not moved (Figure 5.8). Cytokines 
responses measured included Th1/Th2 (Figure 5.8bce), Th17 (Figure 5.8h), Th22 (Figure 
5.8df) and cytokines involed in innate immunity (Figure 5.8ag). 
Cytokines involved in the Th1/Th2 pathway were found overall to increase significantly 
in birds infected with Campylobacter compared to uninfected ones (Figure 5.8 a-e). The 
pro-inflammatory cytokine, IL-8 (Figure 5.8a) and IL-10 (Figure 5.8b), an anti-
inflammatory effector cytokine of Th2 response, were significantly higher (p≤0.0001) in 
the infected birds. IL-18, a T h1 cytokine involved in cell-mediated immunity expressed 
significantly more IFNγ  in the infected birds compared to the uninfected ones 
(p≤0.000; Figure 5.8c). A measurement of TNFα, a Th22 cytokine involved in systemic 
inflammation in chickens, and IFNγ, a cytokine important to both the innate and 
adaptive immune response, secreted by Th1 cells, showed significantly higher 
expression in the infected birds compared to the controls (p≤0.000; Figure 5.8de).  
An early cytokine, which modulated activity and is involved in all Th responses, IL-6, 
was measured; with the uninfected group showing significantly (p≤0.0001) lower levels 
compared to the infected group (Figure 5.8f). Levels of IL-1β, a mediator of the 
inflammatory response and promoter of Th17, and IL-17, a pro-inflammatory cytokine 
secreted by Th17 cells were measured and were expressed significantly more in infected 
birds (p≤0.0001; Figure 5.8gh). 
The expression of the immune biomarkers was then compared to the Campylobacter 
counts of the caeca and ileum (Figure 5.9 and 5.10). Within the caeca of infected 
chickens there appeared to be no correlation between the number of Campylobacter and 
the expression of the Th1/Th2, Th17 and Th22 cytokines expressed from the caecal 
tonsils (Figure 5.9). Campylobacter counts from the ileum displayed a similar pattern 
with no significant correlation (p> 0.05)  seen between expression from the immune 
markers in the caecal tonsils to the number of Campylobacter in the ileum (Figure 
5.10).  
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Figure 5. 8 Expression of a variety of Th1/Th2, Th17 and Th22 (f,g,h) markers in caecal tonsils 
extracted from uninfected chicken, chickens that were infected and kept in chicken sheds and 
chickens who were infected and put through the industry production chain including being 
handled, transportation and gas/stun killed. Immune markers measured were (a) IL-8, (b) IL-10, 
(c) IL-18, (d) TNFα, (e) IFNγ, (f) IL-6, (g) IL-1β and (h) IL-17. Results are also expressed as 
mean +/- SD of all strains measured. Differences were considered significant if p≤0.05. 
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Figure 5.9. Correlations of Campylobacter counts in the caeca compared to expression 
of cytokines. Immune markers measured were (a) IL-8, (b) IL-10, (c) IL-18, (d) TNFα, 
(e) IFNγ, (f) IL-6, (g) IL-1β and (h) IL-17. Results are also expressed as mean +/- SD of 
all strains measured. Differences were considered significant if p≤0.05. 
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Figure 5.10. Correlations of Campylobacter counts in the ileum compared to expression 
of cytokines. Immune markers measured were (a) IL-8, (b) IL-10, (c) IL-18, (d) TNFα, 
(e) IFNγ, (f) IL-6, (g) IL-1β and (h) IL-17. Results are also expressed as mean +/- SD of 
all strains measured. Differences were considered significant if p≤0.05. 
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5.4 Discussion  
This chapter focuses on two sets of data, one set related to Campylobacter strains from 
naturally infected chickens. This set identifies genomic markers in Campylobacter 
associated with presence in the caeca, ileum or liver.  The second set of data relates to 
caecal tonsils extracted from experimentally infected chickens to measure host immune 
responses to assess potential immune biomarkers that define the Campylobacter 
infection response in chickens. 
Fourteen naturally infected birds had Campylobacter in the caeca, ileum and liver and 
these became a collection of 42 „bird-matched‟ strains and were used to investigate 
potential differences isolates from the caeca, ileum and liver genomically and 
phenotypically. A pan-genome of all 42 isolates was created but two (C20 and C26) 
were of a poor sequence quality and thus were omitted. The resultant pan-genome 
contained 10,446 genes, with a very small core genome of 226 genes and 10,217 
accessory ones. The small size of the core genome could be due to both C. jejuni and C. 
coli being present in the pan-genome, as previous studies have shown that no clear 
plateau of genome size occurs and more diverse isolates can cause some genes to be 
shared (Méric et al., 2014). Work by van Tonder et al., (2014) observed that the number 
of isolates can affect measured core genome size (van Tonder et al., 2014). Roary cut 
off of 95% for identity with blastp could also impact on the genome size and less 
stringent cut offs could alter the genome sizes (Page et al., 2015).  
The maximum likelihood tree constructed from the pan genome displayed no clear 
grouping of isolates from any particular birds which demonstrates the diversity of the 
dataset. However, ileum and liver isolates from birds 7 and 11 were shown to cluster 
tightly together which could indicate that they were able to persist in both 
environments. Analysis of the pan-genome identified only two known virulence genes, 
pebA1 and pldA, present in the core genome which could be due to its small size as 
discussed earlier. The two genes are both adhesion-linked genes with pebA1 being 
shown to be interact with epithelial cell since mutations in it causes a reduction in 
interactions with epithelial cells and reduction of colonisation (Pei et al., 1998). The 
gene, pldA, which encodes for a phospholipase could be very useful for Campylobacter 
as the protein aids the bacteria‟s ability to invade into chickens as pldA deficient 
mutants were found to invade and colonize chickens at an impaired rate (Ziprin et al., 
2001).  
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Scoary analysis was able to identity genes linked solely to the caeca, the ileum and the 
liver, with isolates from the liver found to have the most associated genes (178 genes).  
The caeca isolates were found to have 60 genes linked to this trait including, macA, a 
macrolide export protein which makes up part of the MacAB multi-drug efflux system. 
This is an important protein in pathogenicity and host interactions which detects 40% 
aerobiosis and secreted proteases, such as HtrA, which are more abundant at lower 
oxygen concentration (Guccione et al., 2017). This protein could help contribute to the 
survival of Campylobacter in the caeca and allow the bacteria to proliferate in the gut 
environment. Another gene found linked to caecal isolates was ompA, a multi-functional 
outer membrane protein which plays a role in Campylobacter pathogenesis and may 
play a role in the ability to invade and has been seen to be upregulated during in vivo 
growth (Rathbun and Thompson, 2009; Stintzi et al., 2005). 
Scoary identified 41 genes linked to isolates taken from the ileum including capA, an 
autotransporter protein which mediates association with epithelial cells and colonization 
of the chicken gut (Ashgar et al., 2007) . The liver isolates were found to have 178 
related genes, among which were two arsenic resistance genes, arsB and arsC, which 
could be related to arsenical compounds which have been used in the feed of poultry for 
pigmentation, growth promotion and weight gain and thus these genes may help 
survival in the blood of Campylobacter strains to leave the gut and enter the liver 
(Noormohamed and Fakhr, 2013). Another gene, feoA which encodes for an iron 
transporter  and has been found to have a major role in iron acquisition, gut colonisation 
and survival in the gut and blood and so may help survival and proliferation in the liver 
(Naikare et al., 2006). The genes related to liver isolates could make for potential PCR 
biomarkers in Campylobacter strains for invasiveness as isolates from the liver where 
also found to be the most invasive. 
The 42 Campylobacter strains from 14 birds which had Campylobacter in the caeca, 
ileum and liver were further investigated for virulence in an invasion assay on one 
human (Caco-2) and one chicken (8E11) cell line. In both cell lines, the Campylobacter 
strains isolated from the liver invaded the cells at a much higher rate compared to 
strains isolated from the caeca and the ileum in the 8E11 cells, this supports reported 
data that Campylobacter getting into the liver requires a high level of invasion (Jennings 
et al., 2011; Vaezirad et al., 2016; Williams et al., 2013). Three strains, one strain from 
the ileum and two from caeca, were unable to invade into either cell line. 
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Campylobacter has variable invasion potential into cells, and is dependent on strain 
type. For example, the reference strain of NCTC11168 can invade cells at low levels of 
1%, other strains have been shown to invade between 1 and 5% of the original 
population (Friis et al., 2009; Koolman et al., 2016). The choice of cell line can also 
have an impact on the invasion potential of a strain. Caco-2 cells were used during this 
experiment due to the vast number of studies using these cells when investigating the 
effect of infection with Campylobacter and for correlation from results obtained in  vivo 
(Fonseca et al., 2013; Friis et al., 2009; Hanel et al., 2004; Man et al., 2010). 
Of the 42 strains tested on the Caco-2 and 8E11 cells four were chosen to be used to 
infect chickens in the in vivo study (two strains from the caeca, one from the ileum and 
one from the liver).   In addition, two strains; CJ13126 and CJ12662, previously used 
for in vivo infection studies (Friis et al., 2005; Mills et al., 2012), were also chosen to be 
used alongside the four isolated strains to be used as a cocktail to infect chickens.  
These six strains were also subjected to in vitro analysis on three cell lines, two human 
cell lines (HT-29 and Caco-2) and one chicken cell line (8E11). Both, invasiveness into 
each cell line and the inflammatory response was measured. The individual ability of 
the six strains to invade each cell line was very consistent with 0.9-2% of original 
inocula shown to invade the cells (Figure 5.5) and no significant differences observed 
between the strains tested. These results are consistent with invasive responses observed 
by others who used several different strains (Friis et al., 2005; Mills et al., 2012). 
CJ12662 produced the lowest levels of invasion in all cell lines tested, despite being 
reported previously to be invasive (Humphrey et al., 2015). To investigate synergy, the 
six strains were combined and were able to invade effectively and cause expression of 
pro- and anti- inflammatory cytokines in all three cell lines with the level of invasion 
shown to be between 1.4-1.6%. Expression of IL-8/CXCli1/2 was observed to be higher 
than the average expression of the strains individually. No synergism between strains 
was observed however it would be interesting to speculate whether growth and invasion 
in all six strains remained consistent-this was not measured here.  
Analysis of pro- and anti- inflammatory responses in the human and chicken cells in 
response to the six strains in vitro yielded similar results across all three cell lines with 
the cells being able to elicit a response to each Campylobacter strain, with no significant 
differences between cell lines. Interestingly, the characterised Campylobacter strain, 
CJ12662, was observed to elicit the lowest response in each cell line and was also seen 
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to be the weakest invader into the cells. In contrast, the Campylobacter strain isolated 
from the liver of an infected chicken, L4, was the strongest invader into the cells and 
produced the highest expression of the IL-8/CXCLi1/CXCLi2 and IL-10.  These results  
support previous research, by other and within Chapter 4 that a higher pro-inflammatory 
response is linked to higher invasion rate (John et al., 2017; Larson et al., 2008). In 
addition, the fact that the Campylobacter strain with the highest response was from the 
liver of infected chickens gives weight to the hypothesis that Campylobacter must be 
highly invasive to leave the gut and enter the liver.  
The cocktail of these six strains was then used to infect chickens in vivo using a novel 
seeding method (Sandilands et al., 2018). The„infected‟ and „untreated‟ group of birds, 
were housed separately to minimise risk of cross-contamination with Campylobacter. 
RNA extracted was used to assess expression of the immune markers; IL-6, IL-8, IL-10, 
IL-1β, TNFα and IFNγ. Levels of all immune markers tested confirmed that „untreated‟ 
birds had significantly reduced expression compared to infected birds. Plating of gut 
contents from untreated birds confirmed the absence of Campylobacter.  
Overall, expression of the immune markers analysed in the infected birds was 
significantly higher than expression seen in the untreated birds. The pro-inflammatory 
cytokines IL-6 and IL-8 displayed a large expression in the infected group and this pro-
inflammatory response could help Campylobacter to take advantage of the host immune 
response and to move and invade outside of the caeca and ileum and move towards 
organs such as the liver (Humphrey et al., 2014). Other immune markers which could be 
used to help form a clearer picture in the future of the immune response include IL-22 
and IL-23 (Bereswill et al., 2016; Heimesaat et al., 2016). Other factors that may play a 
role in Campylobacter’s ability to proliferate in the gut of chickens may be down to the 
microbiota, where studies have found a change in microbiota can affect the ability of 
Campylobacter to grow and spread (Han et al., 2017). 
The uninfected birds were observed to produce small quantities of Th1, Th2, Th17 and 
Th22  cytokines suggesting that the birds are able to recognise and mount a response to 
commensal bacteria in the gut which supports work by Crhanova et al (2011) who 
showed expression of Th1, Th2 and Th17 in the caecum of noninfected chickens 
(Crhanova et al., 2011). These levels of expression observed could also be due to other 
bacteria such as Salmonella and Escherichia coli which have both been shown to induce 
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immune responses in chickens (Matulova et al., 2013; Sadeyen et al., 2014). Expression 
of cytokines such as IL-1, IL-10 and IL-18 has been observed in the caecal tonsils in 
response to  multiple Lactobacilli strains (Brisbin et al., 2010).   
The expression of immune markers from the caecal tonsils were then compared to 
Campylobacter counts from the caeca and ileum of the infected birds. The caeca tonsils 
lie between the caeca and the ileum and thus Campylobacter counts from these regions 
could be a good indicator of a correlation of Campylobacter effect in the gut. In both the 
caeca and the ileum there appeared to be no correlation between the amount of 
Campylobacter in the gut sections and the expression of biomarkers. The lack of 
correlation could mean that Campylobacter is only partly responsible for the expression 
patterns observed as Kers et al (2018) showed that there is a large diversity in chicken 
microbiota due to host related factors such as age and breed, as well as environment 
related factors such as housing, litter, feed access, climate and biosecurity and thus the 
immune responses shown could be in part  due to the microbiota and potentially 
Campylobacters effect on the microbiota (Kers et al., 2018).  
5.5 Conclusion 
This work helps to bridge the gap between results observed in vitro and in vivo, the 
cocktail of six strains used where able to effectively invade and produce immune 
responses in human and chicken epithelial cells while also being able  to adapt and 
survive within the infected birds with the host‟s immune response being up regulated in 
the infected birds.  GWAS analysis was able to find genes uniquelyassociated with 
Campylobacter strains found in the caeca, ileum and liver with strains from the liver 
found to be the most invasive in both cell lines. The caecal tonsils were able to provide 
insight into the important adaptive immune response in chickens. 
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Chapter 6 - Discussion  
 
6.1 Poultry Industry 
Campylobacter infections have been a cause for concern in the poultry industry for over 
40 years despite many interventions and control strategies being suggested to help 
combat the growing threat (Umaraw et al., 2017). These include preharvest 
interventions and postharvest interventions such as improved biosecurity on the farm 
and during processing, including rigorous cleaning regimes. Preharvest interventions are 
measures of preventing Campylobacter on the farm by reducing the environmental 
exposure with gumboots, overalls, double foot dips, hand sanitisers and changing room 
and increasing the poultry‟s host resistance to reduce Campylobacter in the gut through 
vaccination (Umaraw et al., 2017). 
Postharvest interventions include techniques such as improving hauling and 
transportation as faeces, feathers and skin are the main sources of contamination during 
transport, and logistic slaughter where Campylobacter positive flocks after negative 
flocks to avoid cross contamination (Umaraw et al., 2017). 
6.1.1 Broiler Chickens 
The modern broiler chicken has developed over the past 60 years with the chickens 
adaptability allowing it to be grown globally under a range of husbandry conditions 
(Siegel, 2014).  Most commercial broilers reach slaughter weight at around four to 
seven weeks, with some slower growing breeds reaching slaughter weight at a 
maximum of fourteen weeks (Bessei, 2006). Through selective breeding and feed 
efficiencies the weight of broiler chickens has steadily increased over time with the 
average body weight of broilers has increased from 1,400g in 1985 to 2,440g in 2010 
(Siegel, 2014). The young age of broiler chickens at slaughter contribute to behaviours 
and physiology of an immature bird which can lead to many issues ranging from 
welfare concerns to skeletal dysfunction and malformation (Bessei, 2006). The young 
age of broiler chickens can also lead to immunosuppression resulting in poor 
performance of the birds and increased bacterial infections and mortality which can be a 
large issue for the poultry industry and thus could increase a broiler‟s susceptibility to 
Campylobacter infections (Hoerr, 2010; Vaezirad et al., 2016).   
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6.1.2 Influence of Campylobacter on the poultry industry 
No single strain of Campylobacter can represent the entire population of the genus or 
species and this realisation of „such diversity‟ could lead to a change in design of future 
experiments and trials conducted with industry partnership. In past studies, one strain of 
Campylobacter has been used to infect chickens in vivo (Smith et al., 2008; Vaezirad et 
al., 2016), whereas it would be beneficial to infect chickens with a cocktail of strains 
that better defines the population or a given pathology to gain a better understanding of 
how Campylobacter pathogenesis in chickens progresses.  This may help mimic the 
natural infection that occurs in commercial systems in an in vivo experiment. Genomic 
analysis of isolates from naturally infected chickens in chapters 3 and 5 identified 
important genes that were found to be associated with chicken infection (chapter 3) and 
the caeca, ileum and liver (chapter 5) through GWAS analysis.  Genes identified, such 
as murG, ykkc, hcpA, macA could make for potential candidates for vaccines as they 
were found to be associated with strains from the gut.  There is currently no vaccine 
against Campylobacter despite research into potential vaccine targets. Work by Meunier 
et al (2017) assessed six potential vaccine antigens in Ross broiler chickens which 
required multiple injections into the birds and reduced Campylobacter loads by 2 to 4.2 
log10 CFU/g (Meunier et al., 2017). The requirement of multiple injections into birds 
would make this unfeasible to commercial chicken companies; however more research 
into these vaccine candidates could yield promising results in the future and the genes 
identified in this thesis may provide important targets. 
The in vitro analysis of the immune response of C. jejuni strains in human and chicken 
cell lines demonstrated that chicken cells can recognise and mount an immune response 
to Campylobacter and contributes to the knowledge obtained from previous studies 
showing that Campylobacter can act as a pathogen in the chicken host (Humphrey et al., 
2014; Jennings et al., 2011; Larson et al., 2008). These findings help to challenge the 
view that Campylobacter are commensals in broiler chickens and will further contribute 
to changes within the poultry industry leading to new interventions to increase welfare 
and try to combat Campylobacter levels within flocks.  
The use of signalling inhibitors (Chapter 4) demonstrated the importance of pro – 
(ERK) and anti- inflammatory (PI-3 Kinase-AKT) pathways for the invasiveness and C. 
jejuni induced production of IL-8 and IL-10. The larger responses of IL-10 in the 
chicken cells suggested that the chicken gut may be able to tolerate a larger dose of 
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Campylobacter which supports work by Humphrey et al (2014). Induction of a higher 
anti-inflammatory response in chickens could lead to the animals being able to tolerate 
larger doses of Campylobacter before showing signs of infection such as diarrhoea and 
hock marks (Byrne et al., 2007; Williams et al., 2013). Hock marks and pododermatitis 
are not currently used by the poultry industry as markers for Campylobacter but are 
used for signs of disease from other bacterial species or poor gut health. The use of 
ERK signalling inhibitors reduced C. jejuni invasion into the chicken cells which 
supports previous work (Hu et al., 2006b; Jin et al., 2003; Konkel et al., 2013; 
Samuelson and Konkel, 2013). This work could contribute to strategies to reduce 
Campylobacter numbers in chickens through the use of signalling inhibitors. However, 
the toxicity of inhibitors to the chickens and their effects on chicken meat would need to 
be further researched. 
Analysis of naturally infected chickens showed that Campylobacter isolated from the 
liver of infected chickens displayed the highest level of invasion into human and 
chicken cell lines which supports knowledge that Campylobacter reaching the liver 
requires a high level of invasion (Jennings et al., 2011; Vaezirad et al., 2016; Williams 
et al., 2013). The invasiveness of these strains in the liver could lead to more severe 
human infections from food products such as chicken liver pate and much work has 
linked Campylobacter infection to this food source (Lahti et al., 2017). However, more 
work would need to be investigated into rates of infection and Campylobacter found in 
chicken liver. High levels of Campylobacter in chicken liver may result in the poultry 
industry having to look at more preventative methods to halt the extra-intestinal spread 
of Campylobacter. 
Experimentally infected chickens displayed elevated levels of the pro-inflammatory 
cytokines IL-6 and IL-8 in infected versus uninfected birds.  Elevation of these 
cytokines could help Campylobacter to take advantage of the hosts immune response 
and ultimate leave the gut and move towards organs such as the liver (Humphrey et al., 
2014). The poultry industry could look to the betterment of chicken welfare to reduce 
pro-inflammatory responses and thus could reduce extra-intestinal spread.  
6.2 Campylobacter and public health 
Public Health England have reported a decrease in the number of human cases of 
Campylobacter infections from 2015 to 2016 by 3,316 cases with the highest number of 
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cases affecting people aged 50-59 years old (PHE, 2018). While the decrease in 
confirmed cases can be seen as a positive, the majority of Campylobacter cases go 
unreported and the number of confirmed cases is still larger than reported cases in 2007 
(PHE, 2018), while in August 2018, confirmed human cases were 5000 higher than over 
the same period in 2018. Thus Campylobacter is still  a major worldwide public health 
threat with evidence of a global increase in cases (Kaakoush et al., 2015). Analysis of 
the responses of C. jejuni strains in human and chicken epithelial cells, along with data 
from naturally and experimentally infected chickens showed that human cells may be 
more sensitive to Campylobacter than chicken ones, which supports previous studies 
(Humphrey et al., 2014). The ability of chickens to tolerate larger levels is of a concern 
to public health as a dose as low as 800 CFU of Campylobacter has resulted in 
diarrhoea, with a dose of 360 CFU causing development of campylobacteriosis in 
humans (Kaakoush et al., 2015).  
There is a need to combat human Campylobacter cases through better understanding of 
how Campylobacter interacts with chickens and survives in and on chicken tissues. The 
chicken cells studied were found to employ similar mechanisms in both human and 
chicken hosts. This finding could lead to new interventions on how to deal with 
Campylobacter in chickens using inhibitors of pathways in chicken feed which could 
block Campylobacter invading cells within the chicken and ultimately lead to a 
reduction of human cases through a reduction of Campylobacter numbers in chickens, 
however, a limitation would be to make sure the inhibitors are active in the gut of the 
chickens. Research into the effects of certain inhibitors on chicken health and growth 
would be essential to make sure there are no adverse effects on the welfare of the birds. 
6.3 Genomic Pipeline  
The genomic analysis throughout this thesis was conducted using the recently 
developed software Prokka (Seemann, 2014), Roary (Page et al., 2015), Scoary 
(Brynildsrud et al., 2016) and Gubbins (Croucher et al., 2015). These new pipelines can 
be used easily and efficiently to analyse large numbers of bacterial strains and produce 
clear pan-genomes and produce large amounts of data related to the genomes. Prokka 
and Roary have already been used to analyse Salmonella (Feasey et al., 2017; Petrovska 
et al., 2016),  Legionella (David et al., 2016b) and a number of other bacteria 
(Chewapreecha et al., 2017; Heinz et al., 2016). Scoary has been used to investigate 
Helicobacter (van Vliet, 2017) and Bacillus (Bazinet, 2017) with Gubbins  also being  
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used to measure the recombination in multiple organisms (De Been et al., 2015; Moura 
et al., 2016; Struve et al., 2015). The widespread use of these new genomic tools 
contributes to the reliability of the software with results being comparable to older and 
existing methods. 
There are currently many choices available for bioinformatics software such as Ridom, 
SeqSphere, BIGsdb, Geneious, Piggy, PGAdb and many others. Thus it can be difficult 
to know which software is the best for any particular work (Jolley and Maiden, 2010; 
Kearse et al., 2012a; Liu et al., 2016; Mellmann et al., 2011; Thorpe et al., 2018).  The 
major advantage of the recently developed software is that they are open source and 
therefore free to use; the freedom of availability and ease of their use mean that 
genomes and bacteria can now be analysed easily, quickly and cheaply, which is 
beneficial to all areas of bacterial bioinformatics. This has led to more researchers using 
genomics to understand more about bacterial populations and has expanded the 
knowledge available to the wider scientific community. 
The Roary pipeline developed in this thesis could be used for analysis of the microbiota 
in chickens and humans however this analysis would take time due to the high number 
of difference bacteria and sequences which would be extracted from the microbiota. 
Increasingly there has been a focus on the microbiota and the effect of interactions 
between this and Campylobacter (Han et al., 2017). Through WGS and the Roary 
pipeline the microbiota of healthy chickens and ones infected with Campylobacter 
could be analysed. The genomic differences in expression of certain genes in the 
bacteria found in the microbiota and from Campylobacter could shed light on 
interactions between the two. It is unclear whether Campylobacter has an effect on gut 
microbiota as there are conflicting studies (Connerton et al., 2018; Han et al., 2017). 
These conflicting results warrant further investigation. 
6.4 Genes Identified 
Genomic analysis in this thesis identified many genes, which could be of interest in the 
future. The genes pebA1 and pldA were found to be present in the core genome of the 
population of 100 C. jejuni isolates and that of Campylobacter from naturally infected 
chickens suggesting that these genes are fundamental for the survival of Campylobacter 
in different host environments. They are both adhesion-linked genes which play an 
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important role in invasion into host cells with deficient mutants invading at a reduced 
rate (Pei et al., 1998; Ziprin et al., 2001). 
GWAS analysis of Campylobacter isolates in this thesis resulted in genes found to be 
associated with the caeca, ileum and liver of the chicken gut or with specific hosts. 
Campylobacter isolates from chicken sources were significantly more likely to have the 
multidrug resistance gene ykkC, the regulatory one, ntrC and one for a transferase, 
murG.. These genes could provide the basis of a diagnostic test to identify if a human 
Campylobacter case came from chickens or a different source based on gene 
expression. Using the GWAS results from isolates taken from the caeca, ileum and liver 
could also help to identify Campylobacter isolates that remain in the gut and ones, 
which could be more invasive and leave that environment to infect edible tissues.  
Genes such as acpS or hyaD, which encode for a holo-[acyl-carrier-protein] synthase in 
C. jejuni and a hyaluronan synthase in C. coli, respectively, were found to be associated 
with strains found in the liver and could be used to identify isolates which have the 
ability to invade outside the gut and could potentially cause more damage to the chicken 
host, however there has been little work into the function of these genes and their 
relationship to invasiveness and virulence in the host. 
Comparison of GWAS of potential markers during in vitro pathogenesis and in vivo 
markers in the caeca, ileum and liver unfortunately did not yield a high overlap of genes 
with prmA, being the only gene to be found present in both analysis. This is almost 
certainly due to the Campylobacter strains coming from two very different populations. 
The gene prmA,  which encodes a ribosomal protein methytransferase was found to be 
associated with intermediate level of expression of IL-8/CXCLi1/2 and the ileum of 
naturally infected birds. However, there has not been considerable research into the 
function of this gene in relation to the ability of Campylobacter to invade and infect 
chickens. While there was only one gene overlap in the GWAS results there where two 
families of genes which overlapped. The gene arsB was found to be related to high level 
of invasion into eptihelial cells, whereas the gene arsC was found related to strains 
found in the liver. Both genes relate to a family of genes responsible for arsenic 
resistance in C. jejuni and C. coli which have been found to be present in retail meats in 
very large numbers and so may help survival (Noormohamed and Fakhr, 2013). 
Another family of genes found in both data sets were the rib family. ribA was found 
associated with the liver, whereas ribN was associated with low expression of IL-10. 
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These genes are related to riboflavin and have been found to be associated with ferric 
reduction and iron acquisition by C. jejuni which could help survival within the blood. 
Riboflavin has been found to be a virulence factor in Pseudogymnoascus destructans 
infections as high concentrations were found to be cytotoxic and can enable invasive 
infections (Crossley et al., 2007; Flieger et al., 2016). These genes may cause a similar 
pattern in C. jejuni infections. A high number of metabolic genes were found to be 
associated with each trait analysed and could suggest that survival and ability of 
Campylobacter to adapt to its surroundings play a large role in virulence. 
6.5 New chicken cell in vitro model 
The MM-ChiC clone 8E11 chicken intestinal cell lines were used to investigate how 
Campylobacter interacts with chicken hosts with phenotypic outputs of immune 
markers, toxicity, adhesion and invasion. There are no widespread or widely used  in 
vitro models for chicken systems with most work with Campylobacter using human 
derived cell lines such as T84 (Zheng et al., 2008), INT407 (Borrmann et al., 2007), 
HT-29 (Bahrami et al., 2011) and Caco-2 (Man et al., 2010). The lack of a widely used 
chicken model could lead to large gaps in understanding how Campylobacter behaves 
in different host environments and so the use of the MM-ChiC clone 8E11 chicken 
intestinal cell line is a potential candidate for a chicken cell model. The 8E11 cells are 
derived from leghorn chickens and were confirmed to be chicken „species‟ through 
investigating the expression of chicken MHC in the cells. The 8E11 cells are a robust 
and easily cultured cell line with the cells having a high growth rate and thus can be 
used frequently without the need for long incubation times to wait for growth. 
Campylobacter was shown to be able to invade and induce cytokine expression in the 
cell line with results being comparable to human cells and previously reported work  
(Bahrami et al., 2011; Larson et al., 2008; Li et al., 2011). Sequencing of the cells found 
a small amount of quail DNA within the cells, however work throughout this thesis 
showing the cells express chicken specific MHCs and chickens TLRs along with work 
by Shiina et al (2004) who found that quail and chickens have different MHCs led us to 
confidently call the MM-ChiC clone 8E11 cells chicken intestinal cells (Shiina et al., 
2004). 
Further work is still needed to fully develop this potential chicken cell model through 
many different techniques. Analysing the morphology with scanning electron 
microscopy (SEM) to see if the cells behave in a similar fashion to chicken gut 
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epithelial cells along with analysis of cell behaviour with co-culture of leukocytes, 
which can yield insight in how the epithelial cells are able to interact with the wider 
immune system. Investigating the TLR profiles of the cells to demonstrate whether they 
possess chicken specific TLRs-this work has started (Discussion chapter 4).  Further 
understanding of their „epithelial-like‟ properties will also be essential (e.g formation of 
tight junctions).  In addition the group is also investigating the potential of 3D cell 
culture to grow the cells in an artificially created environment that mimics that of the 
intestine (Edmondson et al., 2014). 
6.6 Caecal Tonsils 
The caecal tonsils represent the largest lymphoid organs of the chicken GALT and thus 
play a significant role in inducing and regulating immune responses in the chicken 
system. The caecal tonsils are a valuable site in the chicken as extraction of RNA from 
them allows a wealth of data to be analysed through gene expression which has already 
been investigated with Salmonella (Sadeyen et al., 2004). The caecal tonsils provide 
information on how the chicken adaptive immune system is activated in response to 
infection. Many pro- and anti- inflammatory markers were analysed to gain an overview 
of the immune response which helped support the idea of Campylobacter taking 
advantage of the host immune response to move and invade from the caeca and ileum, 
which supports earlier work (Humphrey et al., 2014). A drawback to using caecal 
tonsils is that they give cytokine levels at a local lymph node but not from the gut 
epithelium or extra-intestinal organs such as the muscle or more specifically the liver. 
To gain a better understanding of immune responses to infection caecal tonsils should 
be analysed in conjunction with „local biopsy tissues‟ of chickens and Campylobacter 
counts in different areas of chicken gut, immune responses in different gut tissues and 
other organs to gain a more complete view of infection. While this was not possible 
here the responses assayed in the caecal tonsils warrant future studies where more 
samples will be collected.  
6.7 Methods 
The major experimental methods used include the bioinformatics analysis of 
Campylobacter isolates, qPCR of immune responses, invasion assays along with 
experiments involving growth, biofilm, motility, cell viability and in vivo infection of 
chickens. Due to lack of available and inexpensive ELISA kits for chickens no 
comparison could be made between expressions of proteins such as IL-8 which can be 
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done easily for human systems. Western blots are a potential experimental method to 
compare protein expression from both humans and chickens. However, it is difficult to 
gain precise quantification of protein for comparison with western blots and so qPCR to 
analyse gene expression was used to provide the most accurate method to compare the 
human and chicken systems. During the work described in chapter 5 the lab purchased a 
new PCR machine and worked progressed on the AriaMx Real-time PCR (Agilent, UK) 
compared to previous work with the BioRad iCycler (Biorad, UK). The analysis of the 
results differs from those gained during Chapter 4 analysed using the 2
-ΔΔ
Ct method 
against a housekeeping gene to form a relative expression level (Livak and Schmittgen, 
2001). The change in analysis was due to the availability of newer software and 
hardware. To make the results comparable; samples analysed in Chapter 4 were re-
analysed using the AriaMx Real-time PCR and the Pfaffl method. The results yielded 
comparable results from both methods and are thus reliable. The gentamicin protection 
assay was thought to be the best method for analysis of invasive potential of 
Campylobacter isolates due to a lack of alternative methods as well as being a technique 
widely used to investigate invasion (Friis et al., 2005; Konkel et al., 2013; Pfaffl, 2001; 
Russell and Blake, 1994). 
BIGsdb was originally used to generate MLST data and analysis for the C. jejuni 
population (Chapter 3). However; due to unforeseen circumstances alternative methods 
had to be pursued. The Roary pipeline was ultimately chosen for reasons discussed in 
section 6.3. 
6.8 Limitations 
A limitation during this thesis relates to the 8E11 chicken cells, the cell line was 
extracted from a leghorn chicken. Chickens used within the poultry industry for meat 
are broiler chickens and the two breeds behave differently (Williams et al., 2013) and so 
a cell line from a broiler chicken could potentially give rise to different immune 
responses and invasion rates. Another limitation during the caecal extraction 
experimental work (Chapter 5) was with caecal tonsils. They were stored in RNA later 
to preserve the tissue ready for RNA extraction after conclusion of the study. Some of 
the caecal tonsils could have been stored in formalin and so could have then been used 
in histological work to visualise and study the effect of Campylobacter on the tissues 
themselves.  
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6.9 Further Work 
This project opens up many potential avenues for further research. There have been 
many genes identified in this thesis though GWAS and gene by gene analysis, their 
function and effects on the host have to be established. One potential experiment would 
be to generate mutants of Campylobacter using either C. jejuni NCTC 11168 or M1 and 
then use these to infect both human and chicken cell lines to compare the effect of the 
loss of the function knockout in question. During chapter 3, a collection of 100 C. jejuni 
isolates were used to investigate the population, using the genomic pipeline, analysis of 
a much larger population of C. jejuni and C. coli could be undertaken to see if 
comparable results are shown from a much larger sample size. 
Developing the chicken cell model discussed in section 6.5 could also be a very useful 
experiment which could create a standardised model for in vitro analysis of the chicken 
system. Development of chicken specific ELISAs to accurately measure production of 
cytokines in chickens and so compare protein levels post infection in human and 
chicken systems. This project could be very time consuming and thus may not be 
feasible depending on resources and time to complete the method. In Chapter 4, 
signalling and endocytosis pathways were investigated using inhibitors to block 
downstream signalling molecules. The effect of TLR agonist and antagonists on the 
chicken cell lines could provide valuable insight into the signalling pathways in chicken 
systems and whether Campylobacter utilises specific TLRs to invade into cells. The use 
of TLR agonists and antagonists could also identify potential targets to reduce 
Campylobacter numbers in chickens through immunomodulatory approaches. 
Another avenue to pursue would be to undertake more experiments in vivo, extracting 
caecal tonsils from infected and uninfected chickens could then be used to understand 
physiological differences through histology and thus gain a clear idea of the impact 
Campylobacter has on the tissues of the chicken. Measurement of  more immune 
markers from the caecal tonsils could also be used to help form a clearer picture in the 
future of the immune responses include IL-22 and -23 (Bereswill et al., 2016; 
Heimesaat et al., 2016). Mutants created based on the GWAS and phenotypic studies 
from Chapters 3, 4 and 5 could be used to infect chickens in vivo to analyse the 
functional diffeences in these genes and whether they are important in Campylobacter 
invasion to the liver.  These studies may uncover markers which could be used for 
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diagnostic tests or chicken vaccines to help reduce the threat of Campylobacter in the 
poultry industry. 
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8. Appendix and Supplementary Data 
8.1 Optimisation of qPCR 
Studies in the HT-29 human intestinal cells informed our work in 8E11 chicken 
intestinal cells with regard to time points used. In addition, there is a relative paucity of 
ELISAs/antibodies available for chicken cytokines and thus transcriptional responses 
were used to compare human and chicken cells. 
To compare the transcriptional inflammatory responses of human and chicken gut 
epithelial cells, the 100 Campylobacter strains (Table 2.2) were used to infect HT-29, 
human intestinal epithelial cells and 8E11 chicken intestinal epithelial cells. Time point 
experiments suggested that 24 hours was the optimal for IL-8 responses and thus RNA 
was extracted from HT-29 and 8E11 at this time point. Three separate experiments were 
completed (n=3) and the RNA from the M1 infected samples used to optimise primers 
conditions.   
 
 
 
 
 
 
 
Figure 8.1 standard curves showing the efficiency of Real time primers used in this 
study for Human IL-8 and β-actin and Chicken IL-8 and β-actin. 
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Transcriptional analysis of the inflammatory response was determined by measuring 
RNA message for human IL-8, chicken IL-8-like 1, human β-Actin and chicken β-
Actin.  Primer efficiency was established by amplification of a dilution series of reverse 
transcribed total RNA isolated from human and chicken cells infected with the M1 
reference strain of Campylobacter (Figure 8.1). Primer efficiencies were 90.8% for the 
Human IL-8 primers; 99.49% for the Human β-Actin primers; 94.77% for the Chicken 
IL-8 Like 1 primers, 97.45% for the Chicken IL-8 like 2 primers and 96.37% efficiency 
for the Chicken β-actin primers. 
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Figure 8.2. The effect of incubation with gentamicin on Campylobacter in PBS after 6 
hours invasion with HT-29/Caco-2/8E11 cells 
 
 
Table 8.1: 25% Subgroup of isolates used during Motility, Invasion and Adhesion 
assays, showing the presence of flaA/B, cdtA and ciaB genes 
Isolate ST Source flaA/B cdtA ciaB 
CampsClin11 ST-45 human - + + 
CampsClin45 ST-45 human - + + 
CampsClin583 ST-45 human - + + 
CampsClin883 ST-21 human - + + 
cow518 ST-21 cattle + + + 
chickc45 ST-45 chicken + + + 
chick19 ST-21 chicken - + + 
chick50 ST-21 chicken - + + 
chick53 ST-21 chicken - + + 
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chick137 ST-257 chicken - + + 
chick2223 ST-45 chicken + + + 
cow3583 ST-42 cattle - + + 
cow618 ST-61 cattle + + + 
cow237 ST-206 cattle - + + 
cow270 ST-403 cattle - + + 
cow104 ST-21 cattle + + + 
cow3189 
 
cattle + + + 
cow3207 ST-45 cattle - + + 
chick1079 ST-573 chicken + + + 
chickd45 ST-45 chicken + + + 
CampsClin21 
 
human + + + 
OxClinb21 ST-45 human - + + 
OxClina45 ST-45 human + + + 
OxClinb45 ST-21 human - + + 
starling45 ST-45 starling + - + 
starling177 ST-177 starling + + + 
starling682 ST-682 starling - + + 
starling1020 ST-682 starling + + + 
goose1033 
ST-
1034 
goose - + + 
goose702 
 
goose + - - 
goose137 ST-45 goose + + + 
goose696 
  
- + + 
duck45 ST-45 duck  + + + 
 
 
 
Table 8.2. Six Strains used to infect chickens experimentally 
Strain Campylobacter species 
CJ13126 C. jejuni 
CJ12662 C. jejuni 
L4 C. coli 
I4 C. coli 
C8 C. coli 
C15 C. coli 
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Table 8.3. All genes related to human isolates identified with scoary 
Gene Annotation Trait 
positive 
Isolates 
p 
Number 
rppH RNA pyrophosphohydrolase 13 0.026217 
hemH Ferrochelatase 13 0.026217 
nlpA Lipoprotein 28 12 0.031127 
patA Peptidoglycan O-acetyltransferase 11 0.006454 
dsbL Thiol:disulfide interchange protein DsbL 11 0.024205 
clpA ATP-dependent Clp protease ATP-binding subunit 
ClpA 
11 0.024205 
proP Proline/betaine transporter 10 0.010203 
flgE Flagellar hook protein FlgE 8 0.005657 
fabG 3-oxoacyl-[acyl-carrier-protein] reductase FabG 8 0.021386 
aldA Lactaldehyde dehydrogenase 7 0.00667 
hddC D-glycero-alpha-D-manno-heptose 1-phosphate 
guanylyltransferase 
7 0.035565 
ugd UDP-glucose 6-dehydrogenase 6 0.023647 
mshA D-inositol-3-phosphate glycosyltransferase 6 0.032906 
proP Proline/betaine transporter 5 0.008465 
group_613 putative inner membrane transporter YicL 5 0.016809 
hisC Histidinol-phosphate aminotransferase 4 0.006454 
fliY L-cystine-binding protein FliY 3 0.021322 
dcuD Putative cryptic C4-dicarboxylate transporter 
DcuD 
2 0.026217 
group_1649 Colicin I receptor 2 0.026217 
dcuD Putative cryptic C4-dicarboxylate transporter 
DcuD 
2 0.026217 
pctC Methyl-accepting chemotaxis protein McpB 2 0.026217 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 0 0.019585 
 
 
Table 8.4. All genes related to chicken isolated identified with scoary 
Gene Annotation Trait positive Isolates p 
Number 
murG UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
40 0.015864 
flgR Sigma-54 associated transcriptional 
activator 
39 0.039786 
Cj1375 Multidrug efflux transporter 34 0.041552 
grpE Protein GrpE 32 0.000992 
ymfD Bacillibactin exporter 31 0.015862 
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feoB Ferrous iron transport protein B 29 0.000442 
appA Oligopeptide-binding protein AppA 27 0.000397 
group_35 Putative polysaccharide biosynthesis 
protein with aminopeptidase-like 
domain protein 
25 0.010515 
gloB Hydroxyacylglutathione hydrolase 23 0.000146 
torC Cytochrome c-type protein TorC 21 0.006902 
group_108 putative copper-importing P-type 
ATPase A 
18 0.010152 
group_543 Cystathionine beta-lyase 15 0.001326 
group_255 Ferrous iron transport protein B 13 0.000397 
group_1256 Oligopeptide-binding protein AppA 13 0.000397 
group_941 putative methyltransferase 13 0.005506 
group_2141 putative tautomerase 10 0.018056 
group_647 Bacillibactin exporter 10 0.049141 
group_1262 Major outer membrane protein 9 0.004334 
group_2007 Protein GrpE 8 0.000992 
group_40 Sensor protein KdpD 5 0.014972 
rfbC dTDP-4-dehydrorhamnose 3,5-
epimerase 
4 0.020262 
group_8 Potassium-transporting ATPase ATP-
binding subunit 
4 0.035766 
group_1998 Ubiquinone biosynthesis O-
methyltransferase 
4 0.035766 
group_1615 Flagellar hook protein FlgE 4 0.035766 
group_804 putative glycosyltransferase EpsJ 1 0.019899 
group_831 Anaerobic C4-dicarboxylate transporter 
DcuA 
1 0.03832 
hisC_2 Histidinol-phosphate aminotransferase 0 0.031687 
 
 
Table 8.5. All genes related to cattle isolates identified with scoary 
Gene Annotation Trait positive 
Isolates 
p Number 
flgD Basal-body rod modification protein FlgD 25 0.030579 
pyrC_1 Dihydroorotase 25 0.030579 
feoB Ferrous iron transport protein B 25 0.032227 
panB 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
24 0.000306 
phnU Putative 2-aminoethylphosphonate 
transport system permease protein PhnU 
24 0.002764 
dgkA Diacylglycerol kinase 24 0.005679 
panC Pantothenate synthetase 23 0.002187 
panD Aspartate 1-decarboxylase 23 0.002187 
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sbp Sulfate-binding protein 23 0.028673 
gloB Hydroxyacylglutathione hydrolase 23 0.049344 
yafP putative N-acetyltransferase YafP 22 0.002999 
potA Sulfate/thiosulfate import ATP-binding 
protein CysA 
22 0.006116 
hxuB Heme/hemopexin transporter protein 
HuxB 
22 0.006116 
group_1747 Beta-lactamase OXA-133 22 0.011435 
hisJ Putative hydrolase 22 0.011944 
fabD Malonyl CoA-acyl carrier protein 
transacylase 
22 0.019578 
torC Cytochrome c-type protein TorC 21 0.047026 
torZ Trimethylamine-N-oxide reductase 2 20 0.016152 
group_941 putative methyltransferase 18 0.017605 
ssa1 Serotype-specific antigen 1 18 0.018562 
porA Major outer membrane protein 17 0.004488 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 10 0.021465 
epsJ_2 putative glycosyltransferase EpsJ 9 0.044124 
aldA Lactaldehyde dehydrogenase 7 0.009065 
group_1011 GDP-L-fucose synthase 7 0.017522 
group_794 Inner membrane transport protein RhmT 7 0.040523 
group_831 Anaerobic C4-dicarboxylate transporter 
DcuA 
6 0.025047 
group_1670 Flagellar hook protein FlgE 5 0.016396 
group_1636 N-acylneuraminate cytidylyltransferase 5 0.016396 
group_303 GTPase Obg 5 0.035108 
group_169 Bifunctional protein Aas 4 0.019918 
group_2390 D-glycero-alpha-D-manno-heptose 1-
phosphate guanylyltransferase 
3 0.019578 
group_2259 putative metallo-hydrolase 3 0.019578 
lgrD Linear gramicidin synthase subunit D 3 0.019578 
ydiO putative BsuMI modification methylase 
subunit YdiO 
3 0.019578 
group_108 putative copper-importing P-type ATPase 
A 
1 0.000606 
group_791 Diacylglycerol kinase 1 0.005679 
group_1279 Major outer membrane protein 1 0.033251 
group_255 Ferrous iron transport protein B 0 0.008874 
group_461 CRISPR-associated endonuclease Cas1 0 0.030579 
cas9_2 CRISPR-associated endonuclease Cas9 0 0.030579 
 
Table 8.6. All genes related to wild bird isolates identified with scoary 
Gene Annotation Trait 
positive 
Isolates 
p Number 
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hrcA Heat-inducible transcription repressor 
HrcA 
9 0.002728 
hydA_3 Quinone-reactive Ni/Fe-hydrogenase 
small chain 
9 0.004608 
group_924 Sensor protein CpxA 8 0.009051 
group_464 DNA ligase 8 0.029978 
hddA D-glycero-alpha-D-manno-heptose 7-
phosphate kinase 
8 0.033468 
gmhA Phosphoheptose isomerase 8 0.036215 
yajR Inner membrane transport protein YajR 7 0.025536 
vhb Bacterial hemoglobin 7 0.025536 
fdoI Formate dehydrogenase, cytochrome 
b556(fdo) subunit 
7 0.025536 
lpxL Lipid A biosynthesis lauroyltransferase 7 0.04836 
legF_1 CMP-N,N'-diacetyllegionaminic acid 
synthase 
7 0.04836 
carB Carbamoyl-phosphate synthase large 
chain 
7 0.04836 
flaA Flagellin A 6 0.002712 
fliD Flagellar hook-associated protein 2 6 0.002712 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 6 0.003282 
group_791 Diacylglycerol kinase 6 0.004432 
yycB putative transporter YycB 6 0.006428 
tenI Thiazole tautomerase 6 0.006428 
murG UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
6 0.0202 
exsA Exoenzyme S synthesis regulatory protein 
ExsA 
6 0.030612 
proA Gamma-glutamyl phosphate reductase 5 4.93E-05 
ubiE Ubiquinone/menaquinone biosynthesis C-
methyltransferase UbiE 
5 0.000142 
mdaB Modulator of drug activity B 5 0.000235 
group_1420 putative histidine-binding protein 5 0.000589 
proB Glutamate 5-kinase 5 0.001494 
group_1919 Bacteriohemerythrin 5 0.00395 
flgD Basal-body rod modification protein FlgD 5 0.011567 
group_675 Polysialic acid transport protein KpsM 5 0.018378 
group_2171 Gamma-glutamyl phosphate reductase 4 4.93E-05 
ldh L-lactate dehydrogenase 4 5.56E-05 
pyrC_1 Dihydroorotase 4 0.001036 
group_1661 Basal-body rod modification protein FlgD 4 0.007737 
group_302 Glutamate 5-kinase 4 0.007737 
ompR Transcriptional regulatory protein OmpR 4 0.007896 
group_1600 Bacteriohemerythrin 4 0.010701 
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ubiG_1 Ubiquinone biosynthesis O-
methyltransferase 
4 0.018378 
kpsM Polysialic acid transport protein KpsM 4 0.02341 
citN Citrate transporter 4 0.036242 
group_2181 Modulator of drug activity B 3 0.000715 
group_1674 Dihydroorotase 3 0.000715 
group_1677 Thiazole tautomerase 3 0.002712 
group_200 Citrate transporter 3 0.002712 
dgkA Diacylglycerol kinase 3 0.004432 
group_1025 putative transporter YycB 3 0.006428 
group_1303 UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
3 0.006428 
sbp Sulfate-binding protein 3 0.007662 
group_1671 Bacteriohemerythrin 3 0.012183 
group_2170 Phosphoethanolamine transferase EptA 3 0.012183 
group_310 Trimethylamine-N-oxide reductase 2 3 0.030612 
group_1662 Beta-lactamase OXA-133 3 0.043478 
phnU Putative 2-aminoethylphosphonate 
transport system permease protein PhnU 
2 0.000815 
zraS_2 Sensor protein ZraS 2 0.001518 
panB 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
2 0.003453 
panC Pantothenate synthetase 2 0.004429 
panD Aspartate 1-decarboxylase 2 0.004429 
hisJ Putative hydrolase 2 0.004429 
group_1747 Beta-lactamase OXA-133 2 0.00562 
group_2175 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-
L-altrosamine N-acetyltransferase 
2 0.008989 
group_1684 D-glycero-alpha-D-manno-heptose 1-
phosphate guanylyltransferase 
2 0.008989 
group_2235 Lipid A biosynthesis lauroyltransferase 2 0.008989 
group_2224 Bacterial hemoglobin 2 0.008989 
group_2179 GDP-L-fucose synthase 2 0.008989 
torZ_1 Trimethylamine-N-oxide reductase 2 2 0.008989 
yafP putative N-acetyltransferase YafP 2 0.010829 
group_1933 UDP-4-amino-4,6-dideoxy-N-acetyl-beta-
L-altrosamine N-acetyltransferase 
2 0.025536 
group_2166 putative adenylyl-sulfate kinase 2 0.025536 
group_1685 dTDP-4-dehydrorhamnose 3,5-epimerase 2 0.025536 
group_326 Biopolymer transport protein ExbB 2 0.025536 
legF CMP-N,N'-diacetyllegionaminic acid 
synthase 
2 0.025536 
group_409 Thiosulfate dehydrogenase 2 0.025536 
potA Sulfate/thiosulfate import ATP-binding 1 0.000688 
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protein CysA 
cpxA Sensor protein CpxA 1 0.003831 
ligA_2 DNA ligase 1 0.014107 
lagD Lactococcin-G-processing and transport 
ATP-binding protein LagD 
1 0.031524 
 
Table 8.7. All genes related to the caeca isolates identified with scoary 
Gene Annotation Trait 
Positive 
isolates 
p 
Number 
nrfH Cytochrome c-type protein NrfH 4 0.004012 
pglJ_1 N-acetylgalactosamine-N,N'-
diacetylbacillosaminyl-diphospho-
undecaprenol 4-alpha-N-
acetylgalactosaminyltransferase 
4 0.016851 
tilS tRNA(Ile)-lysidine synthase 4 0.04234 
putA_2 Bifunctional protein PutA 4 0.04234 
pbpG Penicillin-binding protein 2D 4 0.04234 
glcC Glc operon transcriptional activator 4 0.04234 
ifcA Fumarate reductase flavoprotein subunit 4 0.04234 
feoA Putative Fe(2 ) transport protein A 4 0.04234 
hhaIM Modification methylase HhaI 4 0.04234 
soj_1 Chromosome-partitioning ATPase Soj 4 0.04234 
yafQ mRNA interferase YafQ 4 0.04234 
epsJ_1 putative glycosyltransferase EpsJ 4 0.04234 
kdsD Arabinose 5-phosphate isomerase KdsD 4 0.04234 
proP_4 Proline/betaine transporter 4 0.04234 
fhaB_3 Filamentous hemagglutinin 4 0.04234 
fcf2 dTDP-fucopyranose mutase 4 0.04234 
intA_2 Prophage integrase IntA 4 0.04234 
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mqnA_1 Chorismate dehydratase 4 0.04234 
polC_2 DNA polymerase III PolC-type 4 0.04234 
relG Toxin RelG 4 0.04234 
dinB DNA polymerase IV 4 0.04234 
intA_1 Prophage integrase IntA 4 0.04234 
dpnA Modification methylase DpnIIB 4 0.04234 
yxeP putative hydrolase YxeP 4 0.04234 
rfbC dTDP-4-dehydrorhamnose 3,5-epimerase 4 0.04234 
kpsT Polysialic acid transport ATP-binding 
protein KpsT 
4 0.04234 
yneB Resolvase YneB 4 0.04234 
kpsM Polysialic acid transport protein KpsM 4 0.04234 
lexA LexA repressor 4 0.04234 
bcs1 Bifunctional ribulose 5-phosphate 
reductase/CDP-ribitol pyrophosphorylase 
Bcs1 
4 0.04234 
fcl GDP-L-fucose synthase 4 0.04234 
nrfA Cytochrome c-552 3 0.018054 
cymR HTH-type transcriptional regulator CymR 3 0.018054 
gltB_6 Glutamate synthase [NADPH] large chain 3 0.018054 
feoA Putative Fe(2 ) transport protein A 2 0.013814 
group_10282 tRNA-Val(tac) 2 0.013814 
msrP Protein-methionine-sulfoxide reductase 
catalytic subunit MsrP 
2 0.037489 
uvrB UvrABC system protein B 0 0.00869 
kdpA_1 Potassium-transporting ATPase potassium-
binding subunit 
0 0.017179 
fic Adenosine monophosphate-protein 0 0.037322 
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transferase SoFic 
katA Catalase 0 0.037322 
tmk_1 Thymidylate kinase 0 0.040346 
blc Outer membrane lipoprotein Blc 0 0.040346 
mshA D-inositol-3-phosphate glycosyltransferase 0 0.040346 
epsJ_5 putative glycosyltransferase EpsJ 0 0.040346 
prkC Serine/threonine-protein kinase PrkC 0 0.040346 
epsJ_2 putative glycosyltransferase EpsJ 0 0.040346 
ubiG_1 Ubiquinone biosynthesis O-
methyltransferase 
0 0.040346 
 
Table 8.8. All genes related to the ileum isolates identified with scoary 
Gene Annotation Trait 
Positive 
isolates 
p Number 
metE 5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase 
10 0.031294 
metQ_1 Membrane lipoprotein TpN32 10 0.031294 
selB Selenocysteine-specific elongation factor 10 0.040742 
folD Bifunctional protein FolD protein 10 0.040742 
paeR7IM Type IIS restriction enzyme Eco57I 8 0.032662 
infC Translation initiation factor IF-3 2 0.037139 
ubiG_1 Ubiquinone biosynthesis O-methyltransferase 2 0.037139 
uvrB UvrABC system protein B 2 0.037139 
mdh Malate dehydrogenase 2 0.044913 
group_4752 N-carbamoyl-D-amino acid hydrolase 2 0.044913 
fieF Ferrous-iron efflux pump FieF 2 0.044913 
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rsxB Electron transport complex subunit RsxB 2 0.044913 
leuC 3-isopropylmalate dehydratase large subunit 2 0.044913 
leuA 2-isopropylmalate synthase 2 0.044913 
cdtB Cytolethal distending toxin subunit B 2 0.044913 
era GTPase Era 2 0.044913 
aguA Agmatine deiminase 2 0.044913 
ybiT putative ABC transporter ATP-binding 
protein YbiT 
1 0.028571 
aroC Chorismate synthase 1 0.028571 
rpsL 30S ribosomal protein S12 1 0.033572 
tmk_2 Thymidylate kinase 1 0.033572 
fusA Elongation factor G 1 0.033572 
pchF_2 4-cresol dehydrogenase [hydroxylating] 
flavoprotein subunit 
1 0.033572 
uxaA_1 Altronate dehydratase 1 0.033572 
uxaA_2 Altronate dehydratase 1 0.033572 
rhaM L-rhamnose mutarotase 1 0.033572 
bcr Bicyclomycin resistance protein 1 0.033572 
dapA_2 4-hydroxy-tetrahydrodipicolinate synthase 1 0.033572 
panC Pantothenate synthetase 0 0.035204 
 
Table 8.9. All genes related to the liver isolates identified with scoary 
Gene Annotation Trait Positive 
isolates 
p Number 
valS Valine--tRNA ligase 10 0.031294 
mprA_2 Response regulator MprA 9 0.034523 
infA Translation initiation factor IF-1 8 0.00214 
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rhaM L-rhamnose mutarotase 8 0.007889 
dapA_2 4-hydroxy-tetrahydrodipicolinate synthase 8 0.007889 
pchF_2 4-cresol dehydrogenase [hydroxylating] 
flavoprotein subunit 
8 0.007889 
uxaA_2 Altronate dehydratase 8 0.007889 
uxaA_1 Altronate dehydratase 8 0.007889 
gatA Glutamyl-tRNA(Gln) amidotransferase 
subunit A 
8 0.032662 
epsN Putative pyridoxal phosphate-dependent 
aminotransferase EpsN 
7 0.007706 
ped (S)-1-Phenylethanol dehydrogenase 7 0.022056 
fucP L-fucose-proton symporter 7 0.022056 
aldA Lactaldehyde dehydrogenase 7 0.022056 
meh_2 Mesaconyl-C(4)-CoA hydratase 7 0.022056 
cysW Sulfate transport system permease protein 
CysW 
7 0.022056 
rhmT Inner membrane transport protein RhmT 7 0.022056 
infA Translation initiation factor IF-1 6 0.007706 
cysW Sulfate transport system permease protein 
CysW 
6 0.007706 
tcdA tRNA threonylcarbamoyladenosine 
dehydratase 
6 0.007706 
panC Pantothenate synthetase 6 0.009811 
epsN Putative pyridoxal phosphate-dependent 
aminotransferase EpsN 
6 0.022056 
panC Pantothenate synthetase 6 0.022056 
panD Aspartate 1-decarboxylase 6 0.022056 
surE 5'-nucleotidase SurE 6 0.022056 
rfbF Glucose-1-phosphate cytidylyltransferase 6 0.038591 
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hxuB_1 Heme/hemopexin transporter protein HuxB 6 0.038591 
group_4331 PGL/p-HBAD biosynthesis 
glycosyltransferase 
6 0.038591 
gspA General stress protein A 6 0.038591 
rfbG CDP-glucose 4,6-dehydratase 6 0.038591 
prk Phosphoribulokinase 6 0.038591 
pglH_2 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-
diNAcBac-PP-undecaprenol alpha-1,4-N-
acetyl-D-galactosaminyltransferase 
6 0.038591 
cdiA tRNA nuclease CdiA 6 0.038591 
hcpC_1 Putative beta-lactamase HcpC 6 0.038591 
colC_1 GDP-L-colitose synthase 6 0.038591 
yigZ IMPACT family member YigZ 6 0.038591 
colC_2 GDP-L-colitose synthase 6 0.038591 
yigZ IMPACT family member YigZ 5 0.013114 
glmU_2 Bifunctional protein GlmU 5 0.030207 
colD_1 GDP-4-keto-6-deoxy-D-mannose-3-
dehydratase / pyridoxamine-phosphate 
transaminase 
5 0.030207 
pgtP_2 Phosphoglycerate transporter protein 5 0.030207 
xerH_2 Tyrosine recombinase XerH 5 0.032662 
tcyP L-cystine uptake protein TcyP 4 0.008693 
group_6824 Non-canonical purine NTP pyrophosphatase 4 0.008693 
nuoN_2 NADH-quinone oxidoreductase subunit N 4 0.008693 
adk_2 Adenylate kinase 4 0.008693 
pta_2 Phosphate acetyltransferase 4 0.008693 
pcrA_2 ATP-dependent DNA helicase PcrA 4 0.008693 
uup_1 ABC transporter ATP-binding protein uup 4 0.034523 
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mco_2 Multicopper oxidase mco 4 0.034523 
alsT Amino-acid carrier protein AlsT 4 0.034523 
hspR_2 Putative heat shock protein HspR 4 0.034523 
mlaC putative phospholipid-binding protein MlaC 4 0.034523 
ttcA_2 tRNA 2-thiocytidine biosynthesis protein 
TtcA 
4 0.034523 
rsmI Ribosomal RNA small subunit 
methyltransferase I 
4 0.034523 
tarL Teichoic acid poly(ribitol-phosphate) 
polymerase 
4 0.034523 
cbpA_2 Curved DNA-binding protein 4 0.034523 
group_6190 Farnesyl diphosphate synthase 4 0.034523 
aspS_2 Aspartate--tRNA(Asp/Asn) ligase 4 0.034523 
tpf1 Antigen TpF1 4 0.034523 
ppiD_2 Peptidyl-prolyl cis-trans isomerase D 4 0.034523 
rpsA_3 30S ribosomal protein S1 4 0.034523 
miaB_2 tRNA-2-methylthio-N(6)-
dimethylallyladenosine synthase 
4 0.034523 
eno_2 Enolase 4 0.034523 
tdeA_2 Toxin and drug export protein A 4 0.034523 
argF_2 Ornithine carbamoyltransferase 4 0.034523 
thyX_1 Flavin-dependent thymidylate synthase 4 0.034523 
nuoI_2 NADH-quinone oxidoreductase subunit I 4 0.034523 
thyX_3 Flavin-dependent thymidylate synthase 4 0.034523 
slyD_2 FKBP-type peptidyl-prolyl cis-trans 
isomerase SlyD 
4 0.034523 
recJ_2 Single-stranded-DNA-specific exonuclease 
RecJ 
4 0.034523 
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fecE Iron(3 )-hydroxamate import ATP-binding 
protein FhuC 
4 0.034523 
rpsH_2 30S ribosomal protein S8 4 0.034523 
group_8113 tRNA-Phe(gaa) 3 0.031294 
fabZ_2 3-hydroxyacyl-[acyl-carrier-protein] 
dehydratase FabZ 
3 0.031294 
cfiB_2 2-oxoglutarate carboxylase small subunit 3 0.031294 
tupA_1 Tungstate-binding protein TupA 3 0.031294 
kpsD_2 Polysialic acid transport protein KpsD 3 0.031294 
cynT_2 Carbonic anhydrase 1 3 0.031294 
pabB_1 Aminodeoxychorismate synthase component 
1 
3 0.031294 
hisF_2 Imidazole glycerol phosphate synthase 
subunit HisF 
3 0.031294 
ddl_2 D-alanine--D-alanine ligase 3 0.031294 
rpsG_2 30S ribosomal protein S7 3 0.031294 
katA_2 Catalase 3 0.031294 
mkl putative ribonucleotide transport ATP-
binding protein mkl 
3 0.031294 
dnaN_3 DNA polymerase III subunit beta 3 0.031294 
pheT_2 Phenylalanine--tRNA ligase beta subunit 3 0.031294 
murG_2 UDP-N-acetylglucosamine--N-
acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
3 0.031294 
tolB_2 Protein TolB 3 0.031294 
colD_4 GDP-4-keto-6-deoxy-D-mannose-3-
dehydratase / pyridoxamine-phosphate 
transaminase 
3 0.031294 
mlaA_2 putative phospholipid-binding lipoprotein 3 0.031294 
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MlaA 
yqgF_2 Putative pre-16S rRNA nuclease 3 0.031294 
rpoZ_1 DNA-directed RNA polymerase subunit 
omega 
3 0.031294 
fbp_3 Fructose-1,6-bisphosphatase class 1 3 0.031294 
nth_3 Endonuclease III 3 0.031294 
hisA_2 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
3 0.031294 
rsh Bifunctional (p)ppGpp synthase/hydrolase 
RelA 
3 0.031294 
sfrA_2 NADPH-Fe(3 ) oxidoreductase subunit alpha 3 0.031294 
mdoB Phosphoglycerol transferase I 3 0.031294 
fliE Flagellar hook-basal body complex protein 
FliE 
3 0.031294 
ilvB Acetolactate synthase large subunit 3 0.031294 
serS_2 Serine--tRNA ligase 3 0.031294 
valS_1 Valine--tRNA ligase 3 0.031294 
ilvH_2 Acetolactate synthase isozyme 3 small 
subunit 
3 0.031294 
proC_2 Pyrroline-5-carboxylate reductase 3 0.031294 
pgtP_1 Phosphoglycerate transporter protein 3 0.031294 
cirA_5 Vitamin B12 transporter BtuB 3 0.031294 
pyrC_5 Dihydroorotase 3 0.031294 
argG_1 Argininosuccinate synthase 3 0.031294 
group_6108 Nitronate monooxygenase 3 0.031294 
nrdA_2 Ribonucleoside-diphosphate reductase 1 
subunit alpha 
3 0.031294 
ccoN1_2 Cbb3-type cytochrome c oxidase subunit 3 0.031294 
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CcoN1 
putP_2 High-affinity proline transporter PutP 3 0.031294 
rssA_2 Swarming motility regulation sensor protein 
RssA 
3 0.031294 
mlaE_2 putative phospholipid ABC transporter 
permease protein MlaE 
3 0.031294 
macB_5 Macrolide export ATP-binding/permease 
protein MacB 
3 0.031294 
pglE_2 UDP-N-acetylbacillosamine transaminase 3 0.031294 
accA_2 Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 
3 0.031294 
yycB_2 putative transporter YycB 3 0.031294 
hisH_2 Imidazole glycerol phosphate synthase 
subunit HisH 
3 0.031294 
pglF_2 UDP-N-acetyl-alpha-D-glucosamine C6 
dehydratase 
3 0.031294 
pyrB_2 Aspartate carbamoyltransferase 3 0.031294 
pglH_1 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-
diNAcBac-PP-undecaprenol alpha-1,4-N-
acetyl-D-galactosaminyltransferase 
3 0.031294 
groL_2 60 kDa chaperonin 3 0.031294 
gluP Rhomboid protease AarA 3 0.031294 
ruvA_2 Holliday junction ATP-dependent DNA 
helicase RuvA 
3 0.031294 
hprA Putative 2-hydroxyacid dehydrogenase 3 0.031294 
sat_2 Sulfate adenylyltransferase 3 0.031294 
mreB_1 Rod shape-determining protein MreB 3 0.031294 
rpoBC_5 Bifunctional DNA-directed RNA polymerase 
subunit beta-beta' 
3 0.031294 
groS_2 10 kDa chaperonin 3 0.031294 
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zupT_2 Zinc transporter ZupT 3 0.031294 
rplI_1 50S ribosomal protein L9 3 0.031294 
thiH_1 2-iminoacetate synthase 3 0.031294 
fabD_2 Malonyl CoA-acyl carrier protein 
transacylase 
3 0.031294 
lapB_2 Lipopolysaccharide assembly protein B 3 0.031294 
mprA_3 Response regulator MprA 3 0.031294 
rpsB_1 30S ribosomal protein S2 3 0.031294 
korA_1 2-oxoglutarate oxidoreductase subunit KorA 3 0.031294 
purB Adenylosuccinate lyase 3 0.031294 
luxS_2 S-ribosylhomocysteine lyase 3 0.031294 
nrdE Ribonucleoside-diphosphate reductase 
subunit alpha 
3 0.031294 
corA Cytochrome c biogenesis protein CcsA 3 0.031294 
hxcR putative type II secretion system protein 
HxcR 
3 0.031294 
galE UDP-glucose 4-epimerase 2 0.017283 
epsM Putative acetyltransferase EpsM 2 0.017283 
algC Phosphomannomutase/phosphoglucomutase 2 0.037139 
rsfS Ribosomal silencing factor RsfS 2 0.037139 
acpS Holo-[acyl-carrier-protein] synthase 2 0.037139 
kdpD_2 Sensor protein KdpD 2 0.044913 
hsdR_2 Type-1 restriction enzyme R protein 2 0.044913 
group_8163 putative type I restriction enzymeP M protein 2 0.044913 
artQ_2 Arginine transport system permease protein 
ArtQ 
1 0.013019 
hxlR_2 HTH-type transcriptional activator HxlR 1 0.028571 
tmk_2 Thymidylate kinase 1 0.028571 
203 
 
fabG_1 3-oxoacyl-[acyl-carrier-protein] reductase 
FabG 
1 0.028571 
gspA General stress protein A 1 0.028571 
xerC Tyrosine recombinase XerC 1 0.028571 
modA Molybdate-binding periplasmic protein 1 0.028571 
fdtA_2 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-
oxoisomerase 
1 0.028571 
rfbB dTDP-glucose 4,6-dehydratase 1 0.028571 
lexA_2 LexA repressor 1 0.028571 
kgtP_2 Alpha-ketoglutarate permease 1 0.033572 
fdtA_1 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-
oxoisomerase 
1 0.033572 
fadD3 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-
octahydro-1H-inden-4-yl]propanoyl:CoA 
ligase 
1 0.033572 
paeR7IM Type IIS restriction enzyme Eco57I 0 0.000937 
hepA Heterocyst differentiation ATP-binding 
protein HepA 
0 0.001375 
 
Table 8.10.  List of cytokines measured in Human cytokine antibody array. 
  1 2 3 4 5 6 7 8 
A Positive IL-1β IL-13 RANTES 
B Positive IL-2 IL-15 TGFβ 
C Negative IL-3 IL-16 TNFα 
D Negative IL-4 IL-7A TNFβ 
E 
Eotaxin-1 
(CCL11) 
IL-6 IP-10 TNF RI 
F 
Eotaxin-2 
(CCL24) 
IL-6R MCP-1 TNF RII 
G GCSF IL-7 MCP-2 PDGF-BB 
H GM-CSf IL-8 M-CSF TIMP-2 
I ICAM-1 IL-10 MIG Blank 
J IFNγ IL-11 MIP-1α Blank 
K I-309 IL-12 p40 MIP-1β Negative 
L IL-1α IL-12 p70 MIP-1δ Positive 
 
